<!DOCTYPE html>
<html xmlns="https://www.w3.org/1999/xhtml" class="fa-events-icons-failed gr__clinicaltrials_gov" lang="en">


<div id="main-content">

<div class="indent2">
        	<h1 class="solo_record">A Clinical Study to Evaluate the Safety
 and Efficacy of Elagolix in Subjects With Moderate to Severe 
Endometriosis-Associated Pain (ELARIS EM-I)</h1>

  <div class="row">
    <div class="column left">
      <div class="usa-alert usa-alert-warning" style="clear:both;margin:2ex 2em;">
        <table>
          <tbody><tr>
            <td style="width:5%">
              <img src="A%20Clinical%20Study%20to%20Evaluate%20the%20Safety%20and%20Efficacy%20of%20Elagolix%20in%20Subjects%20With%20Moderate%20to%20Severe%20Endometriosis-Associated%20Pain%20-%20Study%20Results%20-%20ClinicalTrials.gov_files/warning.png" style="width:1.3em;" alt="">
            </td>
            <td>
              The safety and scientific validity of this study is the 
responsibility of the study sponsor and investigators. Listing a study 
does not mean it has been evaluated by the U.S. Federal Government.
                            Read our <a href="https://clinicaltrials.gov/ct2/about-site/disclaimer">disclaimer</a> for details.
            </td>
          </tr>
        </tbody></table>
      </div>      </div> 
<!--
  <div style="float:right;margin-right:4em">ClinicalTrials.gov Identifier: NCT01620528</div>
-->
    <div class="column right">
  <table style="width:90%">
  <tbody><tr><td>ClinicalTrials.gov Identifier: NCT01620528</td>
  </tr>
  <tr><td>
      
       
              <div class="not-recruiting-status">
                        <span style="display:inline;" class="term" data-term="recruitment status" title="Show definition" tabindex="0">Recruitment Status <i class="fa fa-info-circle term" aria-hidden="true" data-term="recruitment status" style="border-bottom-style:none;" title="Show definition" tabindex="0"></i></span>: 
                    Completed
                  
                
  <div style="font-size:inherit">
  <span style="display:inline;" class="term" data-term="first posted" title="Show definition" tabindex="0">First Posted <i class="fa fa-info-circle term" aria-hidden="true" data-term="first posted" style="border-bottom-style:none;" title="Show definition" tabindex="0"></i></span>: June 15, 2012</div>
      <div style="font-size:inherit">
    <span style="display:inline;" class="term" data-term="results first posted" title="Show definition" tabindex="0">Results First Posted <i class="fa fa-info-circle term" aria-hidden="true" data-term="results first posted" style="border-bottom-style:none;" title="Show definition" tabindex="0"></i></span>: September 18, 2018</div>
    <div style="font-size:inherit">
  <span style="display:inline;" class="term" data-term="last update posted" title="Show definition" tabindex="0">Last Update Posted <i class="fa fa-info-circle term" aria-hidden="true" data-term="last update posted" style="border-bottom-style:none;" title="Show definition" tabindex="0"></i></span>: September 18, 2018</div>

  
      </div>
  </td>
  </tr>
  </tbody></table>
  </div>
  </div>


                <div class="info-title">Sponsor:</div>
                <div class="info-text" id="sponsor"> AbbVie (prior sponsor, Abbott) </div>

                              <div class="info-title">Information provided by (Responsible Party):</div>
                <div class="info-text" id="responsibleparty">AbbVie ( AbbVie (prior sponsor, Abbott) )</div>
              	</div>
<br>


<div id="tabs">
    <ul id="tab-links">
		<li id="full-text"><a href="https://clinicaltrials.gov/ct2/show/study/NCT01620528?sect=X01256">Study Details</a></li>
		<li id="tabular"><a href="https://clinicaltrials.gov/ct2/show/record/NCT01620528?sect=X01256">Tabular View</a></li>
  					<li id="results" class="current"> Study Results</li>
				<li id="disclaimer"><a title="Disclaimer - opens new window" href="https://clinicaltrials.gov/ct2/about-site/disclaimer" onclick="openNewWindow('/ct2/about-site/disclaimer'); return false">Disclaimer</a></li>
		<li id="howtoread"><a title="How to Read a Study Record - opens new window" href="https://clinicaltrials.gov/ct2/help/how-read-study" onclick="openNewWindow('/ct2/help/how-read-study'); return false">How to Read a Study Record</a></li>
    </ul>
</div>  <!--
<div style="background-color:#f6f6f6;margin-top:5.0ex;padding-bottom:1.5ex;"> </div>
-->

  <div id="tab-body">
  <div class="indent2" style="background-color:white;">
  <!-- Title section -->
  <div class="indent3" style="text-align:center;">
    
  
  <table class="data_table" style="margin:3ex 0;" width="80%" cellspacing="0" cellpadding="5" border="1">

        <tbody><tr>
      <th class="header3 pale_banner_color" style="text-align:right;white-space:nowrap;">Study Type: </th>
      <td class="body3" style="text-align:left;">Interventional</td>
    </tr>
    
        <tr>
      <th class="header3 pale_banner_color" style="text-align:right;white-space:nowrap;">Study Design: </th>
      <td class="body3" style="text-align:left;">Allocation:&nbsp;Randomized;
 &nbsp; Intervention&nbsp;Model:&nbsp;Parallel&nbsp;Assignment; &nbsp; 
Masking:&nbsp;Quadruple&nbsp;(Participant,&nbsp;Care&nbsp;Provider,&nbsp;Investigator,&nbsp;Outcomes&nbsp;Assessor);
 &nbsp; Primary&nbsp;Purpose:&nbsp;Treatment</td>
    </tr>
    
        <tr>
      <th class="header3 pale_banner_color" style="text-align:right;white-space:nowrap;">
         Condition:       </th>
      <td class="body3" style="text-align:left;white-space:nowrap;">
                Endometriosis<br>
              </td>
    </tr>
    
        <tr>
      <th class="header3 pale_banner_color" style="text-align:right;white-space:nowrap;">
        Interventions:       </th>
      <td class="body3" style="text-align:left;white-space:nowrap;">
                Drug: elagolix<br>
                Other: placebo<br>
              </td>
    </tr>
    
  </tbody></table>

  
  </div>
  
<!-- participant flow section -->
<div class="indent1">

  <br>
  <img src="A%20Clinical%20Study%20to%20Evaluate%20the%20Safety%20and%20Efficacy%20of%20Elagolix%20in%20Subjects%20With%20Moderate%20to%20Severe%20Endometriosis-Associated%20Pain%20-%20Study%20Results%20-%20ClinicalTrials.gov_files/triangle.gif" alt=""><span class="header2">&nbsp; Participant Flow</span>

  <a name="part" id="part"></a>
  <div class="header3 indent2">

        <div style="margin-top:1.0ex;">      
      <a title="Hide participant flow" href="https://clinicaltrials.gov/ct2/show/results/NCT01620528?sect=X1256#part">
        <img style="float:left" src="A%20Clinical%20Study%20to%20Evaluate%20the%20Safety%20and%20Efficacy%20of%20Elagolix%20in%20Subjects%20With%20Moderate%20to%20Severe%20Endometriosis-Associated%20Pain%20-%20Study%20Results%20-%20ClinicalTrials.gov_files/minus.gif" alt="" border="0"> &nbsp; Hide Participant Flow
      </a>
    </div>

    <br>
    <span class="header3">Recruitment Details</span>
    <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
      <tbody><tr>
        <th class="header3 bold_participant_color" style="text-align:left;">
          Key information relevant to the recruitment process for the
          overall study, such as dates of the recruitment period and locations
        </th>
      </tr>
      <tr>
        <td class="body3 pale_participant_color" style="vertical-align:top;">
                      After completing the Treatment Period, 
participants (who were eligible and provided consent) entered a separate
 continuous-use extension study (Study M12-667, NCT01760954).
                  </td>
      </tr>
    </tbody></table>

    <br>
    <span class="header3">Pre-Assignment Details</span>
    <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
      <tbody><tr>
        <th class="header3 bold_participant_color" style="text-align:left;">
          Significant events and approaches for the overall study
          following participant enrollment, but prior to group assignment
        </th>
      </tr>
      <tr>
        <td class="body3 pale_participant_color" style="vertical-align:top;">
                      Participants who prematurely discontinued from 
study drug and those who declined to participate in or who did not 
qualify for the continuous-use extension study, except for those who 
became pregnant, could elect to enter the Post-Treatment Follow-Up 
(PTFU) Period within this study for up to 12 additional months.
                  </td>
      </tr>
    </tbody></table>

    
    <br>
        
      
            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_participant_color">&nbsp;</th>
      <th class="header3 bold_participant_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_participant_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_participant_color" style="vertical-align:top;">
                          Placebo twice daily (BID) for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_participant_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_participant_color" style="vertical-align:top;">
                          Elagolix 150 mg once daily (QD) for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_participant_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_participant_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>

      <br>
              <span class="header3">Participant Flow for 2 periods<br><br></span>
      
                    
        <span class="header3">Period 1: &nbsp; Treatment Period</span>
        <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0">
          <tbody><tr>
                          <th class="brt bold_participant_color" style="max-width:50%">&nbsp;</th>
                                                      <th class="header3 brt bold_participant_color" style="max-width:20%; text-align:center;">
                              &nbsp; 
                Placebo
              </th>
                                          <th class="header3 brt bold_participant_color" style="max-width:20%; text-align:center;">
                              &nbsp; 
                Elagolix 150 mg QD
              </th>
                                          <th class="header3 brt bold_participant_color" style="max-width:20%; text-align:center;">
                              &nbsp; 
                Elagolix 200 mg BID
              </th>
                      </tr>
                
                
                          <tr>
                <th class="header3 brt bold_participant_color" style="text-align:left;">
                  STARTED&nbsp;                                  </th>
                                  <td class="header3 brt pale_participant_color" style="text-align:center;">
                    &nbsp;374&nbsp;                  </td>
                                  <td class="header3 brt pale_participant_color" style="text-align:center;">
                    &nbsp;249&nbsp;                  </td>
                                  <td class="header3 brt pale_participant_color" style="text-align:center;">
                    &nbsp;249&nbsp;<span class="note_participant_color"><sup>[1]&nbsp;</sup></span>                  </td>
                              </tr>
              
                            
                          <tr>
                <th class="header3 brt bold_participant_color" style="text-align:left;">
                  COMPLETED&nbsp;                                  </th>
                                  <td class="header3 brt pale_participant_color" style="text-align:center;">
                    &nbsp;274&nbsp;                  </td>
                                  <td class="header3 brt pale_participant_color" style="text-align:center;">
                    &nbsp;196&nbsp;                  </td>
                                  <td class="header3 brt pale_participant_color" style="text-align:center;">
                    &nbsp;183&nbsp;                  </td>
                              </tr>
              
                            
                          <tr>
                <th class="header3 brt bold_participant_color" style="text-align:left;">
                  NOT COMPLETED&nbsp;                                  </th>
                                                      <td class="header3 brt pale_participant_color" style="text-align:center;">
                      &nbsp;100&nbsp;                    </td>
                                      <td class="header3 brt pale_participant_color" style="text-align:center;">
                      &nbsp;53&nbsp;                    </td>
                                      <td class="header3 brt pale_participant_color" style="text-align:center;">
                      &nbsp;66&nbsp;                    </td>
                                                </tr>
                              <tr>
                  <td class="header3 br bold_participant_color" style="padding-left:2em;">
                    Did Not Receive Study Drug&nbsp;                                      </td>
                                                            <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 0&nbsp;                      </td>
                                          <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 0&nbsp;                      </td>
                                          <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 1&nbsp;                      </td>
                                                      </tr>
                              <tr>
                  <td class="header3 br bold_participant_color" style="padding-left:2em;">
                    Withdrawal by Subject&nbsp;                                      </td>
                                                            <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 35&nbsp;                      </td>
                                          <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 21&nbsp;                      </td>
                                          <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 16&nbsp;                      </td>
                                                      </tr>
                              <tr>
                  <td class="header3 br bold_participant_color" style="padding-left:2em;">
                    Adverse Event&nbsp;                                      </td>
                                                            <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 17&nbsp;                      </td>
                                          <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 13&nbsp;                      </td>
                                          <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 21&nbsp;                      </td>
                                                      </tr>
                              <tr>
                  <td class="header3 br bold_participant_color" style="padding-left:2em;">
                    Lost to Follow-up&nbsp;                                      </td>
                                                            <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 16&nbsp;                      </td>
                                          <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 8&nbsp;                      </td>
                                          <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 14&nbsp;                      </td>
                                                      </tr>
                              <tr>
                  <td class="header3 br bold_participant_color" style="padding-left:2em;">
                    Not Specified&nbsp;                                      </td>
                                                            <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 9&nbsp;                      </td>
                                          <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 5&nbsp;                      </td>
                                          <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 7&nbsp;                      </td>
                                                      </tr>
                              <tr>
                  <td class="header3 br bold_participant_color" style="padding-left:2em;">
                    Subject Noncompliant&nbsp;                                      </td>
                                                            <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 11&nbsp;                      </td>
                                          <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 2&nbsp;                      </td>
                                          <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 2&nbsp;                      </td>
                                                      </tr>
                              <tr>
                  <td class="header3 br bold_participant_color" style="padding-left:2em;">
                    Pregnancy&nbsp;                                      </td>
                                                            <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 7&nbsp;                      </td>
                                          <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 2&nbsp;                      </td>
                                          <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 2&nbsp;                      </td>
                                                      </tr>
                              <tr>
                  <td class="header3 br bold_participant_color" style="padding-left:2em;">
                    Surgery/Invasive Intervention&nbsp;                                      </td>
                                                            <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 5&nbsp;                      </td>
                                          <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 1&nbsp;                      </td>
                                          <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 3&nbsp;                      </td>
                                                      </tr>
                              <tr>
                  <td class="header3 br bold_participant_color" style="padding-left:2em;">
                    Exclusionary Medication Received&nbsp;                                      </td>
                                                            <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 0&nbsp;                      </td>
                                          <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 1&nbsp;                      </td>
                                          <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 0&nbsp;                      </td>
                                                      </tr>
                                            </tbody></table>
      
                  <div class="indent2" style="margin-top:1ex; margin-bottom:2ex">
            <table class="layout_table" cellspacing="0" cellpadding="0" border="0">
                              <tbody><tr style="vertical-align:top;">
                  <th class="header3 note_participant_color" style="padding-left:1em; text-align:left;"><sup>[1]</sup></th>
                  <td class="body3" style="padding-left:1em; padding-right:2em;">1 subject did not receive study drug</td>
                </tr>
                          </tbody></table>
          </div>
                <br>
        
                    
        <span class="header3">Period 2: &nbsp; Post-Treatment Follow-Up Period</span>
        <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0">
          <tbody><tr>
                          <th class="brt bold_participant_color" style="max-width:50%">&nbsp;</th>
                                                      <th class="header3 brt bold_participant_color" style="max-width:20%; text-align:center;">
                              &nbsp; 
                Placebo
              </th>
                                          <th class="header3 brt bold_participant_color" style="max-width:20%; text-align:center;">
                              &nbsp; 
                Elagolix 150 mg QD
              </th>
                                          <th class="header3 brt bold_participant_color" style="max-width:20%; text-align:center;">
                              &nbsp; 
                Elagolix 200 mg BID
              </th>
                      </tr>
                
                
                          <tr>
                <th class="header3 brt bold_participant_color" style="text-align:left;">
                  STARTED&nbsp;                                  </th>
                                  <td class="header3 brt pale_participant_color" style="text-align:center;">
                    &nbsp;68&nbsp;<span class="note_participant_color"><sup>[1]&nbsp;</sup></span>                  </td>
                                  <td class="header3 brt pale_participant_color" style="text-align:center;">
                    &nbsp;48&nbsp;<span class="note_participant_color"><sup>[1]&nbsp;</sup></span>                  </td>
                                  <td class="header3 brt pale_participant_color" style="text-align:center;">
                    &nbsp;51&nbsp;<span class="note_participant_color"><sup>[1]&nbsp;</sup></span>                  </td>
                              </tr>
              
                            
                          <tr>
                <th class="header3 brt bold_participant_color" style="text-align:left;">
                  Completed PTFU Month 6&nbsp;<span class="note_participant_color"><sup>[2]&nbsp;</sup></span>                                  </th>
                                  <td class="header3 brt pale_participant_color" style="text-align:center;">
                    &nbsp;46&nbsp;                  </td>
                                  <td class="header3 brt pale_participant_color" style="text-align:center;">
                    &nbsp;26&nbsp;<span class="note_participant_color"><sup>[3]&nbsp;</sup></span>                  </td>
                                  <td class="header3 brt pale_participant_color" style="text-align:center;">
                    &nbsp;18&nbsp;<span class="note_participant_color"><sup>[3]&nbsp;</sup></span>                  </td>
                              </tr>
              
                            
                          <tr>
                <th class="header3 brt bold_participant_color" style="text-align:left;">
                  Completed PTFU Month 12&nbsp;                                  </th>
                                  <td class="header3 brt pale_participant_color" style="text-align:center;">
                    &nbsp;2&nbsp;                  </td>
                                  <td class="header3 brt pale_participant_color" style="text-align:center;">
                    &nbsp;5&nbsp;                  </td>
                                  <td class="header3 brt pale_participant_color" style="text-align:center;">
                    &nbsp;19&nbsp;                  </td>
                              </tr>
              
                            
                          <tr>
                <th class="header3 brt bold_participant_color" style="text-align:left;">
                  COMPLETED&nbsp;                                  </th>
                                  <td class="header3 brt pale_participant_color" style="text-align:center;">
                    &nbsp;48&nbsp;                  </td>
                                  <td class="header3 brt pale_participant_color" style="text-align:center;">
                    &nbsp;31&nbsp;                  </td>
                                  <td class="header3 brt pale_participant_color" style="text-align:center;">
                    &nbsp;37&nbsp;                  </td>
                              </tr>
              
                            
                          <tr>
                <th class="header3 brt bold_participant_color" style="text-align:left;">
                  NOT COMPLETED&nbsp;                                  </th>
                                                      <td class="header3 brt pale_participant_color" style="text-align:center;">
                      &nbsp;20&nbsp;                    </td>
                                      <td class="header3 brt pale_participant_color" style="text-align:center;">
                      &nbsp;17&nbsp;                    </td>
                                      <td class="header3 brt pale_participant_color" style="text-align:center;">
                      &nbsp;14&nbsp;                    </td>
                                                </tr>
                              <tr>
                  <td class="header3 br bold_participant_color" style="padding-left:2em;">
                    Withdrawal by Subject&nbsp;                                      </td>
                                                            <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 3&nbsp;                      </td>
                                          <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 7&nbsp;                      </td>
                                          <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 3&nbsp;                      </td>
                                                      </tr>
                              <tr>
                  <td class="header3 br bold_participant_color" style="padding-left:2em;">
                    Lost to Follow-up&nbsp;                                      </td>
                                                            <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 3&nbsp;                      </td>
                                          <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 2&nbsp;                      </td>
                                          <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 4&nbsp;                      </td>
                                                      </tr>
                              <tr>
                  <td class="header3 br bold_participant_color" style="padding-left:2em;">
                    Exclusionary Medication Received&nbsp;                                      </td>
                                                            <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 0&nbsp;                      </td>
                                          <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 1&nbsp;                      </td>
                                          <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 1&nbsp;                      </td>
                                                      </tr>
                              <tr>
                  <td class="header3 br bold_participant_color" style="padding-left:2em;">
                    Surgery/Invasive Intervention&nbsp;                                      </td>
                                                            <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 8&nbsp;                      </td>
                                          <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 3&nbsp;                      </td>
                                          <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 4&nbsp;                      </td>
                                                      </tr>
                              <tr>
                  <td class="header3 br bold_participant_color" style="padding-left:2em;">
                    Not Specified&nbsp;                                      </td>
                                                            <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 6&nbsp;                      </td>
                                          <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 4&nbsp;                      </td>
                                          <td class="header3 br pale_participant_color" style="text-align:center;">
                        &nbsp; &nbsp; &nbsp; &nbsp;  &nbsp; &nbsp; &nbsp; 2&nbsp;                      </td>
                                                      </tr>
                                            </tbody></table>
      
                  <div class="indent2" style="margin-top:1ex; margin-bottom:2ex">
            <table class="layout_table" cellspacing="0" cellpadding="0" border="0">
                              <tbody><tr style="vertical-align:top;">
                  <th class="header3 note_participant_color" style="padding-left:1em; text-align:left;"><sup>[1]</sup></th>
                  <td class="body3" style="padding-left:1em; padding-right:2em;">elected to enter the PTFU Period</td>
                </tr>
                              <tr style="vertical-align:top;">
                  <th class="header3 note_participant_color" style="padding-left:1em; text-align:left;"><sup>[2]</sup></th>
                  <td class="body3" style="padding-left:1em; padding-right:2em;">Met criteria (reported post-treatment menses, met the DXA criteria, and had a PTFU Month 6 visit).</td>
                </tr>
                              <tr style="vertical-align:top;">
                  <th class="header3 note_participant_color" style="padding-left:1em; text-align:left;"><sup>[3]</sup></th>
                  <td class="body3" style="padding-left:1em; padding-right:2em;">Met criteria (reported a post-treatment menses, met the DXA criteria, and had a PTFU Month 6 visit).</td>
                </tr>
                          </tbody></table>
          </div>
                <br>
        
              </div>
</div>
  
<!-- baseline section -->
<br>
<div class="indent1">

  <br>
  <img src="A%20Clinical%20Study%20to%20Evaluate%20the%20Safety%20and%20Efficacy%20of%20Elagolix%20in%20Subjects%20With%20Moderate%20to%20Severe%20Endometriosis-Associated%20Pain%20-%20Study%20Results%20-%20ClinicalTrials.gov_files/triangle.gif" alt=""><span class="header2">&nbsp; Baseline Characteristics</span>

  <a name="base" id="base"></a>
  <div class="header3 indent2">

        <div style="margin-top:1.0ex;">
      <a title="Hide baseline characteristics" href="https://clinicaltrials.gov/ct2/show/results/NCT01620528?sect=X0256#base">
        <img style="float:left" src="A%20Clinical%20Study%20to%20Evaluate%20the%20Safety%20and%20Efficacy%20of%20Elagolix%20in%20Subjects%20With%20Moderate%20to%20Severe%20Endometriosis-Associated%20Pain%20-%20Study%20Results%20-%20ClinicalTrials.gov_files/minus.gif" alt="" border="0"> &nbsp; Hide Baseline Characteristics
      </a>
    </div>

    <br>
    <span class="header3">Population Description</span>
    <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
      <tbody><tr>
        <th class="header3 bold_baseline_color" style="text-align:left;">
          Explanation of how the number of participants for analysis was determined.
          Includes whether analysis was per protocol, intention to treat, or another method.
          Also provides relevant details such as imputation technique, as appropriate.
        </th>
      </tr>
      <tr>
        <td class="body3 pale_baseline_color" style="vertical-align:top;">
                      All participants who received at least 1 dose of study drug
                  </td>
      </tr>
    </tbody></table>

    <br>
    
            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_baseline_color">&nbsp;</th>
      <th class="header3 bold_baseline_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_baseline_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_baseline_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_baseline_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_baseline_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_baseline_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_baseline_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_baseline_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Total</th>
          <td class="body3 pale_baseline_color" style="vertical-align:top;">
                          Total of all reporting groups
                      </td>
        </tr>
      </tbody></table>
      
      <br>
            
          
          
    
      <span class="header3">Baseline Measures</span>
      <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0">
        <tbody><tr>
          <th class="brt bold_baseline_color" style="max-width:50%">&nbsp;</th>
                      <th class="header3 brt bold_baseline_color" style="max-width:20%;text-align:center;">
              &nbsp;Placebo&nbsp;
            </th>
                      <th class="header3 brt bold_baseline_color" style="max-width:20%;text-align:center;">
              &nbsp;Elagolix 150 mg QD&nbsp;
            </th>
                      <th class="header3 brt bold_baseline_color" style="max-width:20%;text-align:center;">
              &nbsp;Elagolix 200 mg BID&nbsp;
            </th>
                      <th class="header3 brt bold_baseline_color" style="max-width:20%;text-align:center;">
              &nbsp;Total&nbsp;
            </th>
                  </tr>
    
            
                      <tr>
              <th class="header3 brt bold_baseline_color" style="text-align:left;">
                Overall Participants Analyzed&nbsp;                <br><span class="body3">[Units:&nbsp;Participants]<br></span>               </th>
                              <td class="header3 brt pale_baseline_color" style="text-align:center;">
                                      &nbsp;374&nbsp;                                  </td>
                              <td class="header3 brt pale_baseline_color" style="text-align:center;">
                                      &nbsp;249&nbsp;                                  </td>
                              <td class="header3 brt pale_baseline_color" style="text-align:center;">
                                      &nbsp;248&nbsp;                                  </td>
                              <td class="header3 brt pale_baseline_color" style="text-align:center;">
                                      &nbsp;871&nbsp;                                  </td>
                          </tr>
            
              
                                    <tr>
                <td class="brt" colspan="1000" style="padding:2px 2px;">
              </td></tr>
                                  
                      <tr>
              <th class="header3 brt bold_baseline_color" style="text-align:left;">
                Age&nbsp;                <br><span class="body3">[Units:&nbsp;Years]<br>Mean (Standard Deviation)</span>               </th>
                              <td class="header3 brt pale_baseline_color" style="text-align:center;">
                                                            
&nbsp;31.7&nbsp;&nbsp;(6.35)&nbsp;                                      
                </td>
                              <td class="header3 brt pale_baseline_color" style="text-align:center;">
                                                            
&nbsp;31.5&nbsp;&nbsp;(5.99)&nbsp;                                      
                </td>
                              <td class="header3 brt pale_baseline_color" style="text-align:center;">
                                                            
&nbsp;31.2&nbsp;&nbsp;(6.33)&nbsp;                                      
                </td>
                              <td class="header3 brt pale_baseline_color" style="text-align:center;">
                                                            
&nbsp;31.5&nbsp;&nbsp;(6.24)&nbsp;                                      
                </td>
                          </tr>
            
              
                                    <tr>
                <td class="brt" colspan="1000" style="padding:2px 2px;">
              </td></tr>
                                  
                      <tr>
              <th class="header3 brt bold_baseline_color" style="text-align:left;">
                Sex: Female, Male&nbsp;                <br><span class="body3">[Units:&nbsp;Participants]<br>Count of Participants</span>               </th>
                                                <td class="brt pale_baseline_color">&nbsp;</td>
                                  <td class="brt pale_baseline_color">&nbsp;</td>
                                  <td class="brt pale_baseline_color">&nbsp;</td>
                                  <td class="brt pale_baseline_color">&nbsp;</td>
                                          </tr>
                          <tr>
                <td class="header3 br bold_baseline_color" style="padding-left:2em;">
                  Female&nbsp;                                  </td>
                                                      <td class="header3 br pale_baseline_color" style="text-align:center;">
                                              &nbsp; &nbsp; 374<span class="body3"> 100.0%</span>&nbsp;                                          </td>
                                      <td class="header3 br pale_baseline_color" style="text-align:center;">
                                              &nbsp; &nbsp; 249<span class="body3"> 100.0%</span>&nbsp;                                          </td>
                                      <td class="header3 br pale_baseline_color" style="text-align:center;">
                                              &nbsp; &nbsp; 248<span class="body3"> 100.0%</span>&nbsp;                                          </td>
                                      <td class="header3 br pale_baseline_color" style="text-align:center;">
                                              &nbsp; &nbsp; 871<span class="body3"> 100.0%</span>&nbsp;                                          </td>
                                                </tr>
                                        <tr>
                <td class="header3 br bold_baseline_color" style="padding-left:2em;">
                  Male&nbsp;                                  </td>
                                                      <td class="header3 br pale_baseline_color" style="text-align:center;">
                                              &nbsp; &nbsp; 0<span class="body3">   0.0%</span>&nbsp;                                          </td>
                                      <td class="header3 br pale_baseline_color" style="text-align:center;">
                                              &nbsp; &nbsp; 0<span class="body3">   0.0%</span>&nbsp;                                          </td>
                                      <td class="header3 br pale_baseline_color" style="text-align:center;">
                                              &nbsp; &nbsp; 0<span class="body3">   0.0%</span>&nbsp;                                          </td>
                                      <td class="header3 br pale_baseline_color" style="text-align:center;">
                                              &nbsp; &nbsp; 0<span class="body3">   0.0%</span>&nbsp;                                          </td>
                                                </tr>
                                        
                                    <tr>
                <td class="brt" colspan="1000" style="padding:2px 2px;">
              </td></tr>
                                    </tbody></table>
      
      
      
        </div>
</div>
  
<!-- outcome measures section -->
<br>
<div class="indent1">

  <br>
  <img src="A%20Clinical%20Study%20to%20Evaluate%20the%20Safety%20and%20Efficacy%20of%20Elagolix%20in%20Subjects%20With%20Moderate%20to%20Severe%20Endometriosis-Associated%20Pain%20-%20Study%20Results%20-%20ClinicalTrials.gov_files/triangle.gif" alt=""><span class="header2">&nbsp; Outcome Measures</span>
  <a name="all" id="all"></a>
  <div class="header3 indent2">

            <div style="margin-top:1.0ex;">
      <a title="Hide all outcome measures" href="https://clinicaltrials.gov/ct2/show/results/NCT01620528?sect=X0156#all">
        <img style="float:left" src="A%20Clinical%20Study%20to%20Evaluate%20the%20Safety%20and%20Efficacy%20of%20Elagolix%20in%20Subjects%20With%20Moderate%20to%20Severe%20Endometriosis-Associated%20Pain%20-%20Study%20Results%20-%20ClinicalTrials.gov_files/minus.gif" alt="" border="0"> &nbsp; Hide All Outcome Measures
      </a>
    </div>
    
                  <a name="outcome1" id="outcome1"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">1.&nbsp; Primary: &nbsp; </td>
            <td>Percentage of Responders at Month 3 Based on Daily 
Assessment of Dysmenorrhea (DYS) &nbsp; [ Time Frame: At Month 3 of the 
Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Primary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Percentage of Responders at Month 3 Based on Daily Assessment of Dysmenorrhea (DYS)</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The DYS pain scale ranges from
 0 (none) to 3 (severe). The criteria for a responder was based on a 
pre-defined threshold and accounted for analgesic use.
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">At Month 3 of the Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The modified intent-to-treat 
(mITT) analysis set; all randomized participants who took at least 1 
dose of randomized, double-blind study drug. Population included mITT 
participants who either had data during the Month 3 35-day window or who
 prematurely discontinued prior to or at Month 3 and met the rules for 
last observation carried forward.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;373&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;248&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;244&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Percentage of Responders at Month 3 Based on 
Daily Assessment of Dysmenorrhea (DYS)&nbsp;                        <br><span class="body3">[Units:&nbsp;Percentage&nbsp;of&nbsp;participants]<br></span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;19.6&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;46.4&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;75.8&nbsp;                                                      </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for Percentage of Responders at Month 3 Based on Daily Assessment of Dysmenorrhea (DYS)</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">Regression, Logistic</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                            
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                           
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for Percentage of Responders at Month 3 Based on Daily Assessment of Dysmenorrhea (DYS)</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 200 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">Regression, Logistic</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                            
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                           
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome2" id="outcome2"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">2.&nbsp; Primary: &nbsp; </td>
            <td>Percentage of Responders at Month 3 Based on Daily 
Assessment of Non-Menstrual Pelvic Pain (NMPP) &nbsp; [ Time Frame: At 
Month 3 of Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Primary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Percentage of Responders at Month 3 Based on Daily Assessment of Non-Menstrual Pelvic Pain (NMPP)</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The NMPP pain scale ranges 
from 0 (none) to 3 (severe). The criteria for a responder was based on a
 pre-defined threshold and accounted for analgesic use.
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">At Month 3 of Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The mITT analysis set; all 
randomized participants who took at least 1 dose of randomized, 
double-blind study drug. Population included mITT participants who 
either had data during the Month 3 35-day window or who prematurely 
discontinued prior to or at Month 3 and met the rules for last 
observation carried forward.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;373&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;248&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;244&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Percentage of Responders at Month 3 Based on 
Daily Assessment of Non-Menstrual Pelvic Pain (NMPP)&nbsp;              
          <br><span class="body3">[Units:&nbsp;Percentage&nbsp;of&nbsp;participants]<br></span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;36.5&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;50.4&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;54.5&nbsp;                                                      </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for Percentage of Responders at Month 3 Based on Daily Assessment of Non-Menstrual Pelvic Pain (NMPP)</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">Regression, Logistic</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                            
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                           
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for Percentage of Responders at Month 3 Based on Daily Assessment of Non-Menstrual Pelvic Pain (NMPP)</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 200 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">Regression, Logistic</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                            
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                           
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome3" id="outcome3"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">3.&nbsp; Secondary: &nbsp; </td>
            <td>Change From Baseline to Month 3 in Numeric Rating Scale 
(NRS) Scores &nbsp; [ Time Frame: Baseline, Month 3 of the Treatment 
Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Change From Baseline to Month 3 in Numeric Rating Scale (NRS) Scores</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The NRS for overall 
endometriosis-associated pain ranges 0 (none) to 10 (worst pain ever).
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline, Month 3 of the Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The mITT analysis set included
 all randomized participants who took at least 1 dose of randomized, 
double-blind study drug. Observed cases.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;329&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;226&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;213&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Change From Baseline to Month 3 in Numeric Rating Scale (NRS) Scores&nbsp;                        <br><span class="body3">[Units:&nbsp;Units&nbsp;on&nbsp;a&nbsp;scale]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-1.09&nbsp;&nbsp;(0.098)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-1.74&nbsp;&nbsp;(0.120)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-2.39&nbsp;&nbsp;(0.122)&nbsp;                  
                                                                  </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for Change From Baseline to Month 3 in Numeric Rating Scale (NRS) Scores</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">mixed-effects model</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Difference in LS Mean Change <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.65</td>
                                                      </tr>
                                                                          <!-- for one-sided confidence interval only display when there is a value -->
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.155)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      Ranked secondary efficacy endpoint 1 of 7.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for Change From Baseline to Month 3 in Numeric Rating Scale (NRS) Scores</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 200 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">mixed-effects model</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Difference in LS Mean Change <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-1.30</td>
                                                      </tr>
                                                                          <!-- for one-sided confidence interval only display when there is a value -->
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.156)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      Ranked secondary efficacy endpoint 1 of 7.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome4" id="outcome4"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">4.&nbsp; Secondary: &nbsp; </td>
            <td>Change From Baseline to Month 6 in DYS &nbsp; [ Time Frame: Baseline, Month 6 of Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Change From Baseline to Month 6 in DYS</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The DYS pain scale ranges from 0 (none) to 3 (severe).
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline, Month 6 of Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The mITT analysis set included
 all randomized participants who took at least 1 dose of randomized, 
double-blind study drug. Observed cases.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;288&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;198&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;182&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Change From Baseline to Month 6 in DYS&nbsp;                        <br><span class="body3">[Units:&nbsp;Units&nbsp;on&nbsp;a&nbsp;scale]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-0.44&nbsp;&nbsp;(0.047)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-0.89&nbsp;&nbsp;(0.057)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-1.75&nbsp;&nbsp;(0.059)&nbsp;                  
                                                                  </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for Change From Baseline to Month 6 in DYS</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">mixed-effects model</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Difference in LS Mean Change <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.45</td>
                                                      </tr>
                                                                          <!-- for one-sided confidence interval only display when there is a value -->
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.074)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      Ranked secondary efficacy endpoint 2 of 7.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for Change From Baseline to Month 6 in DYS</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 200 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">mixed-effects model</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Difference in Least Squares Mean <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-1.32</td>
                                                      </tr>
                                                                          <!-- for one-sided confidence interval only display when there is a value -->
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.076)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      Ranked secondary efficacy endpoint 2 of 7.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome5" id="outcome5"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">5.&nbsp; Secondary: &nbsp; </td>
            <td>Change From Baseline to Month 6 in NMPP &nbsp; [ Time Frame: Baseline, Month 6 of Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Change From Baseline to Month 6 in NMPP</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The NMPP pain scale ranges from 0 (none) to 3 (severe).
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline, Month 6 of Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The mITT analysis set included
 all randomized participants who took at least 1 dose of randomized, 
double-blind study drug. Observed cases.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;288&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;198&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;182&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Change From Baseline to Month 6 in NMPP&nbsp;                        <br><span class="body3">[Units:&nbsp;Units&nbsp;on&nbsp;a&nbsp;scale]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-0.31&nbsp;&nbsp;(0.035)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-0.48&nbsp;&nbsp;(0.043)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-0.72&nbsp;&nbsp;(0.044)&nbsp;                  
                                                                  </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for Change From Baseline to Month 6 in NMPP</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">mixed-effects model</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.004</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Difference in LS Mean Change <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.16</td>
                                                      </tr>
                                                                          <!-- for one-sided confidence interval only display when there is a value -->
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.056)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      Ranked secondary efficacy endpoint 3 of 7.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for Change From Baseline to Month 6 in NMPP</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 200 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">mixed-effects model</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Least Squares Mean Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.41</td>
                                                      </tr>
                                                                          <!-- for one-sided confidence interval only display when there is a value -->
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.057)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      Ranked secondary efficacy endpoint 3 of 7.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome6" id="outcome6"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">6.&nbsp; Secondary: &nbsp; </td>
            <td>Change From Baseline to Month 3 in Analgesic Use Across 
Both Classes of Rescue Analgesics &nbsp; [ Time Frame: Baseline, Month 3
 of Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Change From Baseline to Month 3 in Analgesic Use Across Both Classes of Rescue Analgesics</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          Permitted rescue medications 
included the nonsteroidal anti-inflammatory drug naproxen (500 mg), the 
narcotic analgesics 5 mg hydrocodone + 300 or 325 mg acetaminophen, and 
30 mg codeine + 300 mg acetaminophen. Assessment was based on average 
pill counts.
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline, Month 3 of Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The mITT analysis set included
 all randomized participants who took at least 1 dose of randomized, 
double-blind study drug. Observed cases.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;329&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;226&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;213&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Change From Baseline to Month 3 in Analgesic Use
 Across Both Classes of Rescue Analgesics&nbsp;                        <br><span class="body3">[Units:&nbsp;Pills]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-0.29&nbsp;&nbsp;(0.032)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-0.29&nbsp;&nbsp;(0.039)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-0.55&nbsp;&nbsp;(0.040)&nbsp;                  
                                                                  </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for Change From Baseline to Month 3 in Analgesic Use Across Both Classes of Rescue Analgesics</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">mixed-effects model</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.910</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Difference in LS Mean Change <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.01</td>
                                                      </tr>
                                                                          <!-- for one-sided confidence interval only display when there is a value -->
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.051)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      Ranked secondary efficacy endpoint 4 of 7.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for Change From Baseline to Month 3 in Analgesic Use Across Both Classes of Rescue Analgesics</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 200 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">mixed-effects model</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Difference in LS Mean Change <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.26</td>
                                                      </tr>
                                                                          <!-- for one-sided confidence interval only display when there is a value -->
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.051)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      Ranked secondary efficacy endpoint 4 of 7.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome7" id="outcome7"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">7.&nbsp; Secondary: &nbsp; </td>
            <td>Change From Baseline to Month 6 in Analgesic Use Across 
Both Classes of Rescue Analgesics &nbsp; [ Time Frame: Baseline, Month 6
 of Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Change From Baseline to Month 6 in Analgesic Use Across Both Classes of Rescue Analgesics</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          Permitted rescue medications 
included the nonsteroidal anti-inflammatory drug naproxen (500 mg), the 
narcotic analgesics 5 mg hydrocodone + 300 or 325 mg acetaminophen and 
30 mg codeine + 300 mg acetaminophen. Assessment was based on average 
pill counts.
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline, Month 6 of Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The mITT analysis set included
 all randomized participants who took at least 1 dose of randomized, 
double-blind study drug. Observed cases.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;288&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;198&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;182&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Change From Baseline to Month 6 in Analgesic Use
 Across Both Classes of Rescue Analgesics&nbsp;                        <br><span class="body3">[Units:&nbsp;Pills]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-0.27&nbsp;&nbsp;(0.036)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-0.35&nbsp;&nbsp;(0.043)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-0.56&nbsp;&nbsp;(0.045)&nbsp;                  
                                                                  </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for Change From Baseline to Month 6 in Analgesic Use Across Both Classes of Rescue Analgesics</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">mixed-effects model</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.185</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Difference in LS Mean Change <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.07</td>
                                                      </tr>
                                                                          <!-- for one-sided confidence interval only display when there is a value -->
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.056)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      Ranked secondary efficacy endpoint 5 of 7.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for Change From Baseline to Month 6 in Analgesic Use Across Both Classes of Rescue Analgesics</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 200 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">mixed-effects model</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Least Squares Mean Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.28</td>
                                                      </tr>
                                                                          <!-- for one-sided confidence interval only display when there is a value -->
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.057)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      Ranked secondary efficacy endpoint 5 of 7.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome8" id="outcome8"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">8.&nbsp; Secondary: &nbsp; </td>
            <td>Change From Baseline to Month 3 in Dyspareunia (DYSP) &nbsp; [ Time Frame: Baseline, Month 3 of Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Change From Baseline to Month 3 in Dyspareunia (DYSP)</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The DYSP pain scale ranges from 0 (absent) to 3 (severe).
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline, Month 3 of Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The mITT analysis set included
 all randomized participants who took at least 1 dose of randomized, 
double-blind study drug. Observed cases. Participants who responded "not
 applicable" for the entire time point and at Baseline are excluded from
 the analysis.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;246&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;171&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;153&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Change From Baseline to Month 3 in Dyspareunia (DYSP)&nbsp;                        <br><span class="body3">[Units:&nbsp;Units&nbsp;on&nbsp;a&nbsp;scale]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-0.29&nbsp;&nbsp;(0.041)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-0.39&nbsp;&nbsp;(0.050)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-0.49&nbsp;&nbsp;(0.052)&nbsp;                  
                                                                  </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for Change From Baseline to Month 3 in Dyspareunia (DYSP)</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">mixed-effects model</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.144</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Difference in LS Mean Change <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.09</td>
                                                      </tr>
                                                                          <!-- for one-sided confidence interval only display when there is a value -->
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.065)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      Ranked secondary efficacy endpoint 6 of 7.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for Change From Baseline to Month 3 in Dyspareunia (DYSP)</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 200 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">mixed-effects model</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.003</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Difference in LS Mean Change <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.20</td>
                                                      </tr>
                                                                          <!-- for one-sided confidence interval only display when there is a value -->
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.067)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      Ranked secondary efficacy endpoint 6 of 7.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome9" id="outcome9"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">9.&nbsp; Secondary: &nbsp; </td>
            <td>Change From Baseline to Month 3 in Use of Narcotic Class
 of Medication (Opioids) &nbsp; [ Time Frame: Baseline, Month 3 of 
Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Change From Baseline to Month 3 in Use of Narcotic Class of Medication (Opioids)</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          Permitted rescue narcotic 
analgesics included 5 mg hydrocodone + 300 or 325 mg acetaminophen and 
30 mg codeine + 300 mg acetaminophen. Assessment was based on average 
pill counts.
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline, Month 3 of Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The mITT analysis set included
 all randomized participants who took at least 1 dose of randomized, 
double-blind study drug. Observed cases.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;329&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;226&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;213&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Change From Baseline to Month 3 in Use of 
Narcotic Class of Medication (Opioids)&nbsp;                        <br><span class="body3">[Units:&nbsp;Pills]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-0.10&nbsp;&nbsp;(0.024)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-0.07&nbsp;&nbsp;(0.029)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-0.22&nbsp;&nbsp;(0.029)&nbsp;                  
                                                                  </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for Change From Baseline to Month 3 in Use of Narcotic Class of Medication (Opioids)</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">mixed-effects model</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.424</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Difference in LS Mean Change <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.03</td>
                                                      </tr>
                                                                          <!-- for one-sided confidence interval only display when there is a value -->
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.037)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      Ranked secondary efficacy endpoint 7 of 7.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for Change From Baseline to Month 3 in Use of Narcotic Class of Medication (Opioids)</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 200 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">mixed-effects model</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.002</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Difference in LS Mean Change <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.12</td>
                                                      </tr>
                                                                          <!-- for one-sided confidence interval only display when there is a value -->
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.038)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      Ranked secondary efficacy endpoint 7 of 7.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome10" id="outcome10"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">10.&nbsp; Secondary: &nbsp; </td>
            <td>Percentage of Responders at Month 1 Based on Daily Assessment of DYS &nbsp; [ Time Frame: At Month 1 of the Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Percentage of Responders at Month 1 Based on Daily Assessment of DYS</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The DYS pain scale ranges from
 0 (none) to 3 (severe). The criteria for a responder was based on a 
pre-defined threshold and accounted for analgesic use.
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">At Month 1 of the Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The mITT analysis set included
 all randomized participants who took at least 1 dose of randomized, 
double-blind study drug. Last observation carried forward.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;372&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;248&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;245&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Percentage of Responders at Month 1 Based on Daily Assessment of DYS&nbsp;                        <br><span class="body3">[Units:&nbsp;Percentage&nbsp;of&nbsp;participants]<br></span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;14.5&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;35.1&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;44.1&nbsp;                                                      </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for Percentage of Responders at Month 1 Based on Daily Assessment of DYS</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">Regression, Logistic</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                            
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                           
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for Percentage of Responders at Month 1 Based on Daily Assessment of DYS</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 200 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">Regression, Logistic</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                            
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                           
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome11" id="outcome11"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">11.&nbsp; Secondary: &nbsp; </td>
            <td>Percentage of Responders at Month 2 Based on Daily Assessment of DYS &nbsp; [ Time Frame: At Month 2 of the Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Percentage of Responders at Month 2 Based on Daily Assessment of DYS</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The DYS pain scale ranges from
 0 (none) to 3 (severe). The criteria for a responder was based on a 
pre-defined threshold and accounted for analgesic use.
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">At Month 2 of the Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The mITT analysis set included
 all randomized participants who took at least 1 dose of randomized, 
double-blind study drug. Last observation carried forward.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;373&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;248&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;244&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Percentage of Responders at Month 2 Based on Daily Assessment of DYS&nbsp;                        <br><span class="body3">[Units:&nbsp;Percentage&nbsp;of&nbsp;participants]<br></span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;17.2&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;44.8&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;71.3&nbsp;                                                      </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for Percentage of Responders at Month 2 Based on Daily Assessment of DYS</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">Regression, Logistic</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                            
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                           
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for Percentage of Responders at Month 2 Based on Daily Assessment of DYS</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 200 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">Regression, Logistic</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                            
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                           
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome12" id="outcome12"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">12.&nbsp; Secondary: &nbsp; </td>
            <td>Percentage of Responders at Month 4 Based on Daily Assessment of DYS &nbsp; [ Time Frame: At Month 4 of the Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Percentage of Responders at Month 4 Based on Daily Assessment of DYS</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The DYS pain scale ranges from
 0 (none) to 3 (severe). The criteria for a responder was based on a 
pre-defined threshold and accounted for analgesic use.
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">At Month 4 of the Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The mITT analysis set included
 all randomized participants who took at least 1 dose of randomized, 
double-blind study drug. Last observation carried forward.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;373&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;248&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;243&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Percentage of Responders at Month 4 Based on Daily Assessment of DYS&nbsp;                        <br><span class="body3">[Units:&nbsp;Percentage&nbsp;of&nbsp;participants]<br></span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;21.7&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;47.6&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;75.3&nbsp;                                                      </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for Percentage of Responders at Month 4 Based on Daily Assessment of DYS</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">Regression, Logistic</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                            
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                           
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for Percentage of Responders at Month 4 Based on Daily Assessment of DYS</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 200 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">Regression, Logistic</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                            
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                           
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome13" id="outcome13"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">13.&nbsp; Secondary: &nbsp; </td>
            <td>Percentage of Responders at Month 5 Based on Daily Assessment of DYS &nbsp; [ Time Frame: At Month 5 of the Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Percentage of Responders at Month 5 Based on Daily Assessment of DYS</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The DYS pain scale ranges from
 0 (none) to 3 (severe). The criteria for a responder was based on a 
pre-defined threshold and accounted for analgesic use.
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">At Month 5 of the Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The mITT analysis set included
 all randomized participants who took at least 1 dose of randomized, 
double-blind study drug. Last observation carried forward..
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;371&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;247&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;243&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Percentage of Responders at Month 5 Based on Daily Assessment of DYS&nbsp;                        <br><span class="body3">[Units:&nbsp;Percentage&nbsp;of&nbsp;participants]<br></span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;24.3&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;45.7&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;79.0&nbsp;                                                      </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for Percentage of Responders at Month 5 Based on Daily Assessment of DYS</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">Regression, Logistic</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                            
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                           
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for Percentage of Responders at Month 5 Based on Daily Assessment of DYS</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 200 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">Regression, Logistic</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                            
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                           
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome14" id="outcome14"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">14.&nbsp; Secondary: &nbsp; </td>
            <td>Percentage of Responders at Month 6 Based on Daily Assessment of DYS &nbsp; [ Time Frame: At Month 6 of the Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Percentage of Responders at Month 6 Based on Daily Assessment of DYS</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The DYS pain scale ranges from
 0 (none) to 3 (severe). The criteria for a responder was based on a 
pre-defined threshold and accounted for analgesic use.
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">At Month 6 of the Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The mITT analysis set included
 all randomized participants who took at least 1 dose of randomized, 
double-blind study drug. Last observation carried forward.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;372&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;247&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;243&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Percentage of Responders at Month 6 Based on Daily Assessment of DYS&nbsp;                        <br><span class="body3">[Units:&nbsp;Percentage&nbsp;of&nbsp;participants]<br></span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;23.1&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;42.1&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;75.3&nbsp;                                                      </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for Percentage of Responders at Month 6 Based on Daily Assessment of DYS</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">Regression, Logistic</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                            
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                           
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for Percentage of Responders at Month 6 Based on Daily Assessment of DYS</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 200 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">Regression, Logistic</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                            
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                           
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome15" id="outcome15"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">15.&nbsp; Secondary: &nbsp; </td>
            <td>Percentage of Responders at Month 1 Based on Daily Assessment of NMPP &nbsp; [ Time Frame: At Month 1 of Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Percentage of Responders at Month 1 Based on Daily Assessment of NMPP</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The NMPP pain scale ranges 
from 0 (none) to 3 (severe). The criteria for a responder was based on a
 pre-defined threshold and accounted for analgesic use.
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">At Month 1 of Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The mITT analysis set included
 all randomized participants who took at least 1 dose of randomized, 
double-blind study drug. Last observation carried forward.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;372&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;248&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;245&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Percentage of Responders at Month 1 Based on Daily Assessment of NMPP&nbsp;                        <br><span class="body3">[Units:&nbsp;Percentage&nbsp;of&nbsp;participants]<br></span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;25.8&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;32.3&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;33.9&nbsp;                                                      </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for Percentage of Responders at Month 1 Based on Daily Assessment of NMPP</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">Regression, Logistic</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.103</td>
                                                      </tr>
                                              
                                            
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                           
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for Percentage of Responders at Month 1 Based on Daily Assessment of NMPP</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 200 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">Regression, Logistic</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.023</td>
                                                      </tr>
                                              
                                            
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                           
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome16" id="outcome16"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">16.&nbsp; Secondary: &nbsp; </td>
            <td>Percentage of Responders at Month 2 Based on Daily Assessment of NMPP &nbsp; [ Time Frame: At Month 2 of Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Percentage of Responders at Month 2 Based on Daily Assessment of NMPP</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The NMPP pain scale ranges 
from 0 (none) to 3 (severe). The criteria for a responder was based on a
 pre-defined threshold and accounted for analgesic use.
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">At Month 2 of Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The mITT analysis set included
 all randomized participants who took at least 1 dose of randomized, 
double-blind study drug. Last observation carried forward.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;373&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;248&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;244&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Percentage of Responders at Month 2 Based on Daily Assessment of NMPP&nbsp;                        <br><span class="body3">[Units:&nbsp;Percentage&nbsp;of&nbsp;participants]<br></span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;32.2&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;41.1&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;46.3&nbsp;                                                      </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for Percentage of Responders at Month 2 Based on Daily Assessment of NMPP</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">Regression, Logistic</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.031</td>
                                                      </tr>
                                              
                                            
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                           
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for Percentage of Responders at Month 2 Based on Daily Assessment of NMPP</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 200 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">Regression, Logistic</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                            
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                           
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome17" id="outcome17"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">17.&nbsp; Secondary: &nbsp; </td>
            <td>Percentage of Responders at Month 4 Based on Daily Assessment of NMPP &nbsp; [ Time Frame: At Month 4 of Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Percentage of Responders at Month 4 Based on Daily Assessment of NMPP</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The NMPP pain scale ranges 
from 0 (none) to 3 (severe). The criteria for a responder was based on a
 pre-defined threshold and accounted for analgesic use.
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">At Month 4 of Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The mITT analysis set included
 all randomized participants who took at least 1 dose of randomized, 
double-blind study drug. Last observation carried forward.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;373&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;248&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;243&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Percentage of Responders at Month 4 Based on Daily Assessment of NMPP&nbsp;                        <br><span class="body3">[Units:&nbsp;Percentage&nbsp;of&nbsp;participants]<br></span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;35.4&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;53.2&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;63.8&nbsp;                                                      </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for Percentage of Responders at Month 4 Based on Daily Assessment of NMPP</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">Regression, Logistic</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                            
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                           
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for Percentage of Responders at Month 4 Based on Daily Assessment of NMPP</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 200 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">Regression, Logistic</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                            
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                           
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome18" id="outcome18"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">18.&nbsp; Secondary: &nbsp; </td>
            <td>Percentage of Responders at Month 5 Based on Daily Assessment of NMPP &nbsp; [ Time Frame: At Month 5 of Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Percentage of Responders at Month 5 Based on Daily Assessment of NMPP</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The NMPP pain scale ranges 
from 0 (none) to 3 (severe). The criteria for a responder was based on a
 pre-defined threshold and accounted for analgesic use.
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">At Month 5 of Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The mITT analysis set included
 all randomized participants who took at least 1 dose of randomized, 
double-blind study drug. Last observation carried forward.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;371&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;247&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;243&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Percentage of Responders at Month 5 Based on Daily Assessment of NMPP&nbsp;                        <br><span class="body3">[Units:&nbsp;Percentage&nbsp;of&nbsp;participants]<br></span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;38.3&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;49.8&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;62.1&nbsp;                                                      </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for Percentage of Responders at Month 5 Based on Daily Assessment of NMPP</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">Regression, Logistic</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.005</td>
                                                      </tr>
                                              
                                            
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                           
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for Percentage of Responders at Month 5 Based on Daily Assessment of NMPP</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 200 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">Regression, Logistic</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                            
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                           
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome19" id="outcome19"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">19.&nbsp; Secondary: &nbsp; </td>
            <td>Percentage of Responders at Month 6 Based on Daily Assessment of NMPP &nbsp; [ Time Frame: At Month 6 of Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Percentage of Responders at Month 6 Based on Daily Assessment of NMPP</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The NMPP pain scale ranges 
from 0 (none) to 3 (severe). The criteria for a responder was based on a
 pre-defined threshold and accounted for analgesic use.
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">At Month 6 of Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The mITT analysis set included
 all randomized participants who took at least 1 dose of randomized, 
double-blind study drug. Last observation carried forward.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;372&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;247&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;243&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Percentage of Responders at Month 6 Based on Daily Assessment of NMPP&nbsp;                        <br><span class="body3">[Units:&nbsp;Percentage&nbsp;of&nbsp;participants]<br></span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;34.9&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;45.7&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;62.1&nbsp;                                                      </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for Percentage of Responders at Month 6 Based on Daily Assessment of NMPP</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">Regression, Logistic</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.008</td>
                                                      </tr>
                                              
                                            
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                           
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for Percentage of Responders at Month 6 Based on Daily Assessment of NMPP</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 200 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">Regression, Logistic</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                            
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                           
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome20" id="outcome20"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">20.&nbsp; Secondary: &nbsp; </td>
            <td>Percentage of Responders at Month 1 for DYSP &nbsp; [ Time Frame: At Month 1 of the Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Percentage of Responders at Month 1 for DYSP</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The DYSP pain scale ranged 
from 0 (absent) to 3 (severe). The criteria for a responder was based on
 a pre-defined threshold and accounted for analgesic use.
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">At Month 1 of the Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The mITT analysis set included
 all randomized participants who took at least 1 dose of randomized, 
double-blind study drug. Last observation carried forward.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;293&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;191&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;176&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Percentage of Responders at Month 1 for DYSP&nbsp;                        <br><span class="body3">[Units:&nbsp;Percentage&nbsp;of&nbsp;participants]<br></span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;26.3&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;30.4&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;31.8&nbsp;                                                      </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for Percentage of Responders at Month 1 for DYSP</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">Regression, Logistic</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.306</td>
                                                      </tr>
                                              
                                            
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                           
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for Percentage of Responders at Month 1 for DYSP</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 200 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">Regression, Logistic</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.239</td>
                                                      </tr>
                                              
                                            
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                           
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome21" id="outcome21"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">21.&nbsp; Secondary: &nbsp; </td>
            <td>Percentage of Responders at Month 2 for DYSP &nbsp; [ Time Frame: At Month 2 of the Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Percentage of Responders at Month 2 for DYSP</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The DYSP pain scale ranged 
from 0 (absent) to 3 (severe). The criteria for a responder was based on
 a pre-defined threshold and accounted for analgesic use.
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">At Month 2 of the Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The mITT analysis set included
 all randomized participants who took at least 1 dose of randomized, 
double-blind study drug. Last observation carried forward.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;287&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;190&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;179&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Percentage of Responders at Month 2 for DYSP&nbsp;                        <br><span class="body3">[Units:&nbsp;Percentage&nbsp;of&nbsp;participants]<br></span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;33.1&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;33.7&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;44.7&nbsp;                                                      </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for Percentage of Responders at Month 2 for DYSP</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">Regression, Logistic</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.855</td>
                                                      </tr>
                                              
                                            
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                           
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for Percentage of Responders at Month 2 for DYSP</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 200 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">Regression, Logistic</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.012</td>
                                                      </tr>
                                              
                                            
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                           
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome22" id="outcome22"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">22.&nbsp; Secondary: &nbsp; </td>
            <td>Percentage of Responders at Month 4 for DYSP &nbsp; [ Time Frame: At Month 4 of the Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Percentage of Responders at Month 4 for DYSP</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The DYSP pain scale ranged 
from 0 (absent) to 3 (severe). The criteria for a responder was based on
 a pre-defined threshold and accounted for analgesic use.
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">At Month 4 of the Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The mITT analysis set included
 all randomized participants who took at least 1 dose of randomized, 
double-blind study drug. Last observation carried forward.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;278&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;185&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;168&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Percentage of Responders at Month 4 for DYSP&nbsp;                        <br><span class="body3">[Units:&nbsp;Percentage&nbsp;of&nbsp;participants]<br></span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;33.1&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;44.3&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;54.2&nbsp;                                                      </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for Percentage of Responders at Month 4 for DYSP</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">Regression, Logistic</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.010</td>
                                                      </tr>
                                              
                                            
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                           
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for Percentage of Responders at Month 4 for DYSP</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 200 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">Regression, Logistic</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                            
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                           
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome23" id="outcome23"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">23.&nbsp; Secondary: &nbsp; </td>
            <td>Percentage of Responders at Month 5 for DYSP &nbsp; [ Time Frame: At Month 5 of the Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Percentage of Responders at Month 5 for DYSP</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The DYSP pain scale ranged 
from 0 (absent) to 3 (severe). The criteria for a responder was based on
 a pre-defined threshold and accounted for analgesic use.
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">At Month 5 of the Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The mITT analysis set included
 all randomized participants who took at least 1 dose of randomized, 
double-blind study drug. Last observation carried forward.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;275&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;183&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;166&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Percentage of Responders at Month 5 for DYSP&nbsp;                        <br><span class="body3">[Units:&nbsp;Percentage&nbsp;of&nbsp;participants]<br></span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;35.3&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;43.7&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;54.8&nbsp;                                                      </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for Percentage of Responders at Month 5 for DYSP</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">Regression, Logistic</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.061</td>
                                                      </tr>
                                              
                                            
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                           
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for Percentage of Responders at Month 5 for DYSP</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 200 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">Regression, Logistic</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                            
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                           
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome24" id="outcome24"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">24.&nbsp; Secondary: &nbsp; </td>
            <td>Percentage of Responders at Month 6 for DYSP &nbsp; [ Time Frame: At Month 6 of the Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Percentage of Responders at Month 6 for DYSP</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The DYSP pain scale ranged 
from 0 (absent) to 3 (severe). The criteria for a responder was based on
 a pre-defined threshold and accounted for analgesic use.
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">At Month 6 of the Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The mITT analysis set included
 all randomized participants who took at least 1 dose of randomized, 
double-blind study drug. Last observation carried forward.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;270&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;187&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;161&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Percentage of Responders at Month 6 for DYSP&nbsp;                        <br><span class="body3">[Units:&nbsp;Percentage&nbsp;of&nbsp;participants]<br></span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;33.3&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;39.6&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;50.3&nbsp;                                                      </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for Percentage of Responders at Month 6 for DYSP</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">Regression, Logistic</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.126</td>
                                                      </tr>
                                              
                                            
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                           
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for Percentage of Responders at Month 6 for DYSP</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 200 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">Regression, Logistic</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                            
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                           
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome25" id="outcome25"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">25.&nbsp; Secondary: &nbsp; </td>
            <td>Change From Baseline to Month 1 in Mean Pain Score for DYS &nbsp; [ Time Frame: Baseline, Month 1 of Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Change From Baseline to Month 1 in Mean Pain Score for DYS</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The DYS pain scale ranges from 0 (none) to 3 (severe).
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline, Month 1 of Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The mITT analysis set included
 all randomized participants who took at least 1 dose of randomized, 
double-blind study drug. Observed cases.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;372&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;248&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;245&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Change From Baseline to Month 1 in Mean Pain Score for DYS&nbsp;                        <br><span class="body3">[Units:&nbsp;Units&nbsp;on&nbsp;a&nbsp;scale]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-0.33&nbsp;&nbsp;(0.044)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-0.83&nbsp;&nbsp;(0.054)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-0.98&nbsp;&nbsp;(0.054)&nbsp;                  
                                                                  </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for Change From Baseline to Month 1 in Mean Pain Score for DYS</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">mixed-effects model</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean of Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.50</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">97.5% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-0.65 to -0.34</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.070)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for Change From Baseline to Month 1 in Mean Pain Score for DYS</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 200 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">mixed-effects model</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean of Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.65</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">97.5% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-0.81 to -0.49</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.070)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome26" id="outcome26"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">26.&nbsp; Secondary: &nbsp; </td>
            <td>Change From Baseline to Month 2 in Mean Pain Score for DYS &nbsp; [ Time Frame: Baseline, Month 2 of Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Change From Baseline to Month 2 in Mean Pain Score for DYS</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The DYS pain scale ranges from 0 (none) to 3 (severe).
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline, Month 2 of Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The mITT analysis set included
 all randomized participants who took at least 1 dose of randomized, 
double-blind study drug. Observed cases.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;348&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;232&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;221&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Change From Baseline to Month 2 in Mean Pain Score for DYS&nbsp;                        <br><span class="body3">[Units:&nbsp;Units&nbsp;on&nbsp;a&nbsp;scale]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-0.32&nbsp;&nbsp;(0.042)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-0.96&nbsp;&nbsp;(0.052)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-1.68&nbsp;&nbsp;(0.053)&nbsp;                  
                                                                  </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for Change From Baseline to Month 2 in Mean Pain Score for DYS</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">mixed-effects model</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean of Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.64</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">97.5% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-0.79 to -0.49</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.067)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for Change From Baseline to Month 2 in Mean Pain Score for DYS</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 200 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">mixed-effects model</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean of Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-1.36</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">97.5% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-1.51 to -1.20</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.068)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome27" id="outcome27"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">27.&nbsp; Secondary: &nbsp; </td>
            <td>Change From Baseline to Month 3 in Mean Pain Score for DYS &nbsp; [ Time Frame: Baseline, Month 3 of Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Change From Baseline to Month 3 in Mean Pain Score for DYS</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The DYS pain scale ranges from 0 (none) to 3 (severe).
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline, Month 3 of Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The mITT analysis set included
 all randomized participants who took at least 1 dose of randomized, 
double-blind study drug. Observed cases.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;329&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;226&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;213&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Change From Baseline to Month 3 in Mean Pain Score for DYS&nbsp;                        <br><span class="body3">[Units:&nbsp;Units&nbsp;on&nbsp;a&nbsp;scale]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-0.35&nbsp;&nbsp;(0.043)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-1.03&nbsp;&nbsp;(0.052)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-1.73&nbsp;&nbsp;(0.054)&nbsp;                  
                                                                  </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for Change From Baseline to Month 3 in Mean Pain Score for DYS</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">mixed-effects model</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean of Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.68</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">97.5% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-0.83 to -0.53</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.068)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for Change From Baseline to Month 3 in Mean Pain Score for DYS</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 200 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">mixed-effects model</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean of Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-1.39</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">97.5% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-1.54 to -1.23</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.069)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome28" id="outcome28"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">28.&nbsp; Secondary: &nbsp; </td>
            <td>Change From Baseline to Month 4 in Mean Pain Score for DYS &nbsp; [ Time Frame: Baseline, Month 4 of Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Change From Baseline to Month 4 in Mean Pain Score for DYS</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The DYS pain scale ranges from 0 (none) to 3 (severe).
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline, Month 4 of Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The mITT analysis set included
 all randomized participants who took at least 1 dose of randomized, 
double-blind study drug. Observed cases.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;316&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;219&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;198&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Change From Baseline to Month 4 in Mean Pain Score for DYS&nbsp;                        <br><span class="body3">[Units:&nbsp;Units&nbsp;on&nbsp;a&nbsp;scale]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-0.40&nbsp;&nbsp;(0.045)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-1.05&nbsp;&nbsp;(0.054)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-1.72&nbsp;&nbsp;(0.057)&nbsp;                  
                                                                  </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for Change From Baseline to Month 4 in Mean Pain Score for DYS</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">mixed-effects model</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean of Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.65</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">97.5% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-0.81 to -0.49</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.071)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for Change From Baseline to Month 4 in Mean Pain Score for DYS</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 200 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">mixed-effects model</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean of Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-1.32</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">97.5% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-1.49 to -1.16</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.072)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome29" id="outcome29"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">29.&nbsp; Secondary: &nbsp; </td>
            <td>Change From Baseline to Month 5 in Mean Pain Score for DYS &nbsp; [ Time Frame: Baseline, Month 5 of Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Change From Baseline to Month 5 in Mean Pain Score for DYS</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The DYS pain scale ranges from 0 (none) to 3 (severe).
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline, Month 5 of Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The mITT analysis set included
 all randomized participants who took at least 1 dose of randomized, 
double-blind study drug. Observed cases.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;299&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;202&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;191&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Change From Baseline to Month 5 in Mean Pain Score for DYS&nbsp;                        <br><span class="body3">[Units:&nbsp;Units&nbsp;on&nbsp;a&nbsp;scale]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-0.43&nbsp;&nbsp;(0.045)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-1.02&nbsp;&nbsp;(0.054)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-1.84&nbsp;&nbsp;(0.056)&nbsp;                  
                                                                  </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for Change From Baseline to Month 5 in Mean Pain Score for DYS</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">mixed-effects model</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean of Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.59</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">97.5% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-0.75 to -0.43</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.071)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for Change From Baseline to Month 5 in Mean Pain Score for DYS</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 200 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">mixed-effects model</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean of Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-1.41</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">97.5% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-1.58 to -1.25</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.072)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome30" id="outcome30"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">30.&nbsp; Secondary: &nbsp; </td>
            <td>Percent Change From Baseline to Month 1 in Mean Pain Score for DYS &nbsp; [ Time Frame: Baseline, Month 1 of Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Percent Change From Baseline to Month 1 in Mean Pain Score for DYS</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The DYS pain scale ranges from 0 (none) to 3 (severe).
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline, Month 1 of Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The mITT analysis set included
 all randomized participants who took at least 1 dose of randomized, 
double-blind study drug. Observed cases.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;372&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;248&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;245&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Percent Change From Baseline to Month 1 in Mean Pain Score for DYS&nbsp;                        <br><span class="body3">[Units:&nbsp;Percentage&nbsp;change]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-14.35&nbsp;&nbsp;(2.079)&nbsp;                 
                                                                   </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-38.42&nbsp;&nbsp;(2.547)&nbsp;                 
                                                                   </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-45.35&nbsp;&nbsp;(2.562)&nbsp;                 
                                                                   </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for Percent Change From Baseline to Month 1 in Mean Pain Score for DYS</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">mixed-effects model</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean of Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-24.07</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">97.5% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-31.45 to -16.69</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(3.288)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for Percent Change From Baseline to Month 1 in Mean Pain Score for DYS</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 200 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">mixed-effects model</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean of Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-31.01</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">97.5% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-38.41 to -23.60</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(3.299)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome31" id="outcome31"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">31.&nbsp; Secondary: &nbsp; </td>
            <td>Percent Change From Baseline to Month 2 in Mean Pain Score for DYS &nbsp; [ Time Frame: Baseline, Month 2 of Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Percent Change From Baseline to Month 2 in Mean Pain Score for DYS</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The DYS pain scale ranges from 0 (none) to 3 (severe).
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline, Month 2 of Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The mITT analysis set included
 all randomized participants who took at least 1 dose of randomized, 
double-blind study drug. Observed cases.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;348&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;232&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;221&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Percent Change From Baseline to Month 2 in Mean Pain Score for DYS&nbsp;                        <br><span class="body3">[Units:&nbsp;Percentage&nbsp;change]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-13.44&nbsp;&nbsp;(1.965)&nbsp;                 
                                                                   </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-44.23&nbsp;&nbsp;(2.407)&nbsp;                 
                                                                   </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-77.22&nbsp;&nbsp;(2.460)&nbsp;                 
                                                                   </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for Percent Change From Baseline to Month 2 in Mean Pain Score for DYS</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">mixed-effects model</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">-30.79</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean of Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-30.79</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">97.5% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-37.77 to -23.82</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(3.107)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for Percent Change From Baseline to Month 2 in Mean Pain Score for DYS</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 200 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">mixed-effects model</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean of Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-63.78</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">97.5% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-70.85 to -56.71</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(3.148)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome32" id="outcome32"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">32.&nbsp; Secondary: &nbsp; </td>
            <td>Percent Change From Baseline to Month 3 in Mean Pain Score for DYS &nbsp; [ Time Frame: Baseline, Month 3 of Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Percent Change From Baseline to Month 3 in Mean Pain Score for DYS</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The DYS pain scale ranges from 0 (none) to 3 (severe).
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline, Month 3 of Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The mITT analysis set included
 all randomized participants who took at least 1 dose of randomized, 
double-blind study drug. Observed cases.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;329&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;226&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;213&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Percent Change From Baseline to Month 3 in Mean Pain Score for DYS&nbsp;                        <br><span class="body3">[Units:&nbsp;Percentage&nbsp;change]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-14.80&nbsp;&nbsp;(2.022)&nbsp;                 
                                                                   </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-47.01&nbsp;&nbsp;(2.451)&nbsp;                 
                                                                   </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-79.74&nbsp;&nbsp;(2.519)&nbsp;                 
                                                                   </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for Percent Change From Baseline to Month 3 in Mean Pain Score for DYS</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">mixed-effects model</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean of Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-32.21</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">97.5% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-39.35 to -25.08</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(3.177)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for Percent Change From Baseline to Month 3 in Mean Pain Score for DYS</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 200 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">mixed-effects model</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean of Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-64.94</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">97.5% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-72.19 to -57.68</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(3.230)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome33" id="outcome33"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">33.&nbsp; Secondary: &nbsp; </td>
            <td>Percent Change From Baseline to Month 4 in Mean Pain Score for DYS &nbsp; [ Time Frame: Baseline, Month 4 of Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Percent Change From Baseline to Month 4 in Mean Pain Score for DYS</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The DYS pain scale ranges from 0 (none) to 3 (severe).
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline, Month 4 of Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The mITT analysis set included
 all randomized participants who took at least 1 dose of randomized, 
double-blind study drug. Observed cases.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;316&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;219&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;198&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Percent Change From Baseline to Month 4 in Mean Pain Score for DYS&nbsp;                        <br><span class="body3">[Units:&nbsp;Percentage&nbsp;change]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-18.08&nbsp;&nbsp;(2.088)&nbsp;                 
                                                                   </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-48.02&nbsp;&nbsp;(2.519)&nbsp;                 
                                                                   </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-79.98&nbsp;&nbsp;(2.627)&nbsp;                 
                                                                   </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for Percent Change From Baseline to Month 4 in Mean Pain Score for DYS</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">mixed-effects model</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean of Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-29.94</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">97.5% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-37.28 to -22.59</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(3.272)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for Percent Change From Baseline to Month 4 in Mean Pain Score for DYS</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 200 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">mixed-effects model</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean of Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-61.90</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">97.5% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-69.44 to -54.36</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(3.356)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome34" id="outcome34"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">34.&nbsp; Secondary: &nbsp; </td>
            <td>Percent Change From Baseline to Month 5 in Mean Pain Score for DYS &nbsp; [ Time Frame: Baseline, Month 5 of Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Percent Change From Baseline to Month 5 in Mean Pain Score for DYS</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The DYS pain scale ranges from 0 (none) to 3 (severe).
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline, Month 5 of Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The mITT analysis set included
 all randomized participants who took at least 1 dose of randomized, 
double-blind study drug. Observed cases.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;299&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;202&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;191&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Percent Change From Baseline to Month 5 in Mean Pain Score for DYS&nbsp;                        <br><span class="body3">[Units:&nbsp;Percentage&nbsp;change]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-18.09&nbsp;&nbsp;(2.072)&nbsp;                 
                                                                   </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-46.72&nbsp;&nbsp;(2.517)&nbsp;                 
                                                                   </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-84.58&nbsp;&nbsp;(2.595)&nbsp;                 
                                                                   </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for Percent Change From Baseline to Month 5 in Mean Pain Score for DYS</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">mixed-effects model</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean of Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-28.63</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">97.5% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-35.96 to -21.31</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(3.260)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for Percent Change From Baseline to Month 5 in Mean Pain Score for DYS</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 200 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">mixed-effects model</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean of Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-66.50</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">97.5% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-73.95 to -59.04</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(3.321)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome35" id="outcome35"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">35.&nbsp; Secondary: &nbsp; </td>
            <td>Percent Change From Baseline to Month 6 in Mean Pain Score for DYS &nbsp; [ Time Frame: Baseline, Month 6 of Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Percent Change From Baseline to Month 6 in Mean Pain Score for DYS</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The DYS pain scale ranges from 0 (none) to 3 (severe).
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline, Month 6 of Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The mITT analysis set included
 all randomized participants who took at least 1 dose of randomized, 
double-blind study drug. Observed cases.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;288&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;198&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;182&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Percent Change From Baseline to Month 6 in Mean Pain Score for DYS&nbsp;                        <br><span class="body3">[Units:&nbsp;Percentage&nbsp;change]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-19.21&nbsp;&nbsp;(2.217)&nbsp;                 
                                                                   </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-40.60&nbsp;&nbsp;(2.681)&nbsp;                 
                                                                   </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-79.99&nbsp;&nbsp;(2.782)&nbsp;                 
                                                                   </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for Percent Change From Baseline to Month 6 in Mean Pain Score for DYS</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">mixed-effects model</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean of Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-21.39</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">97.5% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-29.20 to -13.57</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(3.479)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for Percent Change From Baseline to Month 6 in Mean Pain Score for DYS</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 200 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">mixed-effects model</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean of Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-60.78</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">97.5% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-68.77 to -52.79</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(3.557)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome36" id="outcome36"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">36.&nbsp; Secondary: &nbsp; </td>
            <td>Change From Baseline to Month 1 in Mean Pain Score for NMPP &nbsp; [ Time Frame: Baseline, Month 1 of Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Change From Baseline to Month 1 in Mean Pain Score for NMPP</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The NMPP pain scale ranges from 0 (none) to 3 (severe).
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline, Month 1 of Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The mITT analysis set included
 all randomized participants who took at least 1 dose of randomized, 
double-blind study drug. Observed cases
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;372&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;248&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;245&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Change From Baseline to Month 1 in Mean Pain Score for NMPP&nbsp;                        <br><span class="body3">[Units:&nbsp;Units&nbsp;on&nbsp;a&nbsp;scale]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-0.16&nbsp;&nbsp;(0.023)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-0.22&nbsp;&nbsp;(0.028)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-0.26&nbsp;&nbsp;(0.028)&nbsp;                  
                                                                  </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for Change From Baseline to Month 1 in Mean Pain Score for NMPP</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">mixed-effects model</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.111</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean of Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.06</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">97.5% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-0.14 to 0.02</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.036)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for Change From Baseline to Month 1 in Mean Pain Score for NMPP</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 200 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">mixed-effects model</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.008</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean of Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.10</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">97.5% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-0.18 to -0.01</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.036)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome37" id="outcome37"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">37.&nbsp; Secondary: &nbsp; </td>
            <td>Change From Baseline to Month 2 in Mean Pain Score for NMPP &nbsp; [ Time Frame: Baseline, Month 2 of Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Change From Baseline to Month 2 in Mean Pain Score for NMPP</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The NMPP pain scale ranges from 0 (none) to 3 (severe).
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline, Month 2 of Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The mITT analysis set included
 all randomized participants who took at least 1 dose of randomized, 
double-blind study drug. Observed cases
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;348&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;232&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;221&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Change From Baseline to Month 2 in Mean Pain Score for NMPP&nbsp;                        <br><span class="body3">[Units:&nbsp;Units&nbsp;on&nbsp;a&nbsp;scale]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-0.26&nbsp;&nbsp;(0.028)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-0.33&nbsp;&nbsp;(0.035)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-0.44&nbsp;&nbsp;(0.035)&nbsp;                  
                                                                  </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for Change From Baseline to Month 2 in Mean Pain Score for NMPP</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">mixed-effects model</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.092</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean of Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.08</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">97.5% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-0.18 to 0.02</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.045)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for Change From Baseline to Month 2 in Mean Pain Score for NMPP</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 200 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">mixed-effects model</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean of Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.18</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">97.5% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-0.28 to -0.08</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.045)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome38" id="outcome38"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">38.&nbsp; Secondary: &nbsp; </td>
            <td>Change From Baseline to Month 3 in Mean Pain Score for NMPP &nbsp; [ Time Frame: Baseline, Month 3 of Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Change From Baseline to Month 3 in Mean Pain Score for NMPP</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The NMPP pain scale ranges from 0 (none) to 3 (severe).
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline, Month 3 of Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The mITT analysis set included
 all randomized participants who took at least 1 dose of randomized, 
double-blind study drug. Observed cases
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;329&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;226&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;213&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Change From Baseline to Month 3 in Mean Pain Score for NMPP&nbsp;                        <br><span class="body3">[Units:&nbsp;Units&nbsp;on&nbsp;a&nbsp;scale]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-0.32&nbsp;&nbsp;(0.032)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-0.44&nbsp;&nbsp;(0.039)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-0.61&nbsp;&nbsp;(0.039)&nbsp;                  
                                                                  </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for Change From Baseline to Month 3 in Mean Pain Score for NMPP</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">mixed-effects model</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.017</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean of Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.12</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">97.5% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-0.23 to -0.01</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.050)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for Change From Baseline to Month 3 in Mean Pain Score for NMPP</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 200 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">mixed-effects model</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean of Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.29</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">97.5% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-0.41 to -0.18</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.050)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome39" id="outcome39"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">39.&nbsp; Secondary: &nbsp; </td>
            <td>Change From Baseline to Month 4 in Mean Pain Score for NMPP &nbsp; [ Time Frame: Baseline, Month 4 of Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Change From Baseline to Month 4 in Mean Pain Score for NMPP</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The NMPP pain scale ranges from 0 (none) to 3 (severe).
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline, Month 4 of Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The mITT analysis set included
 all randomized participants who took at least 1 dose of randomized, 
double-blind study drug. Observed cases
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;316&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;219&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;198&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Change From Baseline to Month 4 in Mean Pain Score for NMPP&nbsp;                        <br><span class="body3">[Units:&nbsp;Units&nbsp;on&nbsp;a&nbsp;scale]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-0.33&nbsp;&nbsp;(0.034)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-0.51&nbsp;&nbsp;(0.041)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-0.72&nbsp;&nbsp;(0.042)&nbsp;                  
                                                                  </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for Change From Baseline to Month 4 in Mean Pain Score for NMPP</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">mixed-effects model</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean of Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.19</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">97.5% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-0.31 to -0.07</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.053)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for Change From Baseline to Month 4 in Mean Pain Score for NMPP</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 200 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">mixed-effects model</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean of Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.39</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">97.5% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-0.51 to -0.27</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.054)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome40" id="outcome40"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">40.&nbsp; Secondary: &nbsp; </td>
            <td>Change From Baseline to Month 5 in Mean Pain Score for NMPP &nbsp; [ Time Frame: Baseline, Month 5 of Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Change From Baseline to Month 5 in Mean Pain Score for NMPP</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The NMPP pain scale ranges from 0 (none) to 3 (severe).
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline, Month 5 of Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The mITT analysis set included
 all randomized participants who took at least 1 dose of randomized, 
double-blind study drug. Observed cases
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;299&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;202&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;191&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Change From Baseline to Month 5 in Mean Pain Score for NMPP&nbsp;                        <br><span class="body3">[Units:&nbsp;Units&nbsp;on&nbsp;a&nbsp;scale]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-0.34&nbsp;&nbsp;(0.034)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-0.49&nbsp;&nbsp;(0.041)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-0.74&nbsp;&nbsp;(0.042)&nbsp;                  
                                                                  </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for Change From Baseline to Month 5 in Mean Pain Score for NMPP</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">mixed-effects model</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.004</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean of Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.15</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">97.5% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-0.27 to -0.03</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.053)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for Change From Baseline to Month 5 in Mean Pain Score for NMPP</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 200 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">mixed-effects model</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean of Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.39</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">97.5% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-0.52 to -0.27</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.054)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome41" id="outcome41"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">41.&nbsp; Secondary: &nbsp; </td>
            <td>Percent Change From Baseline to Month 1 in Mean Pain Score for NMPP &nbsp; [ Time Frame: Baseline, Month 1 of Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Percent Change From Baseline to Month 1 in Mean Pain Score for NMPP</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The NMPP pain scale ranges from 0 (none) to 3 (severe).
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline, Month 1 of Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The mITT analysis set included
 all randomized participants who took at least 1 dose of randomized, 
double-blind study drug. Observed cases.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;372&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;248&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;245&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Percent Change From Baseline to Month 1 in Mean Pain Score for NMPP&nbsp;                        <br><span class="body3">[Units:&nbsp;Percentage&nbsp;change]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-7.51&nbsp;&nbsp;(1.736)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-13.74&nbsp;&nbsp;(2.131)&nbsp;                 
                                                                   </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-15.23&nbsp;&nbsp;(2.139)&nbsp;                 
                                                                   </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for Percent Change From Baseline to Month 1 in Mean Pain Score for NMPP</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">mixed-effects model</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.024</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean of Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-6.23</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">97.5% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-12.40 to -0.06</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(2.748)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for Percent Change From Baseline to Month 1 in Mean Pain Score for NMPP</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 200 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">mixed-effects model</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.005</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean of Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-7.72</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">97.5% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-13.90 to -1.53</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(2.756)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome42" id="outcome42"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">42.&nbsp; Secondary: &nbsp; </td>
            <td>Percent Change From Baseline to Month 2 in Mean Pain Score for NMPP &nbsp; [ Time Frame: Baseline, Month 2 of Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Percent Change From Baseline to Month 2 in Mean Pain Score for NMPP</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The NMPP pain scale ranges from 0 (none) to 3 (severe).
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline, Month 2 of Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The mITT analysis set included
 all randomized participants who took at least 1 dose of randomized, 
double-blind study drug. Observed cases.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;348&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;232&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;221&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Percent Change From Baseline to Month 2 in Mean Pain Score for NMPP&nbsp;                        <br><span class="body3">[Units:&nbsp;Percentage&nbsp;change]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-13.81&nbsp;&nbsp;(2.039)&nbsp;                 
                                                                   </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-19.50&nbsp;&nbsp;(2.501)&nbsp;                 
                                                                   </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-27.53&nbsp;&nbsp;(2.529)&nbsp;                 
                                                                   </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for Percent Change From Baseline to Month 2 in Mean Pain Score for NMPP</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">mixed-effects model</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.078</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean of Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-5.69</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">97.5% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-12.93 to 1.56</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(3.226)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for Percent Change From Baseline to Month 2 in Mean Pain Score for NMPP</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 200 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">mixed-effects model</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean of Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-13.72</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">97.5% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-21.01 to -6.42</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(3.249)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome43" id="outcome43"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">43.&nbsp; Secondary: &nbsp; </td>
            <td>Percent Change From Baseline to Month 3 in Mean Pain Score for NMPP &nbsp; [ Time Frame: Baseline, Month 3 of Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Percent Change From Baseline to Month 3 in Mean Pain Score for NMPP</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The NMPP pain scale ranges from 0 (none) to 3 (severe).
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline, Month 3 of Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The mITT analysis set included
 all randomized participants who took at least 1 dose of randomized, 
double-blind study drug. Observed cases.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;329&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;226&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;213&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Percent Change From Baseline to Month 3 in Mean Pain Score for NMPP&nbsp;                        <br><span class="body3">[Units:&nbsp;Percentage&nbsp;change]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-17.64&nbsp;&nbsp;(2.204)&nbsp;                 
                                                                   </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-26.10&nbsp;&nbsp;(2.688)&nbsp;                 
                                                                   </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-40.13&nbsp;&nbsp;(2.737)&nbsp;                 
                                                                   </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for Percent Change From Baseline to Month 3 in Mean Pain Score for NMPP</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">mixed-effects model</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.015</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean of Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-8.47</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">97.5% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-16.27 to -0.66</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(3.475)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for Percent Change From Baseline to Month 3 in Mean Pain Score for NMPP</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 200 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">mixed-effects model</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean of Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-22.49</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">97.5% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-30.38 to -14.60</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(3.514)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome44" id="outcome44"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">44.&nbsp; Secondary: &nbsp; </td>
            <td>Percent Change From Baseline to Month 4 in Mean Pain Score for NMPP &nbsp; [ Time Frame: Baseline, Month 4 of Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Percent Change From Baseline to Month 4 in Mean Pain Score for NMPP</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The NMPP pain scale ranges from 0 (none) to 3 (severe).
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline, Month 4 of Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The mITT analysis set included
 all randomized participants who took at least 1 dose of randomized, 
double-blind study drug. Observed cases.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;316&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;219&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;198&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Percent Change From Baseline to Month 4 in Mean Pain Score for NMPP&nbsp;                        <br><span class="body3">[Units:&nbsp;Percentage&nbsp;change]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-17.94&nbsp;&nbsp;(2.333)&nbsp;                 
                                                                   </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-32.05&nbsp;&nbsp;(2.837)&nbsp;                 
                                                                   </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-48.35&nbsp;&nbsp;(2.909)&nbsp;                 
                                                                   </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for Percent Change From Baseline to Month 4 in Mean Pain Score for NMPP</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">mixed-effects model</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean of Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-14.11</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">97.5% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-22.36 to -5.87</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(3.673)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for Percent Change From Baseline to Month 4 in Mean Pain Score for NMPP</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 200 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">mixed-effects model</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean of Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-30.41</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">97.5% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-38.78 to -22.04</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(3.729)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome45" id="outcome45"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">45.&nbsp; Secondary: &nbsp; </td>
            <td>Percent Change From Baseline to Month 5 in Mean Pain Score for NMPP &nbsp; [ Time Frame: Baseline, Month 5 of Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Percent Change From Baseline to Month 5 in Mean Pain Score for NMPP</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The NMPP pain scale ranges from 0 (none) to 3 (severe).
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline, Month 5 of Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The mITT analysis set included
 all randomized participants who took at least 1 dose of randomized, 
double-blind study drug. Observed cases.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;299&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;202&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;191&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Percent Change From Baseline to Month 5 in Mean Pain Score for NMPP&nbsp;                        <br><span class="body3">[Units:&nbsp;Percentage&nbsp;change]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-19.60&nbsp;&nbsp;(2.371)&nbsp;                 
                                                                   </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-31.15&nbsp;&nbsp;(2.888)&nbsp;                 
                                                                   </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-49.28&nbsp;&nbsp;(2.954)&nbsp;                 
                                                                   </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for Percent Change From Baseline to Month 5 in Mean Pain Score for NMPP</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">mixed-effects model</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.002</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean of Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-11.55</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">97.5% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-19.94 to -3.16</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(3.736)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for Percent Change From Baseline to Month 5 in Mean Pain Score for NMPP</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 200 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">mixed-effects model</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean of Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-29.68</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">97.5% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-38.19 to -21.18</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(3.788)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome46" id="outcome46"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">46.&nbsp; Secondary: &nbsp; </td>
            <td>Percent Change From Baseline to Month 6 in Mean Pain Score for NMPP &nbsp; [ Time Frame: Baseline, Month 6 of Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Percent Change From Baseline to Month 6 in Mean Pain Score for NMPP</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The NMPP pain scale ranges from 0 (none) to 3 (severe).
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline, Month 6 of Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The mITT analysis set included
 all randomized participants who took at least 1 dose of randomized, 
double-blind study drug. Observed cases.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;288&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;198&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;182&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Percent Change From Baseline to Month 6 in Mean Pain Score for NMPP&nbsp;                        <br><span class="body3">[Units:&nbsp;Percentage&nbsp;change]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-18.17&nbsp;&nbsp;(2.418)&nbsp;                 
                                                                   </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-30.55&nbsp;&nbsp;(2.939)&nbsp;                 
                                                                   </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-48.14&nbsp;&nbsp;(3.019)&nbsp;                 
                                                                   </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for Percent Change From Baseline to Month 6 in Mean Pain Score for NMPP</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">mixed-effects model</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean of Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-12.37</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">97.5% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-20.92 to -3.83</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(3.805)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for Percent Change From Baseline to Month 6 in Mean Pain Score for NMPP</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 200 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">mixed-effects model</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean of Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-29.97</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">97.5% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-38.66 to -21.28</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(3.868)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome47" id="outcome47"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">47.&nbsp; Secondary: &nbsp; </td>
            <td>Change From Baseline to Month 1 in Mean Pain Score of DYSP &nbsp; [ Time Frame: Baseline, Month 1 of Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Change From Baseline to Month 1 in Mean Pain Score of DYSP</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The DYSP pain scale ranged from 0 (absent) to 3 (severe).
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline, Month 1 of Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The mITT analysis set included
 all randomized participants who took at least 1 dose of randomized, 
double-blind study drug. Observed cases. Participants who responded "not
 applicable" for the entire time point and at Baseline are excluded from
 the analysis.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;293&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;191&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;176&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Change From Baseline to Month 1 in Mean Pain Score of DYSP&nbsp;                        <br><span class="body3">[Units:&nbsp;Units&nbsp;on&nbsp;a&nbsp;scale]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-0.18&nbsp;&nbsp;(0.032)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-0.29&nbsp;&nbsp;(0.040)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-0.22&nbsp;&nbsp;(0.042)&nbsp;                  
                                                                  </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for Change From Baseline to Month 1 in Mean Pain Score of DYSP</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">mixed-effects model</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.038</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean of Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.11</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">97.5% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-0.22 to 0.01</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.052)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for Change From Baseline to Month 1 in Mean Pain Score of DYSP</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 200 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">mixed-effects model</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.488</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean of Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.04</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">97.5% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-0.16 to 0.08</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.053)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome48" id="outcome48"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">48.&nbsp; Secondary: &nbsp; </td>
            <td>Change From Baseline to Month 2 in Mean Pain Score of DYSP &nbsp; [ Time Frame: Baseline, Month 2 of Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Change From Baseline to Month 2 in Mean Pain Score of DYSP</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The DYSP pain scale ranged from 0 (absent) to 3 (severe).
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline, Month 2 of Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The mITT analysis set included
 all randomized participants who took at least 1 dose of randomized, 
double-blind study drug. Observed cases. Participants who responded "not
 applicable" for the entire time point and at Baseline are excluded from
 the analysis.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;267&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;178&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;165&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Change From Baseline to Month 2 in Mean Pain Score of DYSP&nbsp;                        <br><span class="body3">[Units:&nbsp;Units&nbsp;on&nbsp;a&nbsp;scale]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-0.26&nbsp;&nbsp;(0.038)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-0.33&nbsp;&nbsp;(0.046)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-0.38&nbsp;&nbsp;(0.048)&nbsp;                  
                                                                  </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for Change From Baseline to Month 2 in Mean Pain Score of DYSP</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">mixed-effects model</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.252</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean of Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.07</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">97.5% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-0.20 to 0.07</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.060)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for Change From Baseline to Month 2 in Mean Pain Score of DYSP</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 200 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">mixed-effects model</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.058</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean of Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.12</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">97.5% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-0.25 to 0.02</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.061)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome49" id="outcome49"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">49.&nbsp; Secondary: &nbsp; </td>
            <td>Change From Baseline to Month 4 in Mean Pain Score of DYSP &nbsp; [ Time Frame: Baseline, Month 4 of Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Change From Baseline to Month 4 in Mean Pain Score of DYSP</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The DYSP pain scale ranged from 0 (absent) to 3 (severe).
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline, Month 4 of Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The mITT analysis set included
 all randomized participants who took at least 1 dose of randomized, 
double-blind study drug. Observed cases. Participants who responded "not
 applicable" for the entire time point and at Baseline are excluded from
 the analysis.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;231&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;164&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;139&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Change From Baseline to Month 4 in Mean Pain Score of DYSP&nbsp;                        <br><span class="body3">[Units:&nbsp;Units&nbsp;on&nbsp;a&nbsp;scale]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-0.27&nbsp;&nbsp;(0.044)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-0.45&nbsp;&nbsp;(0.053)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-0.61&nbsp;&nbsp;(0.056)&nbsp;                  
                                                                  </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for Change From Baseline to Month 4 in Mean Pain Score of DYSP</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">mixed-effects model</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.009</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean of Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.18</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">97.5% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-0.34 to -0.03</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.069)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for Change From Baseline to Month 4 in Mean Pain Score of DYSP</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 200 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">mixed-effects model</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean of Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.34</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">97.5% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-0.50 to -0.18</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.071)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome50" id="outcome50"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">50.&nbsp; Secondary: &nbsp; </td>
            <td>Change From Baseline to Month 5 in Mean Pain Score of DYSP &nbsp; [ Time Frame: Baseline, Month 5 of Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Change From Baseline to Month 5 in Mean Pain Score of DYSP</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The DYSP pain scale ranged from 0 (absent) to 3 (severe).
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline, Month 5 of Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The mITT analysis set included
 all randomized participants who took at least 1 dose of randomized, 
double-blind study drug. Observed cases. Participants who responded "not
 applicable" for the entire time point and at Baseline are excluded from
 the analysis.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;217&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;149&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;131&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Change From Baseline to Month 5 in Mean Pain Score of DYSP&nbsp;                        <br><span class="body3">[Units:&nbsp;Units&nbsp;on&nbsp;a&nbsp;scale]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-0.30&nbsp;&nbsp;(0.047)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-0.44&nbsp;&nbsp;(0.056)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-0.57&nbsp;&nbsp;(0.060)&nbsp;                  
                                                                  </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for Change From Baseline to Month 5 in Mean Pain Score of DYSP</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">mixed-effects model</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.060</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean of Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.14</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">97.5% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-0.30 to 0.03</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.073)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for Change From Baseline to Month 5 in Mean Pain Score of DYSP</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 200 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">mixed-effects model</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean of Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.27</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">97.5% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-0.44 to -0.10</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.076)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome51" id="outcome51"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">51.&nbsp; Secondary: &nbsp; </td>
            <td>Change From Baseline to Month 6 in Mean Pain Score of DYSP &nbsp; [ Time Frame: Baseline, Month 6 of Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Change From Baseline to Month 6 in Mean Pain Score of DYSP</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The DYSP pain scale ranged from 0 (absent) to 3 (severe).
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline, Month 6 of Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The mITT analysis set included
 all randomized participants who took at least 1 dose of randomized, 
double-blind study drug. Observed cases. Participants who responded "not
 applicable" for the entire time point and at Baseline are excluded from
 the analysis.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;203&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;149&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;120&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Change From Baseline to Month 6 in Mean Pain Score of DYSP&nbsp;                        <br><span class="body3">[Units:&nbsp;Units&nbsp;on&nbsp;a&nbsp;scale]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-0.29&nbsp;&nbsp;(0.048)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-0.41&nbsp;&nbsp;(0.057)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-0.60&nbsp;&nbsp;(0.062)&nbsp;                  
                                                                  </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for Change From Baseline to Month 6 in Mean Pain Score of DYSP</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">mixed-effects model</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.118</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean of Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.12</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">97.5% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-0.28 to 0.05</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.074)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for Change From Baseline to Month 6 in Mean Pain Score of DYSP</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 200 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">mixed-effects model</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean of Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.30</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">97.5% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-0.48 to -0.13</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.078)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome52" id="outcome52"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">52.&nbsp; Secondary: &nbsp; </td>
            <td>Change From Baseline to Month 1 in Analgesic Use Across 
Both Classes of Rescue Analgesics &nbsp; [ Time Frame: Baseline, Month 1
 of Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Change From Baseline to Month 1 in Analgesic Use Across Both Classes of Rescue Analgesics</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          Permitted rescue medications 
included the nonsteroidal anti-inflammatory drug naproxen (500 mg), the 
narcotic analgesics 5 mg hydrocodone + 300 or 325 mg acetaminophen, and 
30 mg codeine + 300 mg acetaminophen. Assessment was based on average 
pill counts.
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline, Month 1 of Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The mITT analysis set included
 all randomized participants who took at least 1 dose of randomized, 
double-blind study drug. Observed cases.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;372&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;248&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;245&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Change From Baseline to Month 1 in Analgesic Use
 Across Both Classes of Rescue Analgesics&nbsp;                        <br><span class="body3">[Units:&nbsp;Pills]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-0.20&nbsp;&nbsp;(0.028)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-0.25&nbsp;&nbsp;(0.034)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-0.32&nbsp;&nbsp;(0.034)&nbsp;                  
                                                                  </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for Change From Baseline to Month 1 in Analgesic Use Across Both Classes of Rescue Analgesics</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">mixed-effects model</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.313</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean of Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.04</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">97.5% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-0.14 to 0.05</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.044)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for Change From Baseline to Month 1 in Analgesic Use Across Both Classes of Rescue Analgesics</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 200 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">mixed-effects model</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.006</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean of Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.12</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">97.5% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-0.22 to -0.02</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.044)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome53" id="outcome53"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">53.&nbsp; Secondary: &nbsp; </td>
            <td>Change From Baseline to Month 2 in Analgesic Use Across 
Both Classes of Rescue Analgesics &nbsp; [ Time Frame: Baseline, Month 2
 of Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Change From Baseline to Month 2 in Analgesic Use Across Both Classes of Rescue Analgesics</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          Permitted rescue medications 
included the nonsteroidal anti-inflammatory drug naproxen (500 mg), the 
narcotic analgesics 5 mg hydrocodone + 300 or 325 mg acetaminophen, and 
30 mg codeine + 300 mg acetaminophen. Assessment was based on average 
pill counts.
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline, Month 2 of Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The modified intent-to-treat 
analysis set included all randomized participants who took at least 1 
dose of randomized, double-blind study drug. Observed cases.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;348&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;232&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;221&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Change From Baseline to Month 2 in Analgesic Use
 Across Both Classes of Rescue Analgesics&nbsp;                        <br><span class="body3">[Units:&nbsp;Pills]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-0.24&nbsp;&nbsp;(0.029)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-0.27&nbsp;&nbsp;(0.036)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-0.46&nbsp;&nbsp;(0.037)&nbsp;                  
                                                                  </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for Change From Baseline to Month 2 in Analgesic Use Across Both Classes of Rescue Analgesics</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">mixed-effects model</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.519</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean of Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.03</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">97.5% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-0.13 to 0.07</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.047)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for Change From Baseline to Month 2 in Analgesic Use Across Both Classes of Rescue Analgesics</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 200 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">mixed-effects model</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean of Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.22</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">97.5% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-0.32 to -0.11</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.047)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome54" id="outcome54"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">54.&nbsp; Secondary: &nbsp; </td>
            <td>Change From Baseline to Month 4 in Analgesic Use Across 
Both Classes of Rescue Analgesics &nbsp; [ Time Frame: Baseline, Month 4
 of Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Change From Baseline to Month 4 in Analgesic Use Across Both Classes of Rescue Analgesics</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          Permitted rescue medications 
included the nonsteroidal anti-inflammatory drug naproxen (500 mg), the 
narcotic analgesics 5 mg hydrocodone + 300 or 325 mg acetaminophen and 
30 mg codeine + 300 mg acetaminophen. Assessment was based on average 
pill counts.
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline, Month 4 of Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The mITT analysis set included
 all randomized participants who took at least 1 dose of randomized, 
double-blind study drug. Observed cases.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;316&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;219&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;198&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Change From Baseline to Month 4 in Analgesic Use
 Across Both Classes of Rescue Analgesics&nbsp;                        <br><span class="body3">[Units:&nbsp;Pills]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-0.28&nbsp;&nbsp;(0.033)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-0.39&nbsp;&nbsp;(0.041)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-0.57&nbsp;&nbsp;(0.042)&nbsp;                  
                                                                  </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for Change From Baseline to Month 4 in Analgesic Use Across Both Classes of Rescue Analgesics</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">mixed-effects model</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.037</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean of Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.11</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">97.5% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-0.23 to 0.01</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.053)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for Change From Baseline to Month 4 in Analgesic Use Across Both Classes of Rescue Analgesics</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 200 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">mixed-effects model</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean of Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.29</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">97.5% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-0.41 to -0.17</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.053)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome55" id="outcome55"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">55.&nbsp; Secondary: &nbsp; </td>
            <td>Change From Baseline to Month 5 in Analgesic Use Across 
Both Classes of Rescue Analgesics &nbsp; [ Time Frame: Baseline, Month 5
 of Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Change From Baseline to Month 5 in Analgesic Use Across Both Classes of Rescue Analgesics</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          Permitted rescue medications 
included the nonsteroidal anti-inflammatory drug naproxen (500 mg), the 
narcotic analgesics 5 mg hydrocodone + 300 or 325 mg acetaminophen, and 
30 mg codeine + 300 mg acetaminophen. Assessment was based on average 
pill counts.
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline, Month 5 of Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The mITT analysis set included
 all randomized participants who took at least 1 dose of randomized, 
double-blind study drug. Observed cases.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;299&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;202&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;191&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Change From Baseline to Month 5 in Analgesic Use
 Across Both Classes of Rescue Analgesics&nbsp;                        <br><span class="body3">[Units:&nbsp;Pills]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-0.29&nbsp;&nbsp;(0.034)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-0.36&nbsp;&nbsp;(0.041)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-0.60&nbsp;&nbsp;(0.042)&nbsp;                  
                                                                  </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for Change From Baseline to Month 5 in Analgesic Use Across Both Classes of Rescue Analgesics</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">mixed-effects model</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.200</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean of Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.07</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">97.5% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-0.19 to 0.05</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.053)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for Change From Baseline to Month 5 in Analgesic Use Across Both Classes of Rescue Analgesics</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 200 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">mixed-effects model</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean of Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.30</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">97.5% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-0.42 to -0.18</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.054)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome56" id="outcome56"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">56.&nbsp; Secondary: &nbsp; </td>
            <td>Response to Patient Global Impression of Change (PGIC) at Month 1 &nbsp; [ Time Frame: Month 1 of Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Response to Patient Global Impression of Change (PGIC) at Month 1</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The PGIC questionnaire is a 
self-reported 7-point scale rating a participant's overall impression of
 change from 1 = very much improved to 7 = very much worse. Participants
 evaluated the change in their endometriosis-associated pain since 
initiation of study drug.
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Month 1 of Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The mITT analysis set included
 all randomized participants who took at least 1 dose of randomized, 
double-blind study drug. Last observation carried forward.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;353&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;234&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;226&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Response to Patient Global Impression of Change (PGIC) at Month 1&nbsp;                        <br><span class="body3">[Units:&nbsp;Units&nbsp;on&nbsp;a&nbsp;scale]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;3.50&nbsp;&nbsp;(0.060)&nbsp;                   
                                                                 </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;2.97&nbsp;&nbsp;(0.073)&nbsp;                   
                                                                 </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;2.76&nbsp;&nbsp;(0.075)&nbsp;                   
                                                                 </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for Response to Patient Global Impression of Change (PGIC) at Month 1</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">ANOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean of Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.53</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-0.72 to -0.34</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.094)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for Response to Patient Global Impression of Change (PGIC) at Month 1</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 200 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">ANOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean of Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.74</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-0.93 to -0.56</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.095)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome57" id="outcome57"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">57.&nbsp; Secondary: &nbsp; </td>
            <td>Response to PGIC at Month 2 &nbsp; [ Time Frame: Month 2 of Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Response to PGIC at Month 2</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The PGIC questionnaire is a 
self-reported 7-point scale rating a participant's overall impression of
 change from 1 = very much improved to 7 = very much worse. Participants
 evaluated the change in their endometriosis-associated pain since 
initiation of study drug.
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Month 2 of Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The mITT analysis set included
 all randomized participants who took at least 1 dose of randomized, 
double-blind study drug. Last observation carried forward.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;353&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;231&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;225&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Response to PGIC at Month 2&nbsp;                        <br><span class="body3">[Units:&nbsp;Units&nbsp;on&nbsp;a&nbsp;scale]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;3.13&nbsp;&nbsp;(0.062)&nbsp;                   
                                                                 </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;2.74&nbsp;&nbsp;(0.076)&nbsp;                   
                                                                 </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;2.11&nbsp;&nbsp;(0.077)&nbsp;                   
                                                                 </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for Response to PGIC at Month 2</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">ANOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean of Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.39</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-0.58 to -0.19</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.098)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for Response to PGIC at Month 2</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 200 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">ANOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean of Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-1.02</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-1.21 to -0.82</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.099)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome58" id="outcome58"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">58.&nbsp; Secondary: &nbsp; </td>
            <td>Response to PGIC at Month 3 &nbsp; [ Time Frame: Month 3 of Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Response to PGIC at Month 3</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The PGIC questionnaire is a 
self-reported 7-point scale rating a participant's overall impression of
 change from 1 = very much improved to 7 = very much worse. Participants
 evaluated the change in their endometriosis-associated pain since 
initiation of study drug.
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Month 3 of Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The mITT analysis set included
 all randomized participants who took at least 1 dose of randomized, 
double-blind study drug. Last observation carried forward.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;346&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;229&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;227&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Response to PGIC at Month 3&nbsp;                        <br><span class="body3">[Units:&nbsp;Units&nbsp;on&nbsp;a&nbsp;scale]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;3.14&nbsp;&nbsp;(0.064)&nbsp;                   
                                                                 </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;2.53&nbsp;&nbsp;(0.079)&nbsp;                   
                                                                 </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;2.01&nbsp;&nbsp;(0.079)&nbsp;                   
                                                                 </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for Response to PGIC at Month 3</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">ANOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean of Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.61</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-0.81 to -0.41</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.101)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for Response to PGIC at Month 3</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 200 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">ANOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean of Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-1.12</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-1.32 to -0.92</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.102)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome59" id="outcome59"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">59.&nbsp; Secondary: &nbsp; </td>
            <td>Response to PGIC at Month 4 &nbsp; [ Time Frame: Month 4 of Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Response to PGIC at Month 4</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The PGIC questionnaire is a 
self-reported 7-point scale rating a participant's overall impression of
 change from 1 = very much improved to 7 = very much worse. Participants
 evaluated the change in their endometriosis-associated pain since 
initiation of study drug.
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Month 4 of Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The mITT analysis set included
 all randomized participants who took at least 1 dose of randomized, 
double-blind study drug. Last observation carried forward.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;352&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;230&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;222&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Response to PGIC at Month 4&nbsp;                        <br><span class="body3">[Units:&nbsp;Units&nbsp;on&nbsp;a&nbsp;scale]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;3.16&nbsp;&nbsp;(0.067)&nbsp;                   
                                                                 </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;2.54&nbsp;&nbsp;(0.082)&nbsp;                   
                                                                 </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;1.91&nbsp;&nbsp;(0.084)&nbsp;                   
                                                                 </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for Response to PGIC at Month 4</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">ANOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean of Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.63</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-0.83 to -0.42</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.106)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for Response to PGIC at Month 4</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 200 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">ANOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean of Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-1.26</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-1.47 to -1.05</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.107)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome60" id="outcome60"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">60.&nbsp; Secondary: &nbsp; </td>
            <td>Response to PGIC at Month 5 &nbsp; [ Time Frame: Month 5 of Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Response to PGIC at Month 5</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The PGIC questionnaire is a 
self-reported 7-point scale rating a participant's overall impression of
 change from 1 = very much improved to 7 = very much worse. Participants
 evaluated the change in their endometriosis-associated pain since 
initiation of study drug.
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Month 5 of Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The mITT analysis set included
 all randomized participants who took at least 1 dose of randomized, 
double-blind study drug. Last observation carried forward.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;350&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;233&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;223&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Response to PGIC at Month 5&nbsp;                        <br><span class="body3">[Units:&nbsp;Units&nbsp;on&nbsp;a&nbsp;scale]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;3.19&nbsp;&nbsp;(0.070)&nbsp;                   
                                                                 </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;2.50&nbsp;&nbsp;(0.086)&nbsp;                   
                                                                 </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;1.87&nbsp;&nbsp;(0.088)&nbsp;                   
                                                                 </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for Response to PGIC at Month 5</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">ANOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean of Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.69</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-0.91 to -0.48</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.111)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for Response to PGIC at Month 5</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 200 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">ANOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean of Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-1.32</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-1.54 to -1.10</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.112)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome61" id="outcome61"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">61.&nbsp; Secondary: &nbsp; </td>
            <td>Response to PGIC at Month 6 &nbsp; [ Time Frame: Month 6 of Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Response to PGIC at Month 6</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The PGIC questionnaire is a 
self-reported 7-point scale rating a participant's overall impression of
 change from 1 = very much improved to 7 = very much worse. Participants
 evaluated the change in their endometriosis-associated pain since 
initiation of study drug.
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Month 6 of Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The mITT analysis set included
 all randomized participants who took at least 1 dose of randomized, 
double-blind study drug. Last observation carried forward.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;308&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;207&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;200&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Response to PGIC at Month 6&nbsp;                        <br><span class="body3">[Units:&nbsp;Units&nbsp;on&nbsp;a&nbsp;scale]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;3.27&nbsp;&nbsp;(0.077)&nbsp;                   
                                                                 </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;2.56&nbsp;&nbsp;(0.094)&nbsp;                   
                                                                 </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;1.92&nbsp;&nbsp;(0.096)&nbsp;                   
                                                                 </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for Response to PGIC at Month 6</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">ANOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean of Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.72</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-0.96 to -0.48</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.122)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for Response to PGIC at Month 6</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 200 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">ANOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean of Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-1.35</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-1.59 to -1.11</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.123)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome62" id="outcome62"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">62.&nbsp; Secondary: &nbsp; </td>
            <td>Change From Baseline to Month 1 in NRS Scores &nbsp; [ Time Frame: Baseline, Month 1 of Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Change From Baseline to Month 1 in NRS Scores</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The NRS for overall 
endometriosis-associated pain ranges 0 (none) to 10 (worst pain ever).
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline, Month 1 of Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The mITT analysis set included
 all randomized participants who took at least 1 dose of randomized, 
double-blind study drug. Observed cases.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;372&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;248&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;244&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Change From Baseline to Month 1 in NRS Scores&nbsp;                        <br><span class="body3">[Units:&nbsp;Units&nbsp;on&nbsp;a&nbsp;scale]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-0.72&nbsp;&nbsp;(0.069)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-1.00&nbsp;&nbsp;(0.085)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-1.12&nbsp;&nbsp;(0.085)&nbsp;                  
                                                                  </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for Change From Baseline to Month 1 in NRS Scores</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">mixed-effects model</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.011</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean of Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.28</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-0.52 to -0.03</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.109)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for Change From Baseline to Month 1 in NRS Scores</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 200 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">mixed-effects model</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean of Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.40</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">97.5% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-0.65 to -0.16</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.110)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome63" id="outcome63"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">63.&nbsp; Secondary: &nbsp; </td>
            <td>Change From Baseline to Month 2 in NRS Scores &nbsp; [ Time Frame: Baseline, Month 2 of Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Change From Baseline to Month 2 in NRS Scores</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The NRS for overall 
endometriosis-associated pain ranges 0 (none) to 10 (worst pain ever).
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline, Month 2 of Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The mITT analysis set included
 all randomized participants who took at least 1 dose of randomized, 
double-blind study drug. Observed cases.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;348&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;232&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;221&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Change From Baseline to Month 2 in NRS Scores&nbsp;                        <br><span class="body3">[Units:&nbsp;Units&nbsp;on&nbsp;a&nbsp;scale]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-0.91&nbsp;&nbsp;(0.086)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-1.38&nbsp;&nbsp;(0.106)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-1.87&nbsp;&nbsp;(0.107)&nbsp;                  
                                                                  </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for Change From Baseline to Month 2 in NRS Scores</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">mixed-effects model</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt;0.001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean of Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.47</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">97.5% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-0.77 to -0.16</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.137)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for Change From Baseline to Month 2 in NRS Scores</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">mixed-effects model</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.96</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean of Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.96</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">97.5% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-1.27 to -0.65</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.138)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome64" id="outcome64"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">64.&nbsp; Secondary: &nbsp; </td>
            <td>Change From Baseline to Month 4 in NRS Scores &nbsp; [ Time Frame: Baseline, Month 4 of Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Change From Baseline to Month 4 in NRS Scores</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The NRS for overall 
endometriosis-associated pain ranges 0 (none) to 10 (worst pain ever).
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline, Month 4 of Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The mITT analysis set included
 all randomized participants who took at least 1 dose of randomized, 
double-blind study drug. Observed cases.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;316&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;219&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;198&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Change From Baseline to Month 4 in NRS Scores&nbsp;                        <br><span class="body3">[Units:&nbsp;Units&nbsp;on&nbsp;a&nbsp;scale]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-1.15&nbsp;&nbsp;(0.103)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-1.95&nbsp;&nbsp;(0.126)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-2.76&nbsp;&nbsp;(0.129)&nbsp;                  
                                                                  </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for Change From Baseline to Month 4 in NRS Scores</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">mixed-effects model</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean of Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.80</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">97.5% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-1.17 to -0.44</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.163)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for Change From Baseline to Month 4 in NRS Scores</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 200 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">mixed-effects model</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean of Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-1.61</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">97.5% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-1.98 to -1.24</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.165)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome65" id="outcome65"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">65.&nbsp; Secondary: &nbsp; </td>
            <td>Change From Baseline to Month 5 in NRS Scores &nbsp; [ Time Frame: Baseline, Month 5 of Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Change From Baseline to Month 5 in NRS Scores</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The NRS for overall 
endometriosis-associated pain ranges 0 (none) to 10 (worst pain ever).
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline, Month 5 of Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The mITT analysis set included
 all randomized participants who took at least 1 dose of randomized, 
double-blind study drug. Observed cases.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;299&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;202&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;191&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Change From Baseline to Month 5 in NRS Scores&nbsp;                        <br><span class="body3">[Units:&nbsp;Units&nbsp;on&nbsp;a&nbsp;scale]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-1.24&nbsp;&nbsp;(0.106)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-1.92&nbsp;&nbsp;(0.129)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-2.85&nbsp;&nbsp;(0.132)&nbsp;                  
                                                                  </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for Change From Baseline to Month 5 in NRS Scores</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">mixed-effects model</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean of Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.68</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">97.5% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-1.05 to -0.30</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.167)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for Change From Baseline to Month 5 in NRS Scores</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 200 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">mixed-effects model</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean of Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-1.61</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">97.5% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-1.99 to -1.23</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.170)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome66" id="outcome66"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">66.&nbsp; Secondary: &nbsp; </td>
            <td>Change From Baseline to Month 6 in NRS Scores &nbsp; [ Time Frame: Baseline, Month 6 of Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Change From Baseline to Month 6 in NRS Scores</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The NRS for overall 
endometriosis-associated pain ranges 0 (none) to 10 (worst pain ever).
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline, Month 6 of Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The mITT analysis set included
 all randomized participants who took at least 1 dose of randomized, 
double-blind study drug. Observed cases.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;288&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;198&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;182&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Change From Baseline to Month 6 in NRS Scores&nbsp;                        <br><span class="body3">[Units:&nbsp;Units&nbsp;on&nbsp;a&nbsp;scale]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-1.15&nbsp;&nbsp;(0.112)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-1.80&nbsp;&nbsp;(0.136)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-2.75&nbsp;&nbsp;(0.140)&nbsp;                  
                                                                  </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for Change From Baseline to Month 6 in NRS Scores</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">mixed-effects model</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean of Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.65</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">97.5% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-1.04 to -0.25</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.176)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for Change From Baseline to Month 6 in NRS Scores</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 200 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">mixed-effects model</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean of Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-1.60</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">97.5% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-2.00 to -1.20</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.179)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome67" id="outcome67"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">67.&nbsp; Secondary: &nbsp; </td>
            <td>Change From Baseline to Month 1 in the Pain Domain of 
the Endometriosis Health Profile-30 (EHP-30) &nbsp; [ Time Frame: 
Baseline, Month 1 of Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Change From Baseline to Month 1 in the Pain Domain of the Endometriosis Health Profile-30 (EHP-30)</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The EHP-30 is a 
disease-specific self-administered questionnaire used to measure 
health-related quality of life in women with endometriosis. Each domain 
is calculated on a scale from 0 = best possible health status to 100 = 
worst possible health status.
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline, Month 1 of Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The mITT analysis set included
 all randomized participants who took at least 1 dose of randomized, 
double-blind study drug. Observed cases.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;345&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;233&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;217&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Change From Baseline to Month 1 in the Pain 
Domain of the Endometriosis Health Profile-30 (EHP-30)&nbsp;            
            <br><span class="body3">[Units:&nbsp;Units&nbsp;on&nbsp;a&nbsp;scale]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-14.47&nbsp;&nbsp;(0.997)&nbsp;                 
                                                                   </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-20.76&nbsp;&nbsp;(1.213)&nbsp;                 
                                                                   </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-24.23&nbsp;&nbsp;(1.257)&nbsp;                 
                                                                   </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for Change From Baseline to Month 1 in the Pain Domain of the Endometriosis Health Profile-30 (EHP-30)</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Difference in LS Means <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-6.29</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-9.37 to -3.21</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(1.57)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for Change From Baseline to Month 1 in the Pain Domain of the Endometriosis Health Profile-30 (EHP-30)</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 200 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Difference in LS Means <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-9.76</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-12.91 to -6.61</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(1.60)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome68" id="outcome68"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">68.&nbsp; Secondary: &nbsp; </td>
            <td>Change From Baseline to Month 3 in the Pain Domain of the EHP-30 &nbsp; [ Time Frame: Baseline, Month 3 of Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Change From Baseline to Month 3 in the Pain Domain of the EHP-30</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The EHP-30 is a 
disease-specific self-administered questionnaire used to measure 
health-related quality of life in women with endometriosis. Each domain 
is calculated on a scale from 0 = best possible health status to 100 = 
worst possible health status.
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline, Month 3 of Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The mITT analysis set included
 all randomized participants who took at least 1 dose of randomized, 
double-blind study drug. Observed cases.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;312&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;217&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;197&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Change From Baseline to Month 3 in the Pain Domain of the EHP-30&nbsp;                        <br><span class="body3">[Units:&nbsp;Units&nbsp;on&nbsp;a&nbsp;scale]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-17.71&nbsp;&nbsp;(1.101)&nbsp;                 
                                                                   </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-26.99&nbsp;&nbsp;(1.321)&nbsp;                 
                                                                   </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-36.46&nbsp;&nbsp;(1.386)&nbsp;                 
                                                                   </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for Change From Baseline to Month 3 in the Pain Domain of the EHP-30</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Difference in LS Means <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-9.28</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-12.66 to -5.91</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(1.72)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for Change From Baseline to Month 3 in the Pain Domain of the EHP-30</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 200 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Difference in LS Means <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-18.75</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-22.22 to -15.27</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(1.77)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome69" id="outcome69"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">69.&nbsp; Secondary: &nbsp; </td>
            <td>Change From Baseline to Month 6 in the Pain Domain of the EHP-30 &nbsp; [ Time Frame: Baseline, Month 6 of Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Change From Baseline to Month 6 in the Pain Domain of the EHP-30</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The EHP-30 is a 
disease-specific self-administered questionnaire used to measure 
health-related quality of life in women with endometriosis. Each domian 
is calculated on a scale from 0 = best possible health status to 100 = 
worst possible health status.
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline, Month 6 of Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The mITT analysis set included
 all randomized participants who took at least 1 dose of randomized, 
double-blind study drug. Observed cases.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;249&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;177&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;162&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Change From Baseline to Month 6 in the Pain Domain of the EHP-30&nbsp;                        <br><span class="body3">[Units:&nbsp;Units&nbsp;on&nbsp;a&nbsp;scale]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-15.42&nbsp;&nbsp;(1.283)&nbsp;                 
                                                                   </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-27.99&nbsp;&nbsp;(1.522)&nbsp;                 
                                                                   </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-40.52&nbsp;&nbsp;(1.591)&nbsp;                 
                                                                   </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for Change From Baseline to Month 6 in the Pain Domain of the EHP-30</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Difference in LS Means <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-12.57</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-16.48 to -8.66</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(1.99)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for Change From Baseline to Month 6 in the Pain Domain of the EHP-30</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 200 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Difference in LS Means <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-25.10</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-29.12 to -21.09</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(2.04)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome70" id="outcome70"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">70.&nbsp; Secondary: &nbsp; </td>
            <td>Change From Baseline to Month 1 in the Sexual 
Intercourse Domain of the EHP-30 &nbsp; [ Time Frame: Baseline, Month 1 
of Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Change From Baseline to Month 1 in the Sexual Intercourse Domain of the EHP-30</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The EHP-30 is a 
disease-specific self-administered questionnaire used to measure 
health-related quality of life in women with endometriosis. Each domian 
is calculated on a scale from 0 = best possible health status to 100 = 
worst possible health status.
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline, Month 1 of Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The mITT analysis set included
 all randomized participants who took at least 1 dose of randomized, 
double-blind study drug. Observed cases.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;248&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;172&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;146&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Change From Baseline to Month 1 in the Sexual 
Intercourse Domain of the EHP-30&nbsp;                        <br><span class="body3">[Units:&nbsp;Units&nbsp;on&nbsp;a&nbsp;scale]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-10.47&nbsp;&nbsp;(1.239)&nbsp;                 
                                                                   </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-11.26&nbsp;&nbsp;(1.488)&nbsp;                 
                                                                   </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-15.52&nbsp;&nbsp;(1.614)&nbsp;                 
                                                                   </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for Change From Baseline to Month 1 in the Sexual Intercourse Domain of the EHP-30</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.685</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean of Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.78</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-4.59 to 3.02</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(1.94)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for Change From Baseline to Month 1 in the Sexual Intercourse Domain of the EHP-30</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 200 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.013</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Difference in LS Means <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-5.04</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-9.04 to -1.05</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(2.03)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome71" id="outcome71"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">71.&nbsp; Secondary: &nbsp; </td>
            <td>Change From Baseline to Month 3 in the Sexual 
Intercourse Domain of the EHP-30 &nbsp; [ Time Frame: Baseline, Month 3 
of Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Change From Baseline to Month 3 in the Sexual Intercourse Domain of the EHP-30</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The EHP-30 is a 
disease-specific self-administered questionnaire used to measure 
health-related quality of life in women with endometriosis. Each domain 
is calculated on a scale from 0 = best possible health status to 100 = 
worst possible health status.
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline, Month 3 of Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The mITT analysis set included
 all randomized participants who took at least 1 dose of randomized, 
double-blind study drug. Observed cases.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;228&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;167&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;133&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Change From Baseline to Month 3 in the Sexual 
Intercourse Domain of the EHP-30&nbsp;                        <br><span class="body3">[Units:&nbsp;Units&nbsp;on&nbsp;a&nbsp;scale]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-12.57&nbsp;&nbsp;(1.551)&nbsp;                 
                                                                   </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-17.32&nbsp;&nbsp;(1.813)&nbsp;                 
                                                                   </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-26.44&nbsp;&nbsp;(2.032)&nbsp;                 
                                                                   </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for Change From Baseline to Month 3 in the Sexual Intercourse Domain of the EHP-30</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.047</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Difference in LS Means <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-4.74</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-9.43 to -0.05</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(2.39)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for Change From Baseline to Month 3 in the Sexual Intercourse Domain of the EHP-30</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 200 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Difference in LS Means <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-13.86</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-18.89 to -8.84</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(2.56)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome72" id="outcome72"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">72.&nbsp; Secondary: &nbsp; </td>
            <td>Change From Baseline to Month 6 in the Sexual 
Intercourse Domain of the EHP-30 &nbsp; [ Time Frame: Baseline, Month 6 
of Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Change From Baseline to Month 6 in the Sexual Intercourse Domain of the EHP-30</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The EHP-30 is a 
disease-specific self-administered questionnaire used to measure 
health-related quality of life in women with endometriosis. Each domian 
is calculated on a scale from 0 = best possible health status to 100 = 
worst possible health status.
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline, Month 6 of Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The mITT analysis set included
 all randomized participants who took at least 1 dose of randomized, 
double-blind study drug. Observed cases.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;170&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;128&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;110&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Change From Baseline to Month 6 in the Sexual 
Intercourse Domain of the EHP-30&nbsp;                        <br><span class="body3">[Units:&nbsp;Units&nbsp;on&nbsp;a&nbsp;scale]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-11.56&nbsp;&nbsp;(1.909)&nbsp;                 
                                                                   </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-16.27&nbsp;&nbsp;(2.203)&nbsp;                 
                                                                   </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-29.07&nbsp;&nbsp;(2.384)&nbsp;                 
                                                                   </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for Change From Baseline to Month 6 in the Sexual Intercourse Domain of the EHP-30</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.107</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Difference in LS Means <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-4.71</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-10.43 to 1.02</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(2.91)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for Change From Baseline to Month 6 in the Sexual Intercourse Domain of the EHP-30</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 200 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Difference in LS Means <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-17.51</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-23.52 to -11.50</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(3.06)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome73" id="outcome73"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">73.&nbsp; Secondary: &nbsp; </td>
            <td>Change From Baseline to Month 1 in Health Related 
Productivity Questionnaire (HRPQ): Number of Hours of Work Lost From 
Workplace Due to Absenteeism &nbsp; [ Time Frame: Baseline, Month 1 of 
Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Change From 
Baseline to Month 1 in Health Related Productivity Questionnaire (HRPQ):
 Number of Hours of Work Lost From Workplace Due to Absenteeism</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The HRPQ consists of questions
 measuring the impact of endometriosis-associated pain and its treatment
 on work productivity (number of work hours lost from the workplace due 
to absenteeism) in the 7 days prior to survey administration.
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline, Month 1 of Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The mITT analysis set included
 all randomized participants who took at least 1 dose of randomized, 
double-blind study drug. Observed cases.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;251&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;171&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;162&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Change From Baseline to Month 1 in Health 
Related Productivity Questionnaire (HRPQ): Number of Hours of Work Lost 
From Workplace Due to Absenteeism&nbsp;                        <br><span class="body3">[Units:&nbsp;Hours]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-1.32&nbsp;&nbsp;(0.236)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-1.20&nbsp;&nbsp;(0.286)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-2.49&nbsp;&nbsp;(0.294)&nbsp;                  
                                                                  </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for 
Change From Baseline to Month 1 in Health Related Productivity 
Questionnaire (HRPQ): Number of Hours of Work Lost From Workplace Due to
 Absenteeism</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.741</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Difference in LS Means <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.12</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-0.61 to 0.85</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.37)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for 
Change From Baseline to Month 1 in Health Related Productivity 
Questionnaire (HRPQ): Number of Hours of Work Lost From Workplace Due to
 Absenteeism</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 200 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.002</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Difference in LS Means <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-1.16</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-1.90 to -0.42</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.38)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome74" id="outcome74"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">74.&nbsp; Secondary: &nbsp; </td>
            <td>Change From Baseline to Month 2 in HRPQ: Number of Hours
 of Work Lost From Workplace Due to Absenteeism &nbsp; [ Time Frame: 
Baseline, Month 2 of Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Change From Baseline to Month 2 in HRPQ: Number of Hours of Work Lost From Workplace Due to Absenteeism</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The HRPQ consists of questions
 measuring the impact of endometriosis-associated pain and its treatment
 on work productivity (number of work hours lost from the workplace due 
to absenteeism) in the 7 days prior to survey administration.
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline, Month 2 of Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The mITT analysis set included
 all randomized participants who took at least 1 dose of randomized, 
double-blind study drug. Observed cases.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;232&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;160&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;147&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Change From Baseline to Month 2 in HRPQ: Number 
of Hours of Work Lost From Workplace Due to Absenteeism&nbsp;           
             <br><span class="body3">[Units:&nbsp;Hours]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-1.29&nbsp;&nbsp;(0.222)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-1.77&nbsp;&nbsp;(0.266)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-2.56&nbsp;&nbsp;(0.278)&nbsp;                  
                                                                  </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for 
Change From Baseline to Month 2 in HRPQ: Number of Hours of Work Lost 
From Workplace Due to Absenteeism</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.172</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Difference in LS Means <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.47</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-1.16 to 0.21</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.35)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for 
Change From Baseline to Month 2 in HRPQ: Number of Hours of Work Lost 
From Workplace Due to Absenteeism</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 200 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Difference in LS Means <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-1.27</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-1.97 to -0.57</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.36)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome75" id="outcome75"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">75.&nbsp; Secondary: &nbsp; </td>
            <td>Change From Baseline to Month 3 in HRPQ: Number of Hours
 of Work Lost From Workplace Due to Absenteeism &nbsp; [ Time Frame: 
Baseline, Month 3 of Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Change From Baseline to Month 3 in HRPQ: Number of Hours of Work Lost From Workplace Due to Absenteeism</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The HRPQ consists of questions
 measuring the impact of endometriosis-associated pain and its treatment
 on work productivity (number of work hours lost from the workplace due 
to absenteeism) in the 7 days prior to survey administration.
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline, Month 3 of Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The mITT analysis set included
 all randomized participants who took at least 1 dose of randomized, 
double-blind study drug. Observed cases.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;215&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;148&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;140&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Change From Baseline to Month 3 in HRPQ: Number 
of Hours of Work Lost From Workplace Due to Absenteeism&nbsp;           
             <br><span class="body3">[Units:&nbsp;Hours]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-0.87&nbsp;&nbsp;(0.277)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-1.92&nbsp;&nbsp;(0.333)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-2.65&nbsp;&nbsp;(0.343)&nbsp;                  
                                                                  </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for 
Change From Baseline to Month 3 in HRPQ: Number of Hours of Work Lost 
From Workplace Due to Absenteeism</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.016</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean of Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-1.05</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-1.90 to -0.19</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.43)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for 
Change From Baseline to Month 3 in HRPQ: Number of Hours of Work Lost 
From Workplace Due to Absenteeism</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 200 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Difference in LS Means <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-1.78</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-2.65 to -0.91</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.44)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome76" id="outcome76"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">76.&nbsp; Secondary: &nbsp; </td>
            <td>Change From Baseline to Month 4 in HRPQ: Number of Hours
 of Work Lost From Workplace Due to Absenteeism &nbsp; [ Time Frame: 
Baseline, Month 4 of Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Change From Baseline to Month 4 in HRPQ: Number of Hours of Work Lost From Workplace Due to Absenteeism</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The HRPQ consists of questions
 measuring the impact of endometriosis-associated pain and its treatment
 on work productivity (number of work hours lost from the workplace due 
to absenteeism) in the 7 days prior to survey administration.
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline, Month 4 of Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The mITT analysis set included
 all randomized participants who took at least 1 dose of randomized, 
double-blind study drug. Observed cases.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;205&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;148&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;134&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Change From Baseline to Month 4 in HRPQ: Number 
of Hours of Work Lost From Workplace Due to Absenteeism&nbsp;           
             <br><span class="body3">[Units:&nbsp;Hours]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-1.08&nbsp;&nbsp;(0.284)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-1.85&nbsp;&nbsp;(0.334)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-2.44&nbsp;&nbsp;(0.351)&nbsp;                  
                                                                  </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for 
Change From Baseline to Month 4 in HRPQ: Number of Hours of Work Lost 
From Workplace Due to Absenteeism</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.080</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Difference in LS Means <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.77</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-1.63 to 0.09</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.44)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for 
Change From Baseline to Month 4 in HRPQ: Number of Hours of Work Lost 
From Workplace Due to Absenteeism</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 200 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.003</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Difference in LS Means <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-1.37</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-2.25 to -0.48</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.45)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome77" id="outcome77"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">77.&nbsp; Secondary: &nbsp; </td>
            <td>Change From Baseline to Month 5 in HRPQ: Number of Hours
 of Work Lost From Workplace Due to Absenteeism &nbsp; [ Time Frame: 
Baseline, Month 5 of Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Change From Baseline to Month 5 in HRPQ: Number of Hours of Work Lost From Workplace Due to Absenteeism</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The HRPQ consists of questions
 measuring the impact of endometriosis-associated pain and its treatment
 on work productivity (number of work hours lost from the workplace due 
to absenteeism) in the 7 days prior to survey administration.
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline, Month 5 of Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The mITT analysis set included
 all randomized participants who took at least 1 dose of randomized, 
double-blind study drug. Observed cases.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;209&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;147&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;128&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Change From Baseline to Month 5 in HRPQ: Number 
of Hours of Work Lost From Workplace Due to Absenteeism&nbsp;           
             <br><span class="body3">[Units:&nbsp;Hours]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-1.10&nbsp;&nbsp;(0.258)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-1.75&nbsp;&nbsp;(0.308)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-2.94&nbsp;&nbsp;(0.330)&nbsp;                  
                                                                  </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for 
Change From Baseline to Month 5 in HRPQ: Number of Hours of Work Lost 
From Workplace Due to Absenteeism</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.106</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Difference in LS Means <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.65</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-1.44 to 0.14</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.40)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for 
Change From Baseline to Month 5 in HRPQ: Number of Hours of Work Lost 
From Workplace Due to Absenteeism</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 200 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Difference in LS Means <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-1.85</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-2.67 to -1.02</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.42)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome78" id="outcome78"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">78.&nbsp; Secondary: &nbsp; </td>
            <td>Change From Baseline to Month 6 in HRPQ: Number of Hours
 of Work Lost From Workplace Due to Absenteeism &nbsp; [ Time Frame: 
Baseline, Month 6 of Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Change From Baseline to Month 6 in HRPQ: Number of Hours of Work Lost From Workplace Due to Absenteeism</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The HRPQ consists of questions
 measuring the impact of endometriosis-associated pain and its treatment
 on work productivity (number of work hours lost from the workplace due 
to absenteeism) in the 7 days prior to survey administration.
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline, Month 6 of Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The mITT analysis set included
 all randomized participants who took at least 1 dose of randomized, 
double-blind study drug. Observed cases.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;159&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;120&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;105&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Change From Baseline to Month 6 in HRPQ: Number 
of Hours of Work Lost From Workplace Due to Absenteeism&nbsp;           
             <br><span class="body3">[Units:&nbsp;Hours]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-0.27&nbsp;&nbsp;(0.409)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-1.02&nbsp;&nbsp;(0.471)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-2.48&nbsp;&nbsp;(0.503)&nbsp;                  
                                                                  </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for 
Change From Baseline to Month 6 in HRPQ: Number of Hours of Work Lost 
From Workplace Due to Absenteeism</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.232</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Difference in LS Means <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.75</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-1.97 to 0.48</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.62)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for 
Change From Baseline to Month 6 in HRPQ: Number of Hours of Work Lost 
From Workplace Due to Absenteeism</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 200 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Difference in LS Means <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-2.21</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-3.48 to -0.93</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.65)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome79" id="outcome79"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">79.&nbsp; Secondary: &nbsp; </td>
            <td>Change From Baseline to Month 1 in HRPQ: Number of Hours
 of Work Lost From Household Due to Absenteeism &nbsp; [ Time Frame: 
Baseline, Month 1 of Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Change From Baseline to Month 1 in HRPQ: Number of Hours of Work Lost From Household Due to Absenteeism</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The HRPQ consists of questions
 measuring the impact of endometriosis-associated pain and its treatment
 on work productivity (number of work hours lost from the household due 
to absenteeism) in the 7 days prior to survey administration.
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline, Month 1 of Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The mITT analysis set included
 all randomized participants who took at least 1 dose of randomized, 
double-blind study drug. Observed cases.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;319&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;200&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;202&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Change From Baseline to Month 1 in HRPQ: Number 
of Hours of Work Lost From Household Due to Absenteeism&nbsp;           
             <br><span class="body3">[Units:&nbsp;Hours]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-1.27&nbsp;&nbsp;(0.229)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-2.19&nbsp;&nbsp;(0.289)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-2.89&nbsp;&nbsp;(0.288)&nbsp;                  
                                                                  </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for 
Change From Baseline to Month 1 in HRPQ: Number of Hours of Work Lost 
From Household Due to Absenteeism</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.013</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Difference in LS Means <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.92</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-1.65 to -0.20</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.37)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for 
Change From Baseline to Month 1 in HRPQ: Number of Hours of Work Lost 
From Household Due to Absenteeism</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 200 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Difference in LS Means <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-1.62</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-2.35 to -0.90</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.37)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome80" id="outcome80"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">80.&nbsp; Secondary: &nbsp; </td>
            <td>Change From Baseline to Month 2 in HRPQ: Number of Hours
 of Work Lost From Household Due to Absenteeism &nbsp; [ Time Frame: 
Baseline, Month 2 of Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Change From Baseline to Month 2 in HRPQ: Number of Hours of Work Lost From Household Due to Absenteeism</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The HRPQ consists of questions
 measuring the impact of endometriosis-associated pain and its treatment
 on work productivity (number of work hours lost from the household due 
to absenteeism) in the 7 days prior to survey administration.
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline, Month 2 of Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The mITT analysis set included
 all randomized participants who took at least 1 dose of randomized, 
double-blind study drug. Observed cases.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;287&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;192&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;183&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Change From Baseline to Month 2 in HRPQ: Number 
of Hours of Work Lost From Household Due to Absenteeism&nbsp;           
             <br><span class="body3">[Units:&nbsp;Hours]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-1.43&nbsp;&nbsp;(0.295)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-2.75&nbsp;&nbsp;(0.360)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-3.06&nbsp;&nbsp;(0.369)&nbsp;                  
                                                                  </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for 
Change From Baseline to Month 2 in HRPQ: Number of Hours of Work Lost 
From Household Due to Absenteeism</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.005</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Difference in LS Means <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-1.33</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-2.24 to -0.41</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.47)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for 
Change From Baseline to Month 2 in HRPQ: Number of Hours of Work Lost 
From Household Due to Absenteeism</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 200 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Difference in LS Means <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-1.64</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-2.56 to -0.71</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.47)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome81" id="outcome81"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">81.&nbsp; Secondary: &nbsp; </td>
            <td>Change From Baseline to Month 3 in HRPQ: Number of Hours
 of Work Lost From Household Due to Absenteeism &nbsp; [ Time Frame: 
Baseline, Month 3 of Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Change From Baseline to Month 3 in HRPQ: Number of Hours of Work Lost From Household Due to Absenteeism</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The HRPQ consists of questions
 measuring the impact of endometriosis-associated pain and its treatment
 on work productivity (number of work hours lost from the household due 
to absenteeism) in the 7 days prior to survey administration.
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline, Month 3 of Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The mITT analysis set included
 all randomized participants who took at least 1 dose of randomized, 
double-blind study drug. Observed cases.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;278&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;185&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;179&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Change From Baseline to Month 3 in HRPQ: Number 
of Hours of Work Lost From Household Due to Absenteeism&nbsp;           
             <br><span class="body3">[Units:&nbsp;Hours]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-1.37&nbsp;&nbsp;(0.292)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-3.00&nbsp;&nbsp;(0.358)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-3.47&nbsp;&nbsp;(0.363)&nbsp;                  
                                                                  </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for 
Change From Baseline to Month 3 in HRPQ: Number of Hours of Work Lost 
From Household Due to Absenteeism</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Difference in LS Means <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-1.63</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-2.53 to -0.72</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.46)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for 
Change From Baseline to Month 3 in HRPQ: Number of Hours of Work Lost 
From Household Due to Absenteeism</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 200 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Difference in LS Means <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-2.10</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-3.02 to -1.19</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.47)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome82" id="outcome82"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">82.&nbsp; Secondary: &nbsp; </td>
            <td>Change From Baseline to Month 4 in HRPQ: Number of Hours
 of Work Lost From Household Due to Absenteeism &nbsp; [ Time Frame: 
Baseline, Month 4 of Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Change From Baseline to Month 4 in HRPQ: Number of Hours of Work Lost From Household Due to Absenteeism</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The HRPQ consists of questions
 measuring the impact of endometriosis-associated pain and its treatment
 on work productivity (number of work hours lost from the household due 
to absenteeism) in the 7 days prior to survey administration.
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline, Month 4 of Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The mITT analysis set included
 all randomized participants who took at least 1 dose of randomized, 
double-blind study drug. Observed cases.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;264&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;170&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;171&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Change From Baseline to Month 4 in HRPQ: Number 
of Hours of Work Lost From Household Due to Absenteeism&nbsp;           
             <br><span class="body3">[Units:&nbsp;Hours]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-1.38&nbsp;&nbsp;(0.265)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-2.59&nbsp;&nbsp;(0.331)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-3.61&nbsp;&nbsp;(0.330)&nbsp;                  
                                                                  </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for 
Change From Baseline to Month 4 in HRPQ: Number of Hours of Work Lost 
From Household Due to Absenteeism</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.004</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Difference in LS Means <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-1.21</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-2.05 to -0.38</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.42)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for 
Change From Baseline to Month 4 in HRPQ: Number of Hours of Work Lost 
From Household Due to Absenteeism</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 200 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Difference in LS Means <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-2.23</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-3.06 to -1.40</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.42)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome83" id="outcome83"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">83.&nbsp; Secondary: &nbsp; </td>
            <td>Change From Baseline to Month 5 in HRPQ: Number of Hours
 of Work Lost From Household Due to Absenteeism &nbsp; [ Time Frame: 
Baseline, Month 5 of Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Change From Baseline to Month 5 in HRPQ: Number of Hours of Work Lost From Household Due to Absenteeism</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The HRPQ consists of questions
 measuring the impact of endometriosis-associated pain and its treatment
 on work productivity (number of work hours lost from the household due 
to absenteeism) in the 7 days prior to survey administration.
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline, Month 5 of Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The mITT analysis set included
 all randomized participants who took at least 1 dose of randomized, 
double-blind study drug. Observed cases.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;253&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;173&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;171&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Change From Baseline to Month 5 in HRPQ: Number 
of Hours of Work Lost From Household Due to Absenteeism&nbsp;           
             <br><span class="body3">[Units:&nbsp;Hours]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-2.13&nbsp;&nbsp;(0.250)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-3.10&nbsp;&nbsp;(0.302)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-3.94&nbsp;&nbsp;(0.304)&nbsp;                  
                                                                  </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for 
Change From Baseline to Month 5 in HRPQ: Number of Hours of Work Lost 
From Household Due to Absenteeism</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.013</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Difference in LS Means <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.97</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-1.74 to -0.20</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.39)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for 
Change From Baseline to Month 5 in HRPQ: Number of Hours of Work Lost 
From Household Due to Absenteeism</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 200 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Difference in LS Means <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-1.81</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-2.58 to -1.04</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.39)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome84" id="outcome84"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">84.&nbsp; Secondary: &nbsp; </td>
            <td>Change From Baseline to Month 6 in HRPQ: Number of Hours
 of Work Lost From Household Due to Absenteeism &nbsp; [ Time Frame: 
Baseline, Month 6 of Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Change From Baseline to Month 6 in HRPQ: Number of Hours of Work Lost From Household Due to Absenteeism</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The HRPQ consists of questions
 measuring the impact of endometriosis-associated pain and its treatment
 on work productivity (number of work hours lost from the household due 
to absenteeism) in the 7 days prior to survey administration.
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline, Month 6 of Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The mITT analysis set included
 all randomized participants who took at least 1 dose of randomized, 
double-blind study drug. Observed cases.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;191&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;145&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;139&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Change From Baseline to Month 6 in HRPQ: Number 
of Hours of Work Lost From Household Due to Absenteeism&nbsp;           
             <br><span class="body3">[Units:&nbsp;Hours]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-1.45&nbsp;&nbsp;(0.313)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-2.73&nbsp;&nbsp;(0.359)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-3.94&nbsp;&nbsp;(0.367)&nbsp;                  
                                                                  </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for 
Change From Baseline to Month 6 in HRPQ: Number of Hours of Work Lost 
From Household Due to Absenteeism</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.007</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Difference in LS Means <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-1.28</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-2.22 to -0.34</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.48)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for 
Change From Baseline to Month 6 in HRPQ: Number of Hours of Work Lost 
From Household Due to Absenteeism</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 200 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Difference in LS Means <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-2.49</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-3.44 to -1.54</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.48)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome85" id="outcome85"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">85.&nbsp; Secondary: &nbsp; </td>
            <td>Change From Baseline to Month 1 in HRPQ: Number of Hours
 of Work Lost From Workplace Due to Presenteeism &nbsp; [ Time Frame: 
Baseline, Month 1 of Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Change From Baseline to Month 1 in HRPQ: Number of Hours of Work Lost From Workplace Due to Presenteeism</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The HRPQ consists of questions
 measuring the impact of endometriosis-associated pain and its treatment
 on work productivity (number of work hours lost from the workplace due 
to presenteeism [working while sick]) in the 7 days prior to survey 
administration.
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline, Month 1 of Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The mITT analysis set included
 all randomized participants who took at least 1 dose of randomized, 
double-blind study drug. Observed cases.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;246&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;170&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;157&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Change From Baseline to Month 1 in HRPQ: Number 
of Hours of Work Lost From Workplace Due to Presenteeism&nbsp;          
              <br><span class="body3">[Units:&nbsp;Hours]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-4.07&nbsp;&nbsp;(0.555)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-4.93&nbsp;&nbsp;(0.668)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-6.00&nbsp;&nbsp;(0.694)&nbsp;                  
                                                                  </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for 
Change From Baseline to Month 1 in HRPQ: Number of Hours of Work Lost 
From Workplace Due to Presenteeism</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.326</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Difference in LS Means <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.86</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-2.57 to 0.85</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.87)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for 
Change From Baseline to Month 1 in HRPQ: Number of Hours of Work Lost 
From Workplace Due to Presenteeism</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 200 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.031</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Difference in LS Means <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-1.93</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-3.67 to -0.18</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.89)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome86" id="outcome86"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">86.&nbsp; Secondary: &nbsp; </td>
            <td>Change From Baseline to Month 2 in HRPQ: Number of Hours
 of Work Lost From Workplace Due to Presenteeism &nbsp; [ Time Frame: 
Baseline, Month 2 of Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Change From Baseline to Month 2 in HRPQ: Number of Hours of Work Lost From Workplace Due to Presenteeism</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The HRPQ consists of questions
 measuring the impact of endometriosis-associated pain and its treatment
 on work productivity (number of work hours lost from the workplace due 
to presenteeism [working while sick]) in the 7 days prior to survey 
administration.
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline, Month 2 of Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The mITT analysis set included
 all randomized participants who took at least 1 dose of randomized, 
double-blind study drug. Observed cases.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;228&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;158&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;145&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Change From Baseline to Month 2 in HRPQ: Number 
of Hours of Work Lost From Workplace Due to Presenteeism&nbsp;          
              <br><span class="body3">[Units:&nbsp;Hours]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-5.42&nbsp;&nbsp;(0.560)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-6.83&nbsp;&nbsp;(0.671)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-8.94&nbsp;&nbsp;(0.701)&nbsp;                  
                                                                  </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for 
Change From Baseline to Month 2 in HRPQ: Number of Hours of Work Lost 
From Workplace Due to Presenteeism</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.107</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Difference in LS Means <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-1.41</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-3.13 to 0.31</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.88)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for 
Change From Baseline to Month 2 in HRPQ: Number of Hours of Work Lost 
From Workplace Due to Presenteeism</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 200 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Difference in LS Means <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-3.52</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-5.28 to -1.75</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.90)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome87" id="outcome87"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">87.&nbsp; Secondary: &nbsp; </td>
            <td>Change From Baseline to Month 3 in HRPQ: Number of Hours
 of Work Lost From Workplace Due to Presenteeism &nbsp; [ Time Frame: 
Baseline, Month 3 of Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Change From Baseline to Month 3 in HRPQ: Number of Hours of Work Lost From Workplace Due to Presenteeism</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The HRPQ consists of questions
 measuring the impact of endometriosis-associated pain and its treatment
 on work productivity (number of work hours lost from the workplace due 
to presenteeism [working while sick]) in the 7 days prior to survey 
administration.
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline, Month 3 of Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The mITT analysis set included
 all randomized participants who took at least 1 dose of randomized, 
double-blind study drug. Observed cases.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;213&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;147&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;136&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Change From Baseline to Month 3 in HRPQ: Number 
of Hours of Work Lost From Workplace Due to Presenteeism&nbsp;          
              <br><span class="body3">[Units:&nbsp;Hours]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-6.23&nbsp;&nbsp;(0.526)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-7.24&nbsp;&nbsp;(0.632)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-9.16&nbsp;&nbsp;(0.657)&nbsp;                  
                                                                  </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for 
Change From Baseline to Month 3 in HRPQ: Number of Hours of Work Lost 
From Workplace Due to Presenteeism</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.219</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Difference in LS Means <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-1.01</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-2.63 to 0.60</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.82)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for 
Change From Baseline to Month 3 in HRPQ: Number of Hours of Work Lost 
From Workplace Due to Presenteeism</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 200 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Difference in LS Means <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-2.93</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-4.59 to -1.28</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.84)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome88" id="outcome88"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">88.&nbsp; Secondary: &nbsp; </td>
            <td>Change From Baseline to Month 4 in HRPQ: Number of Hours
 of Work Lost From Workplace Due to Presenteeism &nbsp; [ Time Frame: 
Baseline, Month 4 of Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Change From Baseline to Month 4 in HRPQ: Number of Hours of Work Lost From Workplace Due to Presenteeism</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The HRPQ consists of questions
 measuring the impact of endometriosis-associated pain and its treatment
 on work productivity (number of work hours lost from the workplace due 
to presenteeism [working while sick]) in the 7 days prior to survey 
administration.
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline, Month 4 of Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The mITT analysis set included
 all randomized participants who took at least 1 dose of randomized, 
double-blind study drug. Observed cases.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;201&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;146&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;132&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Change From Baseline to Month 4 in HRPQ: Number 
of Hours of Work Lost From Workplace Due to Presenteeism&nbsp;          
              <br><span class="body3">[Units:&nbsp;Hours]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-6.81&nbsp;&nbsp;(0.465)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-8.41&nbsp;&nbsp;(0.546)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-10.70&nbsp;&nbsp;(0.573)&nbsp;                 
                                                                   </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for 
Change From Baseline to Month 4 in HRPQ: Number of Hours of Work Lost 
From Workplace Due to Presenteeism</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.026</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Difference in LS Means <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-1.60</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-3.01 to -0.19</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.72)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for 
Change From Baseline to Month 4 in HRPQ: Number of Hours of Work Lost 
From Workplace Due to Presenteeism</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 200 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Difference in LS Means <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-3.89</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-5.34 to -2.43</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.74)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome89" id="outcome89"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">89.&nbsp; Secondary: &nbsp; </td>
            <td>Change From Baseline to Month 5 in HRPQ: Number of Hours
 of Work Lost From Workplace Due to Presenteeism &nbsp; [ Time Frame: 
Baseline, Month 5 of Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Change From Baseline to Month 5 in HRPQ: Number of Hours of Work Lost From Workplace Due to Presenteeism</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The HRPQ consists of questions
 measuring the impact of endometriosis-associated pain and its treatment
 on work productivity (number of work hours lost from the workplace due 
to presenteeism [working while sick]) in the 7 days prior to survey 
administration.
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline, Month 5 of Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The mITT analysis set included
 all randomized participants who took at least 1 dose of randomized, 
double-blind study drug. Observed cases.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;206&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;147&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;123&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Change From Baseline to Month 5 in HRPQ: Number 
of Hours of Work Lost From Workplace Due to Presenteeism&nbsp;          
              <br><span class="body3">[Units:&nbsp;Hours]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-7.80&nbsp;&nbsp;(0.488)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-8.31&nbsp;&nbsp;(0.577)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-10.93&nbsp;&nbsp;(0.631)&nbsp;                 
                                                                   </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for 
Change From Baseline to Month 5 in HRPQ: Number of Hours of Work Lost 
From Workplace Due to Presenteeism</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.502</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Difference in LS Means <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.51</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-2.00 to 0.98</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.76)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for 
Change From Baseline to Month 5 in HRPQ: Number of Hours of Work Lost 
From Workplace Due to Presenteeism</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 200 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Difference in LS Means <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-3.13</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-4.70 to -1.56</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.80)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome90" id="outcome90"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">90.&nbsp; Secondary: &nbsp; </td>
            <td>Change From Baseline to Month 6 in HRPQ: Number of Hours
 of Work Lost From Workplace Due to Presenteeism &nbsp; [ Time Frame: 
Baseline, Month 6 of Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Change From Baseline to Month 6 in HRPQ: Number of Hours of Work Lost From Workplace Due to Presenteeism</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The HRPQ consists of questions
 measuring the impact of endometriosis-associated pain and its treatment
 on work productivity (number of work hours lost from the workplace due 
to presenteeism [working while sick]) in the 7 days prior to survey 
administration.
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline, Month 6 of Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The mITT analysis set included
 all randomized participants who took at least 1 dose of randomized, 
double-blind study drug. Observed cases.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;157&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;118&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;104&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Change From Baseline to Month 6 in HRPQ: Number 
of Hours of Work Lost From Workplace Due to Presenteeism&nbsp;          
              <br><span class="body3">[Units:&nbsp;Hours]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-6.75&nbsp;&nbsp;(0.554)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-8.11&nbsp;&nbsp;(0.637)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-11.21&nbsp;&nbsp;(0.679)&nbsp;                 
                                                                   </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for 
Change From Baseline to Month 6 in HRPQ: Number of Hours of Work Lost 
From Workplace Due to Presenteeism</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.108</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Difference in LS Means <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-1.36</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-3.02 to 0.30</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.85)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for 
Change From Baseline to Month 6 in HRPQ: Number of Hours of Work Lost 
From Workplace Due to Presenteeism</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 200 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Difference in LS Means <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-4.47</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-6.19 to -2.74</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.88)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome91" id="outcome91"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">91.&nbsp; Secondary: &nbsp; </td>
            <td>Change From Baseline to Month 1 in HRPQ: Number of Hours
 of Work Lost From Household Due to Presenteeism &nbsp; [ Time Frame: 
Baseline, Month 1 of Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Change From Baseline to Month 1 in HRPQ: Number of Hours of Work Lost From Household Due to Presenteeism</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The HRPQ consists of questions
 measuring the impact of endometriosis-associated pain and its treatment
 on work productivity (number of work hours lost from the household due 
to presenteeism [working while sick]) in the 7 days prior to survey 
administration.
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline, Month 1 of Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The mITT analysis set included
 all randomized participants who took at least 1 dose of randomized, 
double-blind study drug. Observed cases.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;314&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;200&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;199&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Change From Baseline to Month 1 in HRPQ: Number 
of Hours of Work Lost From Household Due to Presenteeism&nbsp;          
              <br><span class="body3">[Units:&nbsp;Hours]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-0.46&nbsp;&nbsp;(0.224)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-1.64&nbsp;&nbsp;(0.281)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-1.51&nbsp;&nbsp;(0.282)&nbsp;                  
                                                                  </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for 
Change From Baseline to Month 1 in HRPQ: Number of Hours of Work Lost 
From Household Due to Presenteeism</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Difference in LS Means <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-1.19</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-1.90 to -0.48</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.36)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for 
Change From Baseline to Month 1 in HRPQ: Number of Hours of Work Lost 
From Household Due to Presenteeism</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 200 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.004</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Difference in LS Means <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-1.05</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-1.76 to -0.34</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.36)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome92" id="outcome92"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">92.&nbsp; Secondary: &nbsp; </td>
            <td>Change From Baseline to Month 2 in HRPQ: Number of Hours
 of Work Lost From Household Due to Presenteeism &nbsp; [ Time Frame: 
Baseline, Month 2 of Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Change From Baseline to Month 2 in HRPQ: Number of Hours of Work Lost From Household Due to Presenteeism</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The HRPQ consists of questions
 measuring the impact of endometriosis-associated pain and its treatment
 on work productivity (number of work hours lost from the household due 
to presenteeism [working while sick]) in the 7 days prior to survey 
administration.
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline, Month 2 of Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The mITT analysis set included
 all randomized participants who took at least 1 dose of randomized, 
double-blind study drug. Observed cases.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;285&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;190&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;181&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Change From Baseline to Month 2 in HRPQ: Number 
of Hours of Work Lost From Household Due to Presenteeism&nbsp;          
              <br><span class="body3">[Units:&nbsp;Hours]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-1.17&nbsp;&nbsp;(0.238)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-1.93&nbsp;&nbsp;(0.291)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-2.23&nbsp;&nbsp;(0.299)&nbsp;                  
                                                                  </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for 
Change From Baseline to Month 2 in HRPQ: Number of Hours of Work Lost 
From Household Due to Presenteeism</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">mixed-effects model</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.045</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Difference in LS Means <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.76</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-1.49 to -0.02</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.38)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for 
Change From Baseline to Month 2 in HRPQ: Number of Hours of Work Lost 
From Household Due to Presenteeism</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 200 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.006</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Difference in LS Means <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-1.06</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-1.81 to -0.31</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.38)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome93" id="outcome93"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">93.&nbsp; Secondary: &nbsp; </td>
            <td>Change From Baseline to Month 3 in HRPQ: Number of Hours
 of Work Lost From Household Due to Presenteeism &nbsp; [ Time Frame: 
Baseline, Month 3 of Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Change From Baseline to Month 3 in HRPQ: Number of Hours of Work Lost From Household Due to Presenteeism</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The HRPQ consists of questions
 measuring the impact of endometriosis-associated pain and its treatment
 on work productivity (number of work hours lost from the household due 
to presenteeism [working while sick]) in the 7 days prior to survey 
administration.
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline, Month 3 of Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The mITT analysis set included
 all randomized participants who took at least 1 dose of randomized, 
double-blind study drug. Observed cases.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;275&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;185&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;178&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Change From Baseline to Month 3 in HRPQ: Number 
of Hours of Work Lost From Household Due to Presenteeism&nbsp;          
              <br><span class="body3">[Units:&nbsp;Hours]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-1.35&nbsp;&nbsp;(0.210)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-1.89&nbsp;&nbsp;(0.256)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-2.33&nbsp;&nbsp;(0.261)&nbsp;                  
                                                                  </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for 
Change From Baseline to Month 3 in HRPQ: Number of Hours of Work Lost 
From Household Due to Presenteeism</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.103</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Difference in LS Means <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.54</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-1.19 to 0.11</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.33)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for 
Change From Baseline to Month 3 in HRPQ: Number of Hours of Work Lost 
From Household Due to Presenteeism</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 200 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.003</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Difference in LS Means <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.98</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-1.64 to -0.32</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.34)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome94" id="outcome94"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">94.&nbsp; Secondary: &nbsp; </td>
            <td>Change From Baseline to Month 4 in HRPQ: Number of Hours
 of Work Lost From Household Due to Presenteeism &nbsp; [ Time Frame: 
Baseline, Month 4 of Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Change From Baseline to Month 4 in HRPQ: Number of Hours of Work Lost From Household Due to Presenteeism</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The HRPQ consists of questions
 measuring the impact of endometriosis-associated pain and its treatment
 on work productivity (number of work hours lost from the household due 
to presenteeism [working while sick]) in the 7 days prior to survey 
administration.
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline, Month 4 of Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The mITT analysis set included
 all randomized participants who took at least 1 dose of randomized, 
double-blind study drug. Observed cases.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;263&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;168&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;170&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Change From Baseline to Month 4 in HRPQ: Number 
of Hours of Work Lost From Household Due to Presenteeism&nbsp;          
              <br><span class="body3">[Units:&nbsp;Hours]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-1.51&nbsp;&nbsp;(0.224)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-1.81&nbsp;&nbsp;(0.280)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-2.55&nbsp;&nbsp;(0.278)&nbsp;                  
                                                                  </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for 
Change From Baseline to Month 4 in HRPQ: Number of Hours of Work Lost 
From Household Due to Presenteeism</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.390</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Difference in LS Means <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.31</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-1.01 to 0.40</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.36)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for 
Change From Baseline to Month 4 in HRPQ: Number of Hours of Work Lost 
From Household Due to Presenteeism</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 200 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.003</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Difference in LS Means <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-1.05</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-1.75 to -0.35</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.36)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome95" id="outcome95"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">95.&nbsp; Secondary: &nbsp; </td>
            <td>Change From Baseline to Month 5 in HRPQ: Number of Hours
 of Work Lost From Household Due to Presenteeism &nbsp; [ Time Frame: 
Baseline, Month 5 of Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Change From Baseline to Month 5 in HRPQ: Number of Hours of Work Lost From Household Due to Presenteeism</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The HRPQ consists of questions
 measuring the impact of endometriosis-associated pain and its treatment
 on work productivity (number of work hours lost from the household due 
to presenteeism [working while sick]) in the 7 days prior to survey 
administration.
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline, Month 5 of Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The mITT analysis set included
 all randomized participants who took at least 1 dose of randomized, 
double-blind study drug. Observed cases.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;253&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;172&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;169&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Change From Baseline to Month 5 in HRPQ: Number 
of Hours of Work Lost From Household Due to Presenteeism&nbsp;          
              <br><span class="body3">[Units:&nbsp;Hours]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-1.67&nbsp;&nbsp;(0.169)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-1.86&nbsp;&nbsp;(0.205)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-2.71&nbsp;&nbsp;(0.206)&nbsp;                  
                                                                  </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for 
Change From Baseline to Month 5 in HRPQ: Number of Hours of Work Lost 
From Household Due to Presenteeism</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.460</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Difference in LS Means <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.20</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-0.72 to 0.32</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.27)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for 
Change From Baseline to Month 5 in HRPQ: Number of Hours of Work Lost 
From Household Due to Presenteeism</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 200 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Difference in LS Means <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-1.04</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-1.57 to -0.52</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.27)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome96" id="outcome96"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">96.&nbsp; Secondary: &nbsp; </td>
            <td>Change From Baseline to Month 6 in HRPQ: Number of Hours
 of Work Lost From Household Due to Presenteeism &nbsp; [ Time Frame: 
Baseline, Month 6 of Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Change From Baseline to Month 6 in HRPQ: Number of Hours of Work Lost From Household Due to Presenteeism</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The HRPQ consists of questions
 measuring the impact of endometriosis-associated pain and its treatment
 on work productivity (number of work hours lost from the household due 
to presenteeism [working while sick]) in the 7 days prior to survey 
administration.
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline, Month 6 of Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The mITT analysis set included
 all randomized participants who took at least 1 dose of randomized, 
double-blind study drug. Observed cases.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;191&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;145&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;135&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Change From Baseline to Month 6 in HRPQ: Number 
of Hours of Work Lost From Household Due to Presenteeism&nbsp;          
              <br><span class="body3">[Units:&nbsp;Hours]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-1.48&nbsp;&nbsp;(0.232)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-2.07&nbsp;&nbsp;(0.265)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-2.78&nbsp;&nbsp;(0.275)&nbsp;                  
                                                                  </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for 
Change From Baseline to Month 6 in HRPQ: Number of Hours of Work Lost 
From Household Due to Presenteeism</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.095</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">LS Mean of Difference <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.59</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-1.28 to 0.10</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.35)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for 
Change From Baseline to Month 6 in HRPQ: Number of Hours of Work Lost 
From Household Due to Presenteeism</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 200 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Difference in LS Means <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-1.30</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-2.01 to -0.59</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.36)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome97" id="outcome97"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">97.&nbsp; Secondary: &nbsp; </td>
            <td>Change From Baseline to Month 1 in HRPQ: Total 
(Absenteeism and Presenteeism) Number of Hours of Work Lost From 
Workplace &nbsp; [ Time Frame: Baseline, Month 1 of Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Change From Baseline to Month 1 in HRPQ: Total (Absenteeism and Presenteeism) Number of Hours of Work Lost From Workplace</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The HRPQ consists of questions
 measuring the impact of endometriosis-associated pain and its treatment
 on work productivity (number of work hours lost from the workplace due 
to absenteeism and presenteeism) in the 7 days prior to survey 
administration.
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline, Month 1 of Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The mITT analysis set included
 all randomized participants who took at least 1 dose of randomized, 
double-blind study drug. Observed cases.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;251&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;171&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;162&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Change From Baseline to Month 1 in HRPQ: Total 
(Absenteeism and Presenteeism) Number of Hours of Work Lost From 
Workplace&nbsp;                        <br><span class="body3">[Units:&nbsp;Hours]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-5.46&nbsp;&nbsp;(0.615)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-6.17&nbsp;&nbsp;(0.745)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-8.69&nbsp;&nbsp;(0.764)&nbsp;                  
                                                                  </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for 
Change From Baseline to Month 1 in HRPQ: Total (Absenteeism and 
Presenteeism) Number of Hours of Work Lost From Workplace</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.462</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Difference in LS Means <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-0.71</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-2.61 to 1.19</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.97)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for 
Change From Baseline to Month 1 in HRPQ: Total (Absenteeism and 
Presenteeism) Number of Hours of Work Lost From Workplace</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 200 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Difference in LS Means <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-3.23</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-5.16 to -1.30</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.98)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome98" id="outcome98"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">98.&nbsp; Secondary: &nbsp; </td>
            <td>Change From Baseline to Month 2 in HRPQ: Total 
(Absenteeism and Presenteeism) Number of Hours of Work Lost From 
Workplace &nbsp; [ Time Frame: Baseline, Month 2 of Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Change From Baseline to Month 2 in HRPQ: Total (Absenteeism and Presenteeism) Number of Hours of Work Lost From Workplace</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The HRPQ consists of questions
 measuring the impact of endometriosis-associated pain and its treatment
 on work productivity (number of work hours lost from the workplace due 
to absenteeism and presenteeism) in the 7 days prior to survey 
administration.
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline, Month 2 of Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The mITT analysis set included
 all randomized participants who took at least 1 dose of randomized, 
double-blind study drug. Observed cases.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;232&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;160&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;147&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Change From Baseline to Month 2 in HRPQ: Total 
(Absenteeism and Presenteeism) Number of Hours of Work Lost From 
Workplace&nbsp;                        <br><span class="body3">[Units:&nbsp;Hours]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-6.70&nbsp;&nbsp;(0.621)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-8.72&nbsp;&nbsp;(0.746)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-11.56&nbsp;&nbsp;(0.778)&nbsp;                 
                                                                   </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for 
Change From Baseline to Month 2 in HRPQ: Total (Absenteeism and 
Presenteeism) Number of Hours of Work Lost From Workplace</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.039</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Difference in LS Means <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-2.02</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-3.93 to -0.11</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.97)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for 
Change From Baseline to Month 2 in HRPQ: Total (Absenteeism and 
Presenteeism) Number of Hours of Work Lost From Workplace</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 200 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Difference in LS Means <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-4.86</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-6.82 to -2.90</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(1.00)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome99" id="outcome99"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">99.&nbsp; Secondary: &nbsp; </td>
            <td>Change From Baseline to Month 3 in HRPQ: Total 
(Absenteeism and Presenteeism) Number of Hours of Work Lost From 
Workplace &nbsp; [ Time Frame: Baseline, Month 3 of Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Change From Baseline to Month 3 in HRPQ: Total (Absenteeism and Presenteeism) Number of Hours of Work Lost From Workplace</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The HRPQ consists of questions
 measuring the impact of endometriosis-associated pain and its treatment
 on work productivity (number of work hours lost from the workplace due 
to absenteeism and presenteeism) in the 7 days prior to survey 
administration.
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline, Month 3 of Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The mITT analysis set included
 all randomized participants who took at least 1 dose of randomized, 
double-blind study drug. Observed cases.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;215&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;148&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;140&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Change From Baseline to Month 3 in HRPQ: Total 
(Absenteeism and Presenteeism) Number of Hours of Work Lost From 
Workplace&nbsp;                        <br><span class="body3">[Units:&nbsp;Hours]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-7.00&nbsp;&nbsp;(0.654)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-9.20&nbsp;&nbsp;(0.787)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-11.90&nbsp;&nbsp;(0.808)&nbsp;                 
                                                                   </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for 
Change From Baseline to Month 3 in HRPQ: Total (Absenteeism and 
Presenteeism) Number of Hours of Work Lost From Workplace</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.032</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Difference in LS Means <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-2.20</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-4.21 to -0.18</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(1.03)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for 
Change From Baseline to Month 3 in HRPQ: Total (Absenteeism and 
Presenteeism) Number of Hours of Work Lost From Workplace</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 200 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Difference in LS Means <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-4.91</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-6.95 to -2.86</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(1.04)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome100" id="outcome100"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">100.&nbsp; Secondary: &nbsp; </td>
            <td>Change From Baseline to Month 4 in HRPQ: Total 
(Absenteeism and Presenteeism) Number of Hours of Work Lost From 
Workplace &nbsp; [ Time Frame: Baseline, Month 4 of Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Change From Baseline to Month 4 in HRPQ: Total (Absenteeism and Presenteeism) Number of Hours of Work Lost From Workplace</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The HRPQ consists of questions
 measuring the impact of endometriosis-associated pain and its treatment
 on work productivity (number of work hours lost from the workplace due 
to absenteeism and presenteeism) in the 7 days prior to survey 
administration.
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline, Month 4 of Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The mITT analysis set included
 all randomized participants who took at least 1 dose of randomized, 
double-blind study drug. Observed cases.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;205&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;148&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;134&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Change From Baseline to Month 4 in HRPQ: Total 
(Absenteeism and Presenteeism) Number of Hours of Work Lost From 
Workplace&nbsp;                        <br><span class="body3">[Units:&nbsp;Hours]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-7.84&nbsp;&nbsp;(0.605)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-10.26&nbsp;&nbsp;(0.712)&nbsp;                 
                                                                   </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-13.09&nbsp;&nbsp;(0.747)&nbsp;                 
                                                                   </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for 
Change From Baseline to Month 4 in HRPQ: Total (Absenteeism and 
Presenteeism) Number of Hours of Work Lost From Workplace</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.010</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Difference in LS Means <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-2.42</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-4.26 to -0.58</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.94)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for 
Change From Baseline to Month 4 in HRPQ: Total (Absenteeism and 
Presenteeism) Number of Hours of Work Lost From Workplace</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 200 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Difference in LS Means <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-5.25</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-7.14 to -3.36</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.96)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome101" id="outcome101"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">101.&nbsp; Secondary: &nbsp; </td>
            <td>Change From Baseline to Month 5 in HRPQ: Total 
(Absenteeism and Presenteeism) Number of Hours of Work Lost From 
Workplace &nbsp; [ Time Frame: Baseline, Month 5 of Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Change From Baseline to Month 5 in HRPQ: Total (Absenteeism and Presenteeism) Number of Hours of Work Lost From Workplace</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The HRPQ consists of questions
 measuring the impact of endometriosis-associated pain and its treatment
 on work productivity (number of work hours lost from the workplace due 
to absenteeism and presenteeism) in the 7 days prior to survey 
administration.
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline, Month 5 of Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The mITT analysis set included
 all randomized participants who took at least 1 dose of randomized, 
double-blind study drug. Observed cases.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;209&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;147&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;128&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Change From Baseline to Month 5 in HRPQ: Total 
(Absenteeism and Presenteeism) Number of Hours of Work Lost From 
Workplace&nbsp;                        <br><span class="body3">[Units:&nbsp;Hours]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-8.87&nbsp;&nbsp;(0.604)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-10.04&nbsp;&nbsp;(0.719)&nbsp;                 
                                                                   </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-14.00&nbsp;&nbsp;(0.771)&nbsp;                 
                                                                   </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for 
Change From Baseline to Month 5 in HRPQ: Total (Absenteeism and 
Presenteeism) Number of Hours of Work Lost From Workplace</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.215</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Difference in LS Means <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-1.17</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-3.02 to 0.68</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.94)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for 
Change From Baseline to Month 5 in HRPQ: Total (Absenteeism and 
Presenteeism) Number of Hours of Work Lost From Workplace</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 200 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Difference in LS Means <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-5.13</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-7.06 to -3.20</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.98)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome102" id="outcome102"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">102.&nbsp; Secondary: &nbsp; </td>
            <td>Change From Baseline to Month 6 in HRPQ: Total 
(Absenteeism and Presenteeism) Number of Hours of Work Lost From 
Workplace &nbsp; [ Time Frame: Baseline, Month 6 of Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Change From Baseline to Month 6 in HRPQ: Total (Absenteeism and Presenteeism) Number of Hours of Work Lost From Workplace</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The HRPQ consists of questions
 measuring the impact of endometriosis-associated pain and its treatment
 on work productivity (number of work hours lost from the workplace due 
to absenteeism and presenteeism) in the 7 days prior to survey 
administration.
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline, Month 6 of Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The mITT analysis set included
 all randomized participants who took at least 1 dose of randomized, 
double-blind study drug. Observed cases.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;159&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;120&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;105&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Change From Baseline to Month 6 in HRPQ: Total 
(Absenteeism and Presenteeism) Number of Hours of Work Lost From 
Workplace&nbsp;                        <br><span class="body3">[Units:&nbsp;Hours]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-6.88&nbsp;&nbsp;(0.761)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-9.14&nbsp;&nbsp;(0.874)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-13.67&nbsp;&nbsp;(0.936)&nbsp;                 
                                                                   </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for 
Change From Baseline to Month 6 in HRPQ: Total (Absenteeism and 
Presenteeism) Number of Hours of Work Lost From Workplace</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.053</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Difference in LS Means <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-2.25</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-4.53 to 0.03</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(1.16)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for 
Change From Baseline to Month 6 in HRPQ: Total (Absenteeism and 
Presenteeism) Number of Hours of Work Lost From Workplace</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Difference in LS Means <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-6.79</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-9.17 to -4.41</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(1.21)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome103" id="outcome103"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">103.&nbsp; Secondary: &nbsp; </td>
            <td>Change From Baseline to Month 1 in HRPQ: Total 
(Absenteeism and Presenteeism) Number of Hours of Work Lost From 
Household &nbsp; [ Time Frame: Baseline, Month 1 of Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Change From Baseline to Month 1 in HRPQ: Total (Absenteeism and Presenteeism) Number of Hours of Work Lost From Household</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The HRPQ consists of questions
 measuring the impact of endometriosis-associated pain and its treatment
 on work productivity (number of work hours lost from the household due 
to absenteeism and presenteeism) in the 7 days prior to survey 
administration.
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline, Month 1 of Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The mITT analysis set included
 all randomized participants who took at least 1 dose of randomized, 
double-blind study drug. Observed cases.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;319&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;200&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;202&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Change From Baseline to Month 1 in HRPQ: Total 
(Absenteeism and Presenteeism) Number of Hours of Work Lost From 
Household&nbsp;                        <br><span class="body3">[Units:&nbsp;Hours]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-1.76&nbsp;&nbsp;(0.352)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-3.88&nbsp;&nbsp;(0.445)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-4.36&nbsp;&nbsp;(0.443)&nbsp;                  
                                                                  </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for 
Change From Baseline to Month 1 in HRPQ: Total (Absenteeism and 
Presenteeism) Number of Hours of Work Lost From Household</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Difference in LS Means <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-2.12</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-3.24 to -1.01</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.57)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for 
Change From Baseline to Month 1 in HRPQ: Total (Absenteeism and 
Presenteeism) Number of Hours of Work Lost From Household</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 200 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Difference in LS Means <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-2.60</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-3.71 to -1.49</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.57)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome104" id="outcome104"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">104.&nbsp; Secondary: &nbsp; </td>
            <td>Change From Baseline to Month 2 in HRPQ: Total 
(Absenteeism and Presenteeism) Number of Hours of Work Lost From 
Household &nbsp; [ Time Frame: Baseline, Month 2 of Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Change From Baseline to Month 2 in HRPQ: Total (Absenteeism and Presenteeism) Number of Hours of Work Lost From Household</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The HRPQ consists of questions
 measuring the impact of endometriosis-associated pain and its treatment
 on work productivity (number of work hours lost from the household due 
to absenteeism and presenteeism) in the 7 days prior to survey 
administration.
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline, Month 2 of Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The mITT analysis set included
 all randomized participants who took at least 1 dose of randomized, 
double-blind study drug. Observed cases.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;287&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;192&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;183&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Change From Baseline to Month 2 in HRPQ: Total 
(Absenteeism and Presenteeism) Number of Hours of Work Lost From 
Household&nbsp;                        <br><span class="body3">[Units:&nbsp;Hours]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-2.60&nbsp;&nbsp;(0.423)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-4.69&nbsp;&nbsp;(0.517)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-5.25&nbsp;&nbsp;(0.529)&nbsp;                  
                                                                  </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for 
Change From Baseline to Month 2 in HRPQ: Total (Absenteeism and 
Presenteeism) Number of Hours of Work Lost From Household</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.002</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Difference in LS Means <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-2.09</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-3.40 to -0.78</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.67)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for 
Change From Baseline to Month 2 in HRPQ: Total (Absenteeism and 
Presenteeism) Number of Hours of Work Lost From Household</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 200 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Difference in LS Means <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-2.65</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-3.98 to -1.32</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.68)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome105" id="outcome105"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">105.&nbsp; Secondary: &nbsp; </td>
            <td>Change From Baseline to Month 3 in HRPQ: Total 
(Absenteeism and Presenteeism) Number of Hours of Work Lost From 
Household &nbsp; [ Time Frame: Baseline, Month 3 of Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Change From Baseline to Month 3 in HRPQ: Total (Absenteeism and Presenteeism) Number of Hours of Work Lost From Household</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The HRPQ consists of questions
 measuring the impact of endometriosis-associated pain and its treatment
 on work productivity (number of work hours lost from the household due 
to absenteeism and presenteeism) in the 7 days prior to survey 
administration.
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline, Month 3 of Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The mITT analysis set included
 all randomized participants who took at least 1 dose of randomized, 
double-blind study drug. Observed cases.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;278&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;185&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;179&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Change From Baseline to Month 3 in HRPQ: Total 
(Absenteeism and Presenteeism) Number of Hours of Work Lost From 
Household&nbsp;                        <br><span class="body3">[Units:&nbsp;Hours]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-2.73&nbsp;&nbsp;(0.394)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-4.90&nbsp;&nbsp;(0.483)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-5.73&nbsp;&nbsp;(0.492)&nbsp;                  
                                                                  </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for 
Change From Baseline to Month 3 in HRPQ: Total (Absenteeism and 
Presenteeism) Number of Hours of Work Lost From Household</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Difference in LS Means <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-2.17</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-3.39 to -0.95</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.62)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for 
Change From Baseline to Month 3 in HRPQ: Total (Absenteeism and 
Presenteeism) Number of Hours of Work Lost From Household</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 200 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Difference in LS Means <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-3.00</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-4.23 to -1.76</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.63)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome106" id="outcome106"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">106.&nbsp; Secondary: &nbsp; </td>
            <td>Change From Baseline to Month 4 in HRPQ: Total 
(Absenteeism and Presenteeism) Number of Hours of Work Lost From 
Household &nbsp; [ Time Frame: Baseline, Month 4 of Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Change From Baseline to Month 4 in HRPQ: Total (Absenteeism and Presenteeism) Number of Hours of Work Lost From Household</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The HRPQ consists of questions
 measuring the impact of endometriosis-associated pain and its treatment
 on work productivity (number of work hours lost from the household due 
to absenteeism and presenteeism) in the 7 days prior to survey 
administration.
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline, Month 4 of Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The mITT analysis set included
 all randomized participants who took at least 1 dose of randomized, 
double-blind study drug. Observed cases.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;264&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;170&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;171&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Change From Baseline to Month 4 in HRPQ: Total 
(Absenteeism and Presenteeism) Number of Hours of Work Lost From 
Household&nbsp;                        <br><span class="body3">[Units:&nbsp;Hours]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-2.89&nbsp;&nbsp;(0.403)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-4.43&nbsp;&nbsp;(0.502)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-6.13&nbsp;&nbsp;(0.501)&nbsp;                  
                                                                  </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for 
Change From Baseline to Month 4 in HRPQ: Total (Absenteeism and 
Presenteeism) Number of Hours of Work Lost From Household</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.017</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Difference in LS Means <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-1.54</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-2.80 to -0.27</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.64)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for 
Change From Baseline to Month 4 in HRPQ: Total (Absenteeism and 
Presenteeism) Number of Hours of Work Lost From Household</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 200 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Difference in LS Means <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-3.24</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-4.50 to -1.98</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.64)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome107" id="outcome107"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">107.&nbsp; Secondary: &nbsp; </td>
            <td>Change From Baseline to Month 5 in HRPQ: Total 
(Absenteeism and Presenteeism) Number of Hours of Work Lost From 
Household &nbsp; [ Time Frame: Baseline, Month 5 of Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Change From Baseline to Month 5 in HRPQ: Total (Absenteeism and Presenteeism) Number of Hours of Work Lost From Household</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The HRPQ consists of questions
 measuring the impact of endometriosis-associated pain and its treatment
 on work productivity (number of work hours lost from the household due 
to absenteeism and presenteeism) in the 7 days prior to survey 
administration.
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline, Month 5 of Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The mITT analysis set included
 all randomized participants who took at least 1 dose of randomized, 
double-blind study drug. Observed cases.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;253&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;173&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;171&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Change From Baseline to Month 5 in HRPQ: Total 
(Absenteeism and Presenteeism) Number of Hours of Work Lost From 
Household&nbsp;                        <br><span class="body3">[Units:&nbsp;Hours]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-3.80&nbsp;&nbsp;(0.349)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-4.94&nbsp;&nbsp;(0.423)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-6.62&nbsp;&nbsp;(0.425)&nbsp;                  
                                                                  </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for 
Change From Baseline to Month 5 in HRPQ: Total (Absenteeism and 
Presenteeism) Number of Hours of Work Lost From Household</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.038</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Difference in LS Means <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-1.14</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-2.22 to -0.07</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.55)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for 
Change From Baseline to Month 5 in HRPQ: Total (Absenteeism and 
Presenteeism) Number of Hours of Work Lost From Household</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 200 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Difference in LS Means <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-2.83</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-3.91 to -1.74</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.55)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome108" id="outcome108"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">108.&nbsp; Secondary: &nbsp; </td>
            <td>Change From Baseline to Month 6 in HRPQ: Total 
(Absenteeism and Presenteeism) Number of Hours of Work Lost From 
Household &nbsp; [ Time Frame: Baseline, Month 6 of Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Change From Baseline to Month 6 in HRPQ: Total (Absenteeism and Presenteeism) Number of Hours of Work Lost From Household</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The HRPQ consists of questions
 measuring the impact of endometriosis-associated pain and its treatment
 on work productivity (number of work hours lost from the household due 
to absenteeism and presenteeism) in the 7 days prior to survey 
administration.
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Baseline, Month 6 of Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The mITT analysis set included
 all randomized participants who took at least 1 dose of randomized, 
double-blind study drug. Observed cases.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;191&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;145&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;139&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Change From Baseline to Month 6 in HRPQ: Total 
(Absenteeism and Presenteeism) Number of Hours of Work Lost From 
Household&nbsp;                        <br><span class="body3">[Units:&nbsp;Hours]<br>Least Squares Mean (Standard Error)</span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-2.94&nbsp;&nbsp;(0.433)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-4.78&nbsp;&nbsp;(0.496)&nbsp;                  
                                                                  </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;-6.69&nbsp;&nbsp;(0.507)&nbsp;                  
                                                                  </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                                                <br>
                  <span class="header3">Statistical Analysis 1 for 
Change From Baseline to Month 6 in HRPQ: Total (Absenteeism and 
Presenteeism) Number of Hours of Work Lost From Household</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 150 mg QD</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">0.006</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Difference in LS Means <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-1.83</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-3.13 to -0.54</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.66)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                  <br>
                  <span class="header3">Statistical Analysis 2 for 
Change From Baseline to Month 6 in HRPQ: Total (Absenteeism and 
Presenteeism) Number of Hours of Work Lost From Household</span>
                  <div class="indent2">

                                        <table class="data_table" style="margin-top:1.5ex;" cellspacing="0" cellpadding="5" border="1">
                      <tbody><tr>
                        <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Groups <span class="note_outcome_color"><sup>[1]</sup></span></th>
                        <td class="body3 pale_outcome_color">Placebo vs. Elagolix 200 mg BID</td>
                                              </tr>

                                              <tr>
                          <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Test Type <span class="note_outcome_color"><sup>[2]</sup></span></th>
                          <td class="body3 pale_outcome_color">Superiority</td>
                                                  </tr>
                      
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Statistical Method <span class="note_outcome_color"><sup>[3]</sup></span></th>
                            <td class="body3 pale_outcome_color">ANCOVA</td>
                                                      </tr>
                        
                                                  <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">P Value <span class="note_outcome_color"><sup>[4]</sup></span></th>
                            <td class="body3 pale_outcome_color">&lt; 0.001</td>
                                                      </tr>
                                              
                                                                        <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Difference in LS Means <span class="note_outcome_color"><sup>[5]</sup></span></th>
                            <td class="body3 pale_outcome_color">-3.75</td>
                                                      </tr>
                                                                                                      <tr>
                              <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">95% Confidence Interval</th>
                              <td class="body3 pale_outcome_color">-5.06 to -2.44</td>
                            </tr>
                                                                                                    <tr>
                            <th class="header3 bold_outcome_color" style="text-align:left;white-space:nowrap;">Standard Error of the Mean</th>
                            <td class="body3 pale_outcome_color">(0.67)</td>
                          </tr>
                                                                    
                                          </tbody></table>

                                        <table class="data_table" style="padding:2px; margin-top:1ex; border:none;" width="100%" cellspacing="0" cellpadding="2" border="0">
                      <tbody><tr style="vertical-align:top;">
                        <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[1]</th>
                        <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional details about the analysis, such as null hypothesis and power calculation:</td>
                                              </tr>
                      <tr>
                        <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                        <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                      No text entered.
                                                  </td>
                      </tr>

                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left;" nowrap="nowrap">[2]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Details of power calculation, definition of non-inferiority margin, and other key parameters:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[3]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant method information, such as adjustments or degrees of freedom:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[4]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Additional
 information, such as whether or not the p-value is adjusted for 
multiple comparisons and the a priori threshold for statistical 
significance:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                      
                                              <tr style="vertical-align:top;">
                          <th class="header3 note_outcome_color" style="padding:2px; margin:0px; border:none; text-align:left; white-space:nowrap;">[5]</th>
                          <td class="body3" style="padding:2px 2px 2px 1em; margin:0ex; border:none;">Other relevant estimation information:</td>
                                                  </tr>
                        <tr>
                          <td style="padding:2px; margin-top:1ex; border:none;">&nbsp;</td>
                          <td class="body3" style="padding:2px 2px 2px 2em; margin:0ex; border:none;">
                                                          No text entered.
                                                      </td>
                        </tr>
                                                                   
                    </tbody></table>
                  </div>
                                            <br>
              <br>
                              </div>
              <a name="outcome109" id="outcome109"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">109.&nbsp; Secondary: &nbsp; </td>
            <td>Number of Participants With Endometriosis-Related 
Non-Study Health Visits During the Treatment Period &nbsp; [ Time Frame:
 Up to Month 6 of Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Number of Participants With Endometriosis-Related Non-Study Health Visits During the Treatment Period</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          No text entered.
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Up to Month 6 of Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The modified intent-to-treat 
analysis set included all randomized participants who took at least 1 
dose of randomized, double-blind study drug.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;374&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;249&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;248&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Number of Participants With 
Endometriosis-Related Non-Study Health Visits During the Treatment 
Period&nbsp;                        <br><span class="body3">[Units:&nbsp;Participants]<br>Count of Participants</span>                       </th>
                                                                        <td class="brt pale_outcome_color">&nbsp;</td>
                                                  <td class="brt pale_outcome_color">&nbsp;</td>
                                                  <td class="brt pale_outcome_color">&nbsp;</td>
                                                                  </tr>
                                          <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Baseline&nbsp;                                                  </td>
                                                                              <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;69&nbsp;                                                          </td>
                                                      <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;54&nbsp;                                                          </td>
                                                      <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;51&nbsp;                                                          </td>
                                                                        </tr>
                                                                <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Month 1&nbsp;                                                  </td>
                                                                              <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;70&nbsp;                                                          </td>
                                                      <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;50&nbsp;                                                          </td>
                                                      <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;47&nbsp;                                                          </td>
                                                                        </tr>
                                                                <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Month 2&nbsp;                                                  </td>
                                                                              <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;59&nbsp;                                                          </td>
                                                      <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;38&nbsp;                                                          </td>
                                                      <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;33&nbsp;                                                          </td>
                                                                        </tr>
                                                                <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Month 3&nbsp;                                                  </td>
                                                                              <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;66&nbsp;                                                          </td>
                                                      <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;37&nbsp;                                                          </td>
                                                      <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;48&nbsp;                                                          </td>
                                                                        </tr>
                                                                <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Month 4&nbsp;                                                  </td>
                                                                              <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;54&nbsp;                                                          </td>
                                                      <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;35&nbsp;                                                          </td>
                                                      <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;42&nbsp;                                                          </td>
                                                                        </tr>
                                                                <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Month 5&nbsp;                                                  </td>
                                                                              <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;43&nbsp;                                                          </td>
                                                      <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;32&nbsp;                                                          </td>
                                                      <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;22&nbsp;                                                          </td>
                                                                        </tr>
                                                                <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Month 6&nbsp;                                                  </td>
                                                                              <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;38&nbsp;                                                          </td>
                                                      <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;26&nbsp;                                                          </td>
                                                      <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;21&nbsp;                                                          </td>
                                                                        </tr>
                                                                <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Overall&nbsp;                                                  </td>
                                                                              <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;189&nbsp;                                                         
 </td>
                                                      <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;126&nbsp;                                                         
 </td>
                                                      <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;113&nbsp;                                                         
 </td>
                                                                        </tr>
                                                                                          </tbody></table>
            
                            <br>


                              <span class="header3">No statistical 
analysis provided for Number of Participants With Endometriosis-Related 
Non-Study Health Visits During the Treatment Period</span>
                <br>

                            <br>
              <br>
                              </div>
              <a name="outcome110" id="outcome110"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">110.&nbsp; Secondary: &nbsp; </td>
            <td>Number of Days of Hospitalization &nbsp; [ Time Frame: Up to Month 6 of Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Number of Days of Hospitalization</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          No text entered.
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Up to Month 6 of Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The modified intent-to-treat 
analysis set included all randomized participants who took at least 1 
dose of randomized, double-blind study drug. Includes participants who 
were hospitalized during the Treatment Period.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;15&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;3&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;13&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Number of Days of Hospitalization&nbsp;                        <br><span class="body3">[Units:&nbsp;Days]<br>Mean (Standard Deviation)</span>                       </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;2.9&nbsp;&nbsp;(2.45)&nbsp;                     
                                                               </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;2.0&nbsp;&nbsp;(1.00)&nbsp;                     
                                                               </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                                        
                  &nbsp;2.0&nbsp;&nbsp;(1.68)&nbsp;                     
                                                               </td>
                                                                  </tr>
                    
                                                </tbody></table>
            
                            <br>


                              <span class="header3">No statistical analysis provided for Number of Days of Hospitalization</span>
                <br>

                            <br>
              <br>
                              </div>
              <a name="outcome111" id="outcome111"></a>

        <br>
        <table class="layout_table header2" style="margin-top:0.5ex" cellspacing="0" cellpadding="0" border="0">
          <tbody><tr style="vertical-align:top;">
            <td nowrap="nowrap">111.&nbsp; Secondary: &nbsp; </td>
            <td>Number of Participants With Emergency Room/Outpatient 
Procedures During the Treatment Period, by Type &nbsp; [ Time Frame: Up 
to Month 6 of Treatment Period ]</td>
          </tr>
        </tbody></table>

        <div class="body3 indent2" style="margin-top:0.5ex;">

          
            
              
              <br>
              <table class="data_table" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Type</th>
                  <td class="body3 pale_outcome_color">Secondary</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Measure&nbsp;Title</th>
                  <td class="body3 pale_outcome_color">Number of Participants With Emergency Room/Outpatient Procedures During the Treatment Period, by Type</td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;">Measure&nbsp;Description</th>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          No text entered.
                                      </td>
                </tr>
                <tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">Time&nbsp;Frame</th>
                  <td class="body3 pale_outcome_color">Up to Month 6 of Treatment Period &nbsp;</td>
                </tr>
              </tbody></table>
              <br>

              <span class="header3">Population Description</span>
              <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
                <tbody><tr>
                  <th class="header3 bold_outcome_color" style="text-align:left;">
                    Explanation of how the number of participants for analysis was determined.
                    Includes whether analysis was per protocol, intention to treat, or another method.
                    Also provides relevant details such as imputation technique, as appropriate.
                  </th>
                </tr>
                <tr>
                  <td class="body3 pale_outcome_color" style="vertical-align:top;">
                                          The modified intent-to-treat 
analysis set included all randomized participants who took at least 1 
dose of randomized, double-blind study drug.
                                      </td>
                </tr>
              </tbody></table>

              
              <br>
                            
  <span class="header3">Reporting Groups</span>
  <table class="data_table" style="margin-top:0.5ex" cellspacing="0" cellpadding="5" border="1">
    <tbody><tr>
      <th class="header3 bold_outcome_color">&nbsp;</th>
      <th class="header3 bold_outcome_color" style="text-align:left;">Description</th>
    </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Placebo</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Placebo BID for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 150 mg QD</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 150 mg QD for the 6-month Treatment Period
                      </td>
        </tr>
            <tr>
          <th class="header3 bold_outcome_color" style="text-align:left;vertical-align:top;white-space:nowrap;">Elagolix 200 mg BID</th>
          <td class="body3 pale_outcome_color" style="vertical-align:top;">
                          Elagolix 200 mg BID for the 6-month Treatment Period
                      </td>
        </tr>
      </tbody></table>


              <br>
              <span class="header3">Measured Values</span>
              <table class="results_table" style="margin-top:0.5ex;" cellspacing="0" cellpadding="0" border="0">
                <tbody><tr>
                  <th class="brt bold_outcome_color" style="max-width:50%">&nbsp;</th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Placebo&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 150 mg QD&nbsp; 
                    </th>
                                      <th class="header3 brt bold_outcome_color style=" max-width:20%;text-align:center;"="">
                      &nbsp;Elagolix 200 mg BID&nbsp; 
                    </th>
                                  </tr>
            
                            
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Participants Analyzed&nbsp;                                              </th>
                                                                        <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;374&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;249&nbsp;                                                      </td>
                                                  <td class="header3 brt pale_outcome_color" style="text-align:center;">
                                                          &nbsp;248&nbsp;                                                      </td>
                                                                  </tr>
                    
                                              
                                      <tr>
                      <th class="header3 brt bold_outcome_color" style="text-align:left;">
                        Number of Participants With Emergency 
Room/Outpatient Procedures During the Treatment Period, by Type&nbsp;   
                     <br><span class="body3">[Units:&nbsp;Participants]<br>Count of Participants</span>                       </th>
                                                                        <td class="brt pale_outcome_color">&nbsp;</td>
                                                  <td class="brt pale_outcome_color">&nbsp;</td>
                                                  <td class="brt pale_outcome_color">&nbsp;</td>
                                                                  </tr>
                                          <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          All Categories&nbsp;                                                  </td>
                                                                              <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;62&nbsp;                                                          </td>
                                                      <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;21&nbsp;                                                          </td>
                                                      <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;32&nbsp;                                                          </td>
                                                                        </tr>
                                                                <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Abdominal Hysterectomy&nbsp;                                                  </td>
                                                                              <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;0&nbsp;                                                          </td>
                                                      <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;0&nbsp;                                                          </td>
                                                      <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;0&nbsp;                                                          </td>
                                                                        </tr>
                                                                <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Angiography&nbsp;                                                  </td>
                                                                              <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;0&nbsp;                                                          </td>
                                                      <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;0&nbsp;                                                          </td>
                                                      <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;0&nbsp;                                                          </td>
                                                                        </tr>
                                                                <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Arthroscopy&nbsp;                                                  </td>
                                                                              <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;0&nbsp;                                                          </td>
                                                      <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;0&nbsp;                                                          </td>
                                                      <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;1&nbsp;                                                          </td>
                                                                        </tr>
                                                                <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Biopsy&nbsp;                                                  </td>
                                                                              <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;1&nbsp;                                                          </td>
                                                      <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;0&nbsp;                                                          </td>
                                                      <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;1&nbsp;                                                          </td>
                                                                        </tr>
                                                                <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Blood Draw&nbsp;                                                  </td>
                                                                              <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;27&nbsp;                                                          </td>
                                                      <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;7&nbsp;                                                          </td>
                                                      <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;16&nbsp;                                                          </td>
                                                                        </tr>
                                                                <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Consultation&nbsp;                                                  </td>
                                                                              <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;6&nbsp;                                                          </td>
                                                      <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;3&nbsp;                                                          </td>
                                                      <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;3&nbsp;                                                          </td>
                                                                        </tr>
                                                                <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          CT Scan&nbsp;                                                  </td>
                                                                              <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;21&nbsp;                                                          </td>
                                                      <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;3&nbsp;                                                          </td>
                                                      <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;6&nbsp;                                                          </td>
                                                                        </tr>
                                                                <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Diagnostic Laparoscopy&nbsp;                                                  </td>
                                                                              <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;0&nbsp;                                                          </td>
                                                      <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;1&nbsp;                                                          </td>
                                                      <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;0&nbsp;                                                          </td>
                                                                        </tr>
                                                                <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Electrocardiogram&nbsp;                                                  </td>
                                                                              <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;3&nbsp;                                                          </td>
                                                      <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;1&nbsp;                                                          </td>
                                                      <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;3&nbsp;                                                          </td>
                                                                        </tr>
                                                                <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Endometrial Ablation&nbsp;                                                  </td>
                                                                              <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;0&nbsp;                                                          </td>
                                                      <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;0&nbsp;                                                          </td>
                                                      <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;0&nbsp;                                                          </td>
                                                                        </tr>
                                                                <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Histological Exam&nbsp;                                                  </td>
                                                                              <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;0&nbsp;                                                          </td>
                                                      <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;0&nbsp;                                                          </td>
                                                      <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;0&nbsp;                                                          </td>
                                                                        </tr>
                                                                <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Intrauterine Insemination&nbsp;                                                  </td>
                                                                              <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;0&nbsp;                                                          </td>
                                                      <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;0&nbsp;                                                          </td>
                                                      <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;0&nbsp;                                                          </td>
                                                                        </tr>
                                                                <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          In Vitro Fertilization&nbsp;                                                  </td>
                                                                              <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;0&nbsp;                                                          </td>
                                                      <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;0&nbsp;                                                          </td>
                                                      <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;0&nbsp;                                                          </td>
                                                                        </tr>
                                                                <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Laparoscopic Hysterectomy&nbsp;                                                  </td>
                                                                              <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;0&nbsp;                                                          </td>
                                                      <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;0&nbsp;                                                          </td>
                                                      <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;0&nbsp;                                                          </td>
                                                                        </tr>
                                                                <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Laparotomy&nbsp;                                                  </td>
                                                                              <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;0&nbsp;                                                          </td>
                                                      <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;0&nbsp;                                                          </td>
                                                      <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;0&nbsp;                                                          </td>
                                                                        </tr>
                                                                <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Magnetic Resonance Imaging&nbsp;                                                  </td>
                                                                              <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;0&nbsp;                                                          </td>
                                                      <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;0&nbsp;                                                          </td>
                                                      <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;0&nbsp;                                                          </td>
                                                                        </tr>
                                                                <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Oophorectomy&nbsp;                                                  </td>
                                                                              <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;0&nbsp;                                                          </td>
                                                      <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;0&nbsp;                                                          </td>
                                                      <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;0&nbsp;                                                          </td>
                                                                        </tr>
                                                                <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Pelvic Exam&nbsp;                                                  </td>
                                                                              <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;5&nbsp;                                                          </td>
                                                      <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;1&nbsp;                                                          </td>
                                                      <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;2&nbsp;                                                          </td>
                                                                        </tr>
                                                                <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Physical Examination&nbsp;                                                  </td>
                                                                              <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;32&nbsp;                                                          </td>
                                                      <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;10&nbsp;                                                          </td>
                                                      <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;15&nbsp;                                                          </td>
                                                                        </tr>
                                                                <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Surgery for Adhesions&nbsp;                                                  </td>
                                                                              <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;0&nbsp;                                                          </td>
                                                      <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;0&nbsp;                                                          </td>
                                                      <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;0&nbsp;                                                          </td>
                                                                        </tr>
                                                                <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Therapeutic Laparoscopy&nbsp;                                                  </td>
                                                                              <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;0&nbsp;                                                          </td>
                                                      <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;0&nbsp;                                                          </td>
                                                      <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;1&nbsp;                                                          </td>
                                                                        </tr>
                                                                <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Transfusion&nbsp;                                                  </td>
                                                                              <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;0&nbsp;                                                          </td>
                                                      <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;0&nbsp;                                                          </td>
                                                      <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;0&nbsp;                                                          </td>
                                                                        </tr>
                                                                <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Ultrasound&nbsp;                                                  </td>
                                                                              <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;14&nbsp;                                                          </td>
                                                      <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;3&nbsp;                                                          </td>
                                                      <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;6&nbsp;                                                          </td>
                                                                        </tr>
                                                                <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Urine Test&nbsp;                                                  </td>
                                                                              <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;26&nbsp;                                                          </td>
                                                      <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;8&nbsp;                                                          </td>
                                                      <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;11&nbsp;                                                          </td>
                                                                        </tr>
                                                                <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Vaginal Hysterectomy&nbsp;                                                  </td>
                                                                              <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;0&nbsp;                                                          </td>
                                                      <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;0&nbsp;                                                          </td>
                                                      <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;0&nbsp;                                                          </td>
                                                                        </tr>
                                                                <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          X-Ray&nbsp;                                                  </td>
                                                                              <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;14&nbsp;                                                          </td>
                                                      <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;2&nbsp;                                                          </td>
                                                      <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;5&nbsp;                                                          </td>
                                                                        </tr>
                                                                <tr>
                        <td class="header3 br bold_outcome_color" style="padding-left:2em;">
                          Other (Not Specified)&nbsp;                                                  </td>
                                                                              <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;16&nbsp;                                                          </td>
                                                      <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;10&nbsp;                                                          </td>
                                                      <td class="header3 br pale_outcome_color" style="text-align:center;">
                                                              
&nbsp;10&nbsp;                                                          </td>
                                                                        </tr>
                                                                                          </tbody></table>
            
                            <br>


                              <span class="header3">No statistical 
analysis provided for Number of Participants With Emergency 
Room/Outpatient Procedures During the Treatment Period, by Type</span>
                <br>

                            <br>
              <br>
                              </div>
          </div>
</div>
  
<!-- adverse events section -->
<br>
<div class="indent1">

  <br>
  <img src="A%20Clinical%20Study%20to%20Evaluate%20the%20Safety%20and%20Efficacy%20of%20Elagolix%20in%20Subjects%20With%20Moderate%20to%20Severe%20Endometriosis-Associated%20Pain%20-%20Study%20Results%20-%20ClinicalTrials.gov_files/triangle.gif" alt=""><span class="header2">&nbsp; Serious Adverse Events</span><br>
  <a name="evnt" id="evnt"></a>
  <div class="header3 indent2">

      <div style="margin-top:1.0ex;">
      <a title="Show serious adverse events" href="https://clinicaltrials.gov/ct2/show/results/NCT01620528?sect=X301256#evnt">
        <img style="float:left" src="A%20Clinical%20Study%20to%20Evaluate%20the%20Safety%20and%20Efficacy%20of%20Elagolix%20in%20Subjects%20With%20Moderate%20to%20Severe%20Endometriosis-Associated%20Pain%20-%20Study%20Results%20-%20ClinicalTrials.gov_files/plus.gif" alt="" border="0"> &nbsp; Show Serious Adverse Events
      </a>
    </div>
      </div>

  <br>
  <br>
  <img src="A%20Clinical%20Study%20to%20Evaluate%20the%20Safety%20and%20Efficacy%20of%20Elagolix%20in%20Subjects%20With%20Moderate%20to%20Severe%20Endometriosis-Associated%20Pain%20-%20Study%20Results%20-%20ClinicalTrials.gov_files/triangle.gif" alt=""><span class="header2">&nbsp; Other Adverse Events</span>
  <a name="othr" id="othr"></a>
  <div class="header3 indent2">

      <div style="margin-top:1.0ex;">
      <a title="Show other adverse events" href="https://clinicaltrials.gov/ct2/show/results/NCT01620528?sect=X401256#othr">
        <img style="float:left" src="A%20Clinical%20Study%20to%20Evaluate%20the%20Safety%20and%20Efficacy%20of%20Elagolix%20in%20Subjects%20With%20Moderate%20to%20Severe%20Endometriosis-Associated%20Pain%20-%20Study%20Results%20-%20ClinicalTrials.gov_files/plus.gif" alt="" border="0"> &nbsp; Show Other Adverse Events
      </a>
    </div>
      </div>
</div>
  
<!-- limitations and caveats section -->
<div class="indent1">

  <br>
  <br>
  <img src="A%20Clinical%20Study%20to%20Evaluate%20the%20Safety%20and%20Efficacy%20of%20Elagolix%20in%20Subjects%20With%20Moderate%20to%20Severe%20Endometriosis-Associated%20Pain%20-%20Study%20Results%20-%20ClinicalTrials.gov_files/triangle.gif" alt=""><span class="header2">&nbsp; Limitations and Caveats</span>

  <a name="limit" id="limit"></a>
  <div class="header3 indent2">

        <div style="margin-top:1.0ex;">
      <a title="Hide Limitations and Caveats" href="https://clinicaltrials.gov/ct2/show/results/NCT01620528?sect=X0126#limit">
        <img style="float:left" src="A%20Clinical%20Study%20to%20Evaluate%20the%20Safety%20and%20Efficacy%20of%20Elagolix%20in%20Subjects%20With%20Moderate%20to%20Severe%20Endometriosis-Associated%20Pain%20-%20Study%20Results%20-%20ClinicalTrials.gov_files/minus.gif" alt="" border="0"> &nbsp; Hide Limitations and Caveats
      </a>
    </div>

    <br>
    <table class="data_table" style="margin-top:0.5ex" width="100%" cellspacing="0" cellpadding="5" border="1">
      <tbody><tr>
        <th class="header3 bold_more_info_color" style="text-align:left;">
          Limitations of the study, such as early termination leading to small numbers of participants
          analyzed and technical problems with measurement leading to unreliable or uninterpretable data
        </th>
      </tr>
      <tr>
        <td class="body3 pale_more_info_color" style="vertical-align:top;">
                      No text entered.
                  </td>
      </tr>
    </tbody></table>

    </div>
</div>
  
<!-- more results info section -->
<br>
<div class="indent1">

  <br>
  <img src="A%20Clinical%20Study%20to%20Evaluate%20the%20Safety%20and%20Efficacy%20of%20Elagolix%20in%20Subjects%20With%20Moderate%20to%20Severe%20Endometriosis-Associated%20Pain%20-%20Study%20Results%20-%20ClinicalTrials.gov_files/triangle.gif" alt=""><span class="header2">&nbsp; More Information</span>
  <a name="more" id="more"></a>
  <div class="header3 indent2">

        <div style="margin-top:1.0ex;">
      <a title="Hide more information" href="https://clinicaltrials.gov/ct2/show/results/NCT01620528?sect=X0125#more">
        <img style="float:left" src="A%20Clinical%20Study%20to%20Evaluate%20the%20Safety%20and%20Efficacy%20of%20Elagolix%20in%20Subjects%20With%20Moderate%20to%20Severe%20Endometriosis-Associated%20Pain%20-%20Study%20Results%20-%20ClinicalTrials.gov_files/minus.gif" alt="" border="0"> &nbsp; Hide More Information
      </a>
    </div>

    <br>
    <div class="body3">

          <span class="header3">Certain Agreements: &nbsp; </span>
      <table class="layout_table" style="margin-top:0.5ex; border:1px solid #ccc;" width="100%" cellspacing="0" cellpadding="5">
              <tbody><tr>
          <td class="body3 pale_more_info_color">
                          Principal Investigators are <b>NOT</b> employed by the organization sponsoring the study.
                      </td>
        </tr>
      
              <tr>
          <td class="body3 pale_more_info_color">
                          There <b>IS</b> an agreement between Principal Investigators and the Sponsor (or its agents) that restricts
              the PI's rights to discuss or publish trial results after the trial is completed.
                      </td>
        </tr>
      
              <tr>
          <td class="body3 pale_more_info_color">
          The agreement is:<br>

          <table class="layout_table" cellspacing="0" cellpadding="5" border="0">
            <tbody><tr style="vertical-align:middle;">
              <td class="header1" style="white-space:nowrap;">
                <img src="A%20Clinical%20Study%20to%20Evaluate%20the%20Safety%20and%20Efficacy%20of%20Elagolix%20in%20Subjects%20With%20Moderate%20to%20Severe%20Endometriosis-Associated%20Pain%20-%20Study%20Results%20-%20ClinicalTrials.gov_files/uncheck.gif" alt="unchecked">              </td>
              <td class="body3">
                The only disclosure restriction on the PI is that the 
sponsor can review results communications prior to public release
                and can embargo communications regarding trial results 
for a period that is <b>less than or equal to 60 days</b>.
                The sponsor cannot require changes to the communication and cannot extend the embargo.
              </td>
            </tr>
            <tr style="vertical-align:middle;">
              <td class="header1" style="white-space:nowrap;">
                <img src="A%20Clinical%20Study%20to%20Evaluate%20the%20Safety%20and%20Efficacy%20of%20Elagolix%20in%20Subjects%20With%20Moderate%20to%20Severe%20Endometriosis-Associated%20Pain%20-%20Study%20Results%20-%20ClinicalTrials.gov_files/uncheck.gif" alt="unchecked">              </td>
              <td class="body3">
                The only disclosure restriction on the PI is that the 
sponsor can review results communications prior to public release
                and can embargo communications regarding trial results 
for a period that is <b>more than 60 days but less than
                or equal to 180 days</b>. The sponsor cannot require changes to the communication and cannot extend the embargo.
              </td>
            </tr>
            <tr class="banner_color" style="vertical-align:middle;">
              <td class="header1" nowrap="nowrap">
                <img src="A%20Clinical%20Study%20to%20Evaluate%20the%20Safety%20and%20Efficacy%20of%20Elagolix%20in%20Subjects%20With%20Moderate%20to%20Severe%20Endometriosis-Associated%20Pain%20-%20Study%20Results%20-%20ClinicalTrials.gov_files/check.gif" alt="checked">              </td>
              <td class="body3">
                Other disclosure agreement that restricts the right of 
the PI to discuss or publish trial results after the trial is completed.
                                  <br>
                  <br>
                  <span class="header3">Restriction Description:</span> 
&nbsp;
                                      AbbVie requests that any 
investigator or institution that plans on presenting/publishing results 
disclosure, provide written notification of their request 60 days prior 
to their presentation/publication. AbbVie requests that no 
presentation/publication will be instituted until 12 months after a 
study is completed, or after the first presentation/publication 
whichever occurs first. A delay may be proposed of a 
presentation/publication if AbbVie needs to secure patent or proprietary
 protection.
                                                </td>
            </tr>
          </tbody></table>
          </td>
        </tr>
            </tbody></table>
    
    <br>
          <br>
            <span class="header3">Results Point of Contact: &nbsp; </span>
      <div class="indent2" style="margin-top:1ex">
        Name/Title: Global Medical Services<br>
                  Organization: AbbVie (prior sponsor Abbott)<br>
                          phone: 800-633-9110<br>
                      </div>
      <br>
    
    <br>

        <span class="header3">Publications of Results:</span>
    <div class="indent2">
            <div style="margin-top:2ex">
                <a href="https://clinicaltrials.gov/ct2/bye/rQoPWwoRrXS9-i-wudNgpQDxudhWudNzlXNiZip9Ei7ym67VZR0JLR08FR4nA6h9Ei4L3BUgWwNG0it." title="Taylor HS, Giudice LC, Lessey BA, Abrao MS, Kotarski J, Archer DF, Diamond MP, Surrey E, Johnson NP, Watts NB, Gallagher JC, Simon JA, Carr BR, Dmowski WP, Leyland N, Rowan JP, Duan WR, Ng J, Schwefel B, Thomas JW, Jain RI, Chwalisz K. Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist. N Engl J Med. 2017 Jul 6;377(1):28-40. doi: 10.1056/NEJMoa1700089. Epub 2017 May 19." onclick="openNewWindow('/ct2/bye/rQoPWwoRrXS9-i-wudNgpQDxudhWudNzlXNiZip9Ei7ym67VZR0JLR08FR4nA6h9Ei4L3BUgWwNG0it.'); return false">Taylor
 HS, Giudice LC, Lessey BA, Abrao MS, Kotarski J, Archer DF, Diamond MP,
 Surrey E, Johnson NP, Watts NB, Gallagher JC, Simon JA, Carr BR, 
Dmowski WP, Leyland N, Rowan JP, Duan WR, Ng J, Schwefel B, Thomas JW, 
Jain RI, Chwalisz K. Treatment of Endometriosis-Associated Pain with 
Elagolix, an Oral GnRH Antagonist. N Engl J Med. 2017 Jul 
6;377(1):28-40. doi: 10.1056/NEJMoa1700089. Epub 2017 May 19.</a>
                      </div>
          </div>
    <br>
    
    
    
    <br>
    <table class="layout_table" cellspacing="0" cellpadding="0" border="0">
            <tbody><tr style="vertical-align:top;">
        <td nowrap="nowrap">Responsible Party:</td>
        <td style="padding-left:1em">AbbVie ( AbbVie (prior sponsor, Abbott) )</td>
      </tr>
            <tr style="vertical-align:top;">
        <td nowrap="nowrap">ClinicalTrials.gov Identifier:</td>
        <td style="padding-left:1em">
          <a title="Current version of study NCT01620528 on ClinicalTrials.gov" href="https://clinicaltrials.gov/show/NCT01620528">NCT01620528</a> &nbsp; &nbsp;
          <a href="https://clinicaltrials.gov/ct2/archive/NCT01620528" title="Historical versions of study NCT01620528 on ClinicalTrials.gov Archive Site" onclick="openNewWindow('/ct2/archive/NCT01620528'); return false;">History of Changes</a>
        </td>
      </tr>
                  <tr style="vertical-align:top;">
        <td headers="colTitle" nowrap="nowrap">Other Study ID Numbers:</td>
        <td headers="colData" style="padding-left:1em">
                                    M12-665 <br>
                              </td>
      </tr>
      
            <tr style="vertical-align:top;">
        <td nowrap="nowrap">First Submitted:</td>
        <td style="padding-left:1em">May 15, 2012</td>
      </tr>
                  <tr style="vertical-align:top;">
        <td nowrap="nowrap">First Posted:</td>
        <td style="padding-left:1em">June 15, 2012</td>
      </tr>
                  <tr style="vertical-align:top;">
        <td nowrap="nowrap">Results First Submitted:</td>
        <td style="padding-left:1em">August 9, 2018</td>
      </tr>
                  <tr style="vertical-align:top;">
        <td nowrap="nowrap">Results First Posted:</td>
        <td style="padding-left:1em">September 18, 2018</td>
      </tr>
            <tr style="vertical-align:top;">
        <td nowrap="nowrap">Last Update Posted:</td>
        <td style="padding-left:1em">September 18, 2018
        </td>
      </tr>

    </tbody></table>

    </div>
    </div>
</div>

<br>
<br>
<br>
</div>
<div id="to-top"><a href="#wrapper">To Top</a></div>
</div>


	<div style="clear:both;"></div>
</div> 

<div>       <div id="for-footer">
        <ul class="horz-list">
            <li style="border-left:0;"><a href="https://clinicaltrials.gov/ct2/help/for-patient">For Patients and Families</a></li>
            <li><a href="https://clinicaltrials.gov/ct2/help/for-researcher">For Researchers</a></li>
            <li><a href="https://clinicaltrials.gov/ct2/help/for-manager">For Study Record Managers</a></li>
        </ul>
    </div>

</div>  
<div id="footer-menu">
    <ul class="horz-list" style="padding-bottom:1.5ex;">
		<li><a href="https://clinicaltrials.gov/ct2/home" style="white-space:nowrap">Home</a></li>
		<li><a href="https://clinicaltrials.gov/ct2/resources/rss" style="white-space:nowrap">RSS Feeds</a></li>
		<li><a href="https://clinicaltrials.gov/ct2/sitemap" style="white-space:nowrap">Site Map</a></li>
		<li><a href="https://clinicaltrials.gov/ct2/about-site/terms-conditions" style="white-space:nowrap">Terms and Conditions</a></li>
		<li><a href="https://clinicaltrials.gov/ct2/about-site/disclaimer" style="white-space:nowrap">Disclaimer</a></li>
		<li><a href="https://support.nlm.nih.gov/knowledgebase/category/?id=CAT-01242&amp;category=clinicaltrials.gov&amp;hd_url=https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2Fresults%2FNCT01620528%3Fsect%3DX01256" style="white-space:nowrap" onclick="openNewWindow('https://support.nlm.nih.gov/knowledgebase/category/?id=CAT-01242&amp;category=clinicaltrials.gov&amp;hd_url=https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2Fresults%2FNCT01620528%3Fsect%3DX01256'); return false">Customer Support</a></li>
	</ul>
</div>

</div>  
<div id="fine-print">
	<ul class="horz-list">
		<li><a title="NLM copyright information - opens new window" href="https://www.nlm.nih.gov/copyright.html" onclick="openNewWindow('https://www.nlm.nih.gov/copyright.html'); return false">Copyright</a></li>
		<li><a title="NLM privacy policy - opens new window" href="https://www.nlm.nih.gov/privacy.html" onclick="openNewWindow('https://www.nlm.nih.gov/privacy.html'); return false">Privacy</a></li>
		<li><a href="https://clinicaltrials.gov/ct2/accessibility" title="NLM Accessibility">Accessibility</a></li>
		<li><a title="NLM viewers and players - opens new window" href="https://www.nlm.nih.gov/plugins.html" onclick="openNewWindow('https://www.nlm.nih.gov/plugins.html'); return false">Viewers and Players</a></li>
		<li><a title="NIH Freedom of Information Act office - opens new window" href="https://www.nih.gov/icd/od/foia/index.htm" onclick="openNewWindow('https://www.nih.gov/icd/od/foia/index.htm'); return false">Freedom of Information Act</a></li>
		<li class="last-item"><a title="USA.gov - opens new window" href="https://www.usa.gov/" onclick="openNewWindow('https://www.usa.gov/'); return false">USA.gov</a></li>
	</ul>
    <ul class="horz-list">
       <li><a title="U.S. National Library of Medicine - opens new window" href="https://www.nlm.nih.gov/" onclick="openNewWindow('https://www.nlm.nih.gov/'); return false">U.S. National Library of Medicine</a></li>
       <li><a title="U.S. National Institutes of Health - opens new window" href="https://www.nih.gov/" onclick="openNewWindow('https://www.nih.gov/'); return false">U.S. National Institutes of Health</a></li>
       <li class="last-item"><a title="U.S. Department of Health and Human Services - opens new window" href="https://www.hhs.gov/" onclick="openNewWindow('https://www.hhs.gov/'); return false">
            U.S. Department of Health and Human Services</a></li>
    </ul>
</div>

<script type="text/javascript">__ncbi_sg_gaMode="clinicaltrials"</script>
<script type="text/javascript" src="A%20Clinical%20Study%20to%20Evaluate%20the%20Safety%20and%20Efficacy%20of%20Elagolix%20in%20Subjects%20With%20Moderate%20to%20Severe%20Endometriosis-Associated%20Pain%20-%20Study%20Results%20-%20ClinicalTrials.gov_files/instrumentNCBIBaseJS.js"></script><script async="1" src="A%20Clinical%20Study%20to%20Evaluate%20the%20Safety%20and%20Efficacy%20of%20Elagolix%20in%20Subjects%20With%20Moderate%20to%20Severe%20Endometriosis-Associated%20Pain%20-%20Study%20Results%20-%20ClinicalTrials.gov_files/analytics.js"></script><noscript></noscript>
<script type="text/javascript" src="A%20Clinical%20Study%20to%20Evaluate%20the%20Safety%20and%20Efficacy%20of%20Elagolix%20in%20Subjects%20With%20Moderate%20to%20Severe%20Endometriosis-Associated%20Pain%20-%20Study%20Results%20-%20ClinicalTrials.gov_files/main-glossary.js"></script><noscript></noscript>



<ul class="print-log"><li></li></ul></body></html>